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Summary 
The twin arginine translocase (Tat) pathway is expressed in the inner 
membrane of both Gram-negative and Gram-positive bacteria. The model 
organism for each of these bacteria is Escherichia coli and Bacillus subtilis, 
respectively.  
In B. subtilis the Tat machinery is comprised of only TatA and TatC subunits. 
Namely, TatAdCd and TatAyCy translocases, which act in parallel, yet possess 
different substrate specificities. Little structural information is known about 
these multimeric integral membrane protein complexes owing to the difficulty 
in their purifications, small size and compositional heterogeneity. A primary 
structural investigation was performed on TatAyCy to gauge the true molecular 
weight and heterogeneity of this complex, providing fundamental insight into 
the effect that detergent solubilisation can have on a detergent-solubilised 
protein. Therefore, I circumvented the use of detergent and analysed Tat 
machinery in its native cellular environment. To achieve this, I developed a 
novel combinatorial approach of immunogold labelling with the volumetric 
microscopy technique- array tomography.   
The E. coli Tat system is comprised of three proteins: TatA, TatB and TatC. 
TatA is believed to constitute the protein-conducting element of the translocase 
machinery. However recent structural data has cast doubt on the biological 
significance of the properties of this protein, and consequently its role in the 
translocation process. Therefore, by using array tomography, I endeavoured to 
directly visualise TatA in its native cellular environment to gain insight into the 
localisation and distribution of this protein in E. coli. TatA was shown to cluster 
along the inner membrane in a TatBC-dependent manner. This is the first time 
that any Tat component has been visualised in 3D space, in situ.         
Additionally, the detailed insight into the exploitation of Tat machinery for the 
export of high value, biotechnologically-relevant protein was investigated; with 
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1.1 Protein translocation in bacteria 
All organisms transport proteins into or across biological membranes to reach their 
final cellular location. In bacteria, 20-30% (Holland, 2004; Pugsley, 1993) of 
proteins synthesized in the cytoplasm are destined for extra-cytoplasmic locations. 
To reach such destinations, the protein(s) must traverse the inner membrane (Figure 
1.1.1): a phospholipid bilayer which serves to compartmentalise the cell.  
Bacteria are prokaryotes which can be sub-divided into 2 broad classifications based 
upon a bacterium’s ability to retain a Gram-stain. Gram-positive bacteria, as the 
name suggests, are those that retain the dye, as opposed to those that lack the ability 
which are termed: Gram-negative bacteria. The ability to retain the dye is owed to a 
differing composition of the bacterial cell wall.  
Gram-positive bacteria have a ‘simple’ cell-wall structure of a single cell membrane 
which is enclosed by a thick peptidoglycan layer. Therefore, non-cytoplasmic 
proteins only have to traverse a single bilayer to enter the extracellular space/growth 
medium. However, Gram-negative bacteria have a more complicated cell-wall 
structure. The peptidoglycan layer is much thinner, which is surrounded by an outer 
membrane, thus generating an extra cellular compartment called the periplasm. Some 
proteins reside in this periplasmic space, or they can be inserted into the outer 
membrane. A schematic depicting the differences between these two types of 
bacteria is presented in Figure 1.1.1. 
3 major transport systems exist in Gram-negative bacteria, for the translocation and 
insertion of proteins across or into the inner membrane, namely: Sec translocase, 
YidC insertase and Tat translocase. This thesis focuses on the translocation of 















Figure 1.1.1. The cell walls of Gram-negative and Gram-positive bacteria. 
A schematic representation of the cell walls of Gram-negative (left) and Gram–positive 
(right) bacteria. Both contain and inner membrane and a peptidoglycan layer; however this 
layer is much thicker in Gram-positive bacteria. Gram–negative bacteria have an outer 
membrane thus creating an additional cellular compartment: the periplasm.     
  
1.2 The Sec translocase  
The Sec translocase is a heterotrimeric integral membrane protein complex that 
serves to transport unfolded proteins either into the lipid bilayer of the inner 
membrane, or into the periplasmic space. It is a highly conserved system present in 
all bacteria, archaea and the ER membrane of eukaryotic cells (Pohlschröder et al., 
1997). Only the bacterial Sec system will be discussed in this thesis.  
Proteins are targeted to the Sec pathway by virtue of an N-terminal signal peptide. 
Inner membrane proteins that require lateral transfer into the phospholipid bilayer 
possess an N-terminal signal anchor sequence (SA) which lacks a signal peptidase 
cleave site that would otherwise be present in signal peptides of less hydrophobic, 
secretory proteins that are to traverse the inner membrane.   
The Sec translocon consists of three main components: SecY, SecE and SecG 
(Figure 1.2.1). SecY is a 48 kDa protein which consists of 10 α-helical 
transmembrane helices (TMH) forming a clam-shell arrangement in the inner 
membrane, and constitutes the aqueous channel of the Sec translocase (Berg et al., 
2004). The channel forms an hourglass shape with the central constriction region 
being lined with 6 isoleucine residues (Park & Rapoport, 2012). This hydrophobic 
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ring in the middle of the channel is predicted to form a seal around the passenger 
protein, preventing ion leakage during transport. Additionally, an extension of TMH2 
of SecY blocks the channel forming a “plug” on the periplasmic side of the 
constriction site (Berg et al., 2004; Tsukazaki et al., 2008) and has been proposed, 
through its hydrophobic surface, to guide the substrate through the channel. Cross-
linking data has led to the idea that upon substrate binding this plug is displaced to 
open the channel for translocation (Berg et al., 2004). TMH2 of SecY (along with 
TMH7) forms what is termed the ‘lateral gate’ of the Sec translocon. Contact of the 
preprotein with this region of SecY induces separation of the two halves of this 
protein, allowing the lateral partitioning of TMHs and signal sequences into the lipid 
bilayer (du Plessis et al., 2011).  
SecE is a small integral membrane protein of 14 kDa that clamps the two halves of 
SecY together (Berg et al., 2004). It is essential for Sec transport and cell viability, 
since in its absence, SecY is unstable and is degraded (Kihara et al., 1995).  
SecG is the third, and smallest, component of the Sec translocase being only 12 kDa. 
Whilst it is not essential for translocation in the E. coli system (Nishiyama et al., 
1994), it has been shown to increase the stability of the SecYE complex (Belin et al., 
2015).  
This translocase interacts with different cytosolic proteins depending on the nature of 
the substrate to be transported. For example, if the nascent polypeptide chain 
emerging in the ribosome tunnel (RNC) displays a high degree of hydrophobicity 
(Heijne, 1986) and helicity (Bruch et al., 1989), it is bound by the signal recognition 
particle (SRP).  
1.2.1. The SRP pathway 
The SRP is a ribonucleoprotein complex comprised of a 48 kDa GTPase protein, Ffh, 
and 4.5S RNA. Ffh is a tri-domain protein, whose C-terminal M domain is 
responsible for substrate binding (Batey et al., 2000; Koch et al., 2003; Zheng & 
Gierasch, 1997). This is a methionine-rich region which is predicted to provide a 




Once bound to the RNC, the RNC-SRP complex is targeted to the inner membrane 
(hence co-translational pathway) (Figure 1.2.1.) for interaction with SRP receptor, 
FtsY, which is located in a ribosome-binding site on SecY for efficient delivery of 
the nascent polypeptide chain to the Sec machinery (Kudva et al., 2013; Ng et al., 
1996). SRP binds to FtsY, displacing its receptor from SecY and promotes GTP 
hydrolysis. This hydrolysis drives the dissociation of RNC-SRP complex such that 
the RNC fully docks onto the SecYEG machinery, aligning with the SecY channel 
(Beckmann et al., 2001; de Leeuw et al., 2000; Valent et al., 1998).      
The SA sequence of the RNC then inserts into the SecY channel and moves towards 
lateral gate (Egea & Stroud, 2010). It is predicted this movement is followed by 
displacement of the plug domain in the central constriction site thus opening the Sec 
translocon (Kudva et al., 2013). The protein is then able to exit via the lateral gate 
into the inner membrane (Figure 1.2.1).   
1.2.2. The Sec pathway 
Alternatively, if the nascent polypeptide signal peptide is less hydrophobic, cytosolic 
Trigger Factor (TF) binds to the signal peptide to prevent SRP binding. SecB then 
binds the fully-synthesized protein (hence post-translational pathway), keeping the 
protein in a translocation-competent state, and subsequently targets the unfolded 
protein to SecA at the inner membrane (Figure 1.2.1).  
SecA is the soluble receptor of SecB, and is the motor protein of the Sec translocase. 
Upon release of SecB and consequent transfer of preprotein to SecA, ATP is 
hydrolysed and translocation is initiated (Fekkes et al., 1999). Repeated cycles of 
ATP hydrolysis push the preprotein through the SecY channel approximately 30-40 
amino acids at a time (Schiebel et al., 1991) resulting in a step-wise translocation of 
the substrate across the inner membrane (Tomkiewicz et al., 2006).      
Some membrane proteins insert into the inner membrane independently of Sec 
machinery, and instead use the membrane-localised insertase YidC (Dalbey et al., 
2011; Wang & Dalbey, 2011; Welte et al., 2012). However, this mechanism of 















Figure 1.2.1. Overview of protein transport by the Sec machinery 
Post-translational transport: 1- the nascent polypeptide chain (NPC) is bound by SecB and 2- transported to the Sec translocase where it is transferred to SecA. 
3- the unfolded protein is threaded through the SecY channel, powered by repeated cycles of ATP hydrolysis.  The protein gains entry into the periplasm and 
folds to form a mature protein. Co-translational transport: A- SRP binds to the NPC as it exits the ribosome. B- the SRP-bound ribosome is then targeted to the 
Sec machinery. SRP binds its receptor FtsY, and is displaced from the ribosome complex. The ribosome aligns with the SecY channel and translocation is 
initiated. C- The protein exits the translocase via a lateral gate and gains entry into the inner membrane. The proton motive force (PMF) is also important for 
translocation. Some membrane proteins use YidC as an alternative insertion: (i) the NPC is directly targeted to YidC (ii) the mechanism of YidC insertion is 
largely unknown. YidC also has the capability to cooperate with the Sec translocon during membrane protein insertion.         
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1.3 The Twin arginine translocase pathway 
1.3.1. Introduction to Tat 
In contrast to the aforementioned Sec translocase the twin arginine translocase (tat) 
pathway transports fully-folded proteins. This translocase was discovered in the 
thylakoid membrane of chloroplasts in the early 1990s (Mould & Robinson, 1991), 
and was found to require three essential protein components: (Tha4 (Mori et al., 
1999; Walker et al., 1999), Hcf106 (Settles et al., 1997), and cpTatC (Cline & Mori, 
2001)), and a proton motive force (Klösgen et al., 1992) for the translocation of 
fully-folded proteins (Clark & Theg, 1997; Creighton et al., 1995; Hynds et al., 
1998). The complex was subsequently found to be expressed in some bacteria, 
archaea and mitochondria (Yen et al., 2002). The bacterial homologues are TatA, 
TatB and TatC, respectively (Bogsch et al., 1998; Sargent et al., 1998; Sargent et al., 
1999), and will remain the focus of this introduction. For a recent review of the 
chloroplast Tat pathway see (Albiniak et al., 2012).  
The bacterial Tat pathway is essential for many processes including energy 
metabolism (Bernhardt & De Boer, 2003; Ize et al., 2003),  formation of the cell 
envelope (Bernhardt & De Boer, 2003; Ize et al., 2003), biofilm formation (Ize et al., 
2004), heavy metal resistance (Ize et al., 2004), nitrogen-fixing symbiosis (Meloni et 
al., 2003) and bacterial pathogenesis (Ding & Christie, 2003; Ochsner et al., 2002; 
Pradel et al., 2003). 
This unique system has been studied intensively over the past two-and-a-half 
decades; yet the understanding of the mechanism of translocation remains unsolved. 
This is owed to the innate difficulties in working with large, heterogeneous, 
multimeric integral membrane protein complexes. Recent studies have utilised 
structural and localisation experiments in their endeavours to gain more information 
on this translocase. Undoubtedly these avenues of research, in combination with the 
fast-developing world of both light and electron microscopy will provide invaluable 
tools to help decipher this unique translocase’s mechanism.    
1.3.2. Bacterial Tat genes  
The most intensively studied bacterial Tat pathway is that of the Gram-negative 
bacterium, Escherichia coli (E. coli). This translocase’s proteins are constitutively 
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expressed from the TatABC operon (Santini et al., 1998; Sargent et al., 1998; Weiner 
et al., 1998) (Figure 1.3.1.) and reside in the inner membrane. Another gene tatD is 
expressed downstream, encoding a DNase protein TatD (Wexler et al., 2000). 
Despite this protein originally not being thought to operate within the Tat pathway, 
data has revealed that this protein is implicated in the proof-reading of Tat substrates 
(Matos et al., 2009). Another tat gene, tatE, is also expressed elsewhere in the 
genome. This gene is thought to be a cryptic gene duplication of tatA and not possess 
an important role in Tat translocation; however recent data has shown the TatE 
protein to be capable of substituting for TatA , efficiently translocating the largest 
Tat substrate in E. coli: TorA (90 kDa) (Baglieri et al., 2012). 
The Gram-positive model organism, Bacillus subtilis (B. subtilis), expresses two 
minimal pathways comprised of only TatA and TatC proteins, TatAdCd and 
TatAyCy (Jongbloed et al., 2004). The genes encoding these proteins are organised 
in 2 operons: tatAd, TatCd and phoD (the only known substrate of this complex). 
Similarly, for the second operon: tatAy, tatCy and ywbN, respectively (Figure 1.3.1.). 
A third tatA-type gene, tatAc, is expressed on its own and its role in the translocation 
of fully-folded substrates remains unknown; however a recent study by (Beck et al., 
2013) showed that the TatAc protein can functionally replace TatA and TatE 
































Figure 1.3.1. Organisation of bacterial tat genes from E. coli and B. subtilis 
A) The tatABC genes are constitutively expressed from a single operon in E. coli and express 
the essential TatABC proteins of the Tat translocase. The tatD gene is also expressed in this 
operon. The tatE gene is a paralog of tatA and is expressed elsewhere in the genome. B) The 
two minimal Tat systems of B. subtilis are expressed in separate operons alongside their 
respective substrates. The first is: tatAd and tatCd genes alongside substrate phoD. Secondly, 
tatAy and tatCy genes are expressed with substrate YwbN elsewhere in the genome. There a 
third tatA gene, tatAc, which is not expressed with any of the other tat genes.  
 
1.3.3. Tat subunits  
The E. coli TatA subunit is the most abundant component of the Tat machinery, 
expressed in 20-fold excess of TatB and TatC (Sargent et al., 2001). This 9.6 kDa 
protein of 89 amino acids is a single transmembrane-spanning protein with an N-out 
topology (Porcelli et al., 2002). Further biophysical analysis by (Lange et al., 2007) 
used a multi-construct approach to confirm the conformation and alignment of TatA 
from B. subtilis in the inner membrane. CD spectroscopy showed TatA to possess a 
short -terminal alpha-helix connected to a central transmembrane helix (TMH), 
which is linked via an amphipathic helix (APH) to an unstructured C-terminus (Lee 
et al., 2002; Sargent et al., 1998; Settles et al., 1997) (Figure 1.3.2.). 
Protease accessibility experiments probed the topology of the TatA protein in the 
inner membrane and found that the non-essential TatC region exhibited a dual 
topology (Chan et al., 2007; Gouffi et al., 2004).           
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NMR experiments on the TatA protein from B. subtilis confirmed the L-shaped 
arrangement of this protein in the inner membrane (Müller et al., 2007). Further 
analysis also revealed that the TMH (14-16 residues in length) tilts 17
o
 with respect 
to the membrane normal, which bears implications for predicted mechanisms of Tat 
translocation (discussed in section 1.5). Such arrangement was supported by 
(Walther et al., 2010) who then went on to reveal that the APH exhibits a slanted 
alignment relative to the membrane normal. This is contrary to the membrane-
parallel orientation predicted by (Lange et al., 2007), and alludes to the idea that the 
APH does not simply serve as a flexible linker between the TMH and C-terminal 
region, and instead adopts a conformation key to the translocase assembly. 
The 7 kDa TatE protein shares over 50% sequence similarity with TatA (Sargent et 
al., 1998), and thought to arise from a cryptic gene duplication of tatA gene (Yen et 
al., 2002). Despite this similarity, TatE is much shorter than TatA, possessing only 
67 amino acids (Sargent et al., 1998). Given its low abundance, it was anticipated 
that TatE is largely redundant regarding Tat translocation (Jack et al., 2001); 
however data has shown that this protein is capable of functionally substituting for 
TatA protein (Baglieri et al., 2012); and for some substrates, the absence of TatE 
significantly hinders translocation into the periplasm (Sargent et al., 1998), 
proposing a specific role for the TatE protein. 
TatB protein of E. coli shares a 20% sequence similarity to TatA (Hicks et al., 2003), 
and is predicted to adopt a similar secondary structure and membrane topology to 
TatA in the inner membrane (Bolhuis et al., 2001)(Figure 1.3.2.). However, the two 
proteins exhibit functionally distinct roles within the inner membrane: TatA is 
predicted to form the pore-forming element of the translocase (Gohlke et al., 2005), 
whereas TatB forms part of the substrate binding site (Tarry et al., 2009) and is thus 
an essential component for translocation of native E. coli substrates (Blaudeck et al., 
2005; Ize et al., 2002) (discussed in section 1.4). At 171 amino acids in length (18.4 
kDa), this protein is a lot longer than TatA, possessing a long, unstructured C-
terminus (Lee et al., 2002); however the hinge region and APH are essential for 
function with single amino acid substitutions causing significant effects on 
translocation (Barrett et al., 2003; Hicks et al., 2003; Lee et al., 2006). Interestingly, 
Tat has been shown to tolerate the translocation of non-native fusion proteins in the 
absence of TatB (Blaudeck et al., 2005; Ize et al., 2002); implying that lack of TatB 
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activity could be compensated for by TatA. This would mirror the situation in the 
Gram-positive bacterium B. subtilis that contains only TatAC-type 
translocases(Barnett et al., 2008). In fact- N-terminal, single amino acid mutations 
have been shown to induce bifunctionality in E. coli TatA (Barrett et al., 2007; 
Blaudeck et al., 2005).    
Finally, TatC is the largest and most conserved subunit of the Tat translocase, 
forming part of the substrate-binding complex (Tarry et al., 2009) (discussed in 
section 1.4.1). Primary sequence analysis of this 32 kDa protein has predicted that 
the 258 amino acids possess a secondary structure of 6 TMH in the inner membrane, 
with an N-in C-in topology (Behrendt et al., 2004) (Figure 1.3.2.). Site-directed 
mutagenesis studies have revealed that residues essential to the functionality of this 
protein (and thus the Tat translocase), are localised to the cytoplasmic N-region and 
the first cytoplasmic loop of the TatC protein (Allen et al., 2002; Barrett et al., 2005; 
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Figure 1.3.2. Organisation of TatA, TatB and TatC proteins in the inner membrane 
Three integral membrane proteins, encoded by the tatABC operon, are the essential 
components of the twin arginine translocase in Gram-negative bacteria. TatA and TatB 
possess similar topologies: they have a short periplasmic N-terminal region connected to a 
single pass transmembrane helix (TMH), which is linked via a hinge region to an 
amphipathic helix (APH) and a highly charged, unstructured C-terminus on the cytoplasmic 
side of the inner membrane. Recent evidence (Walther et al., 2010) suggests that the APH is 
tilted relative to the membrane normal. TatC is predicted to contain 6 TMH, with both the N- 
and C-terminus residing at the cytoplasmic side of the inner membrane. E. coli expresses a 
TatA paralog, TatE which is expressed elsewhere in the genome. The Gram-positive 
bacterium, B. subtilis possesses both TatA (TatAy and TatAd) and TatC (TatCy and TatCd) 
proteins with identical topologies in the inner membrane. They lack a TatB protein.    
 
1.3.4. Signal peptides 
Substrates are targeted to the Tat translocase by virtue of an N-terminal signal 
peptide. Tat signal peptides possess a tripartite structure of a: basic N-terminal 
region, central hydrophobic region and a polar C-terminal region (Figure 1.3.3.). It is 
within this latter region that a signal peptidase cleavage site is located for cleavage of 
the precursor protein in the periplasm to produce a mature protein (Lüke et al., 2009; 
Yahr & Wickner, 2001). Sec and Tat signal peptides actually possess the same basic 
structure; however there are important differences that target a particular substrate to 
its specific translocation machinery.  
The Tat translocase derives its name from the presence of a highly conserved twin 
arginine motif, SRRxFLK (where x is any polar amino acid), located immediately 
before the hydrophobic region of the signal peptide (Figure 1.3.3.) (Berks, 1996; 
Cristóbal et al., 1999). 
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The RR residues are completely invariant and are essential for transport. Substitution 
of one of the arginine residues to lysine slowed transport, whereas substitution of 
both residues abolished Tat activity (Buchanan et al., 2001; DeLisa et al., 2002; Ize 
et al., 2002; Mendel et al., 2008; Stanley et al., 2000). Therefore, at least one 
arginine in the consensus motif is a prerequisite of Tat transport. These results are in 
contrast to mutations affecting the overall charge of the N-terminal consensus region 
of Sec signal peptides, which did not affect transport efficiency at all (Sasaki et al., 
1990); supporting the idea that these twin-arginine residues play important roles in 
specific interactions of substrate signal peptide with Tat machinery. Although, these 
residues are not the only factor that play an important role in directing Tat substrates 
specifically to Tat machinery. The hydrophobic domains of Tat signal peptides are 
less hydrophobic than Sec signal peptides (Cristóbal et al., 1999). In fact- a Tat 
substrate can be redirected to Sec machinery by increasing the hydrophobicity of its 
signal peptide (Cristóbal et al., 1999); demonstrating the importance of this factor to 
targeting to Tat machinery. Additionally, the C-terminal region contains basic 
residues that are rarely found in Sec signal peptides, and are predicted to prevent 
interactions with the Sec machinery (Blaudeck et al., 2003; Bogsch et al., 1997; 
Cristóbal et al., 1999).    
Aside of RR, the other residues within the consensus motif are important for 
directing the substrate to the Tat machinery. The phenylalanine residue (+3 Figure 
1.3.3.) is the most highly conserved residue in the consensus motif, present in 80% of 
Tat signal peptides (Stanley et al., 2000). Results of single amino acid substitutions 
have shown that it is the hydrophobicity of this region, as opposed to the side chain 
functionality, that is important for efficient export (Stanley et al., 2000). The 
remainder consensus motif residues occur at an average frequency of >50% (Berks, 
1996).  
Substitutions of serine, leucine and lysine amino acids (-1, +4 and +5 positions, 
respectively (Figure 1.3.3.), have varying effects on transport efficiency. 
Substitutions of serine to cysteine substantially slowed Tat export; suggesting that 
low hydrophobicity of this region of the signal peptide, is important for efficient 
export. In contrast, the high hydrophobicity of leucine at position +4 is important for 
efficient export (Stanley et al., 2000). The importance of these residues varies 
14 
 
between substrates; particularly lysine, where the presence of this particular residue 
abolishes export in one substrate yet is important in another (Stanley et al., 2000). 
Interestingly, the expression of an N-terminal signal peptide is not an absolute 
prerequisite for Tat transport; some proteins are able to traverse the inner membrane 
via “hitchhiking” i.e. they form complexes with other proteins which express a Tat 
signal peptide (Jack et al., 2004; Rodrigue et al., 1999; Sargent et al., 1998).   
 
    
 
 
Figure 1.3.3. Tat signal peptide 
Schematic to depict the tripartite structure of a Tat signal peptide. A positively-charged N-
terminal region (n-region), a hydrophobic core (h-region) and a polar c-region which 
contains an A-x-A motif which encodes a peptidase cleavage site for removal of the signal 
peptide in the periplasm (indicated). The consensus motif is located at the junction of the n- 
and –h region (indicated). Signal peptide sequences of typical Tat substrates are shown as an 
example (SufI and TorA). Residues that match the consensus motif are in red font (twin 
arginine underlined), and C-terminal signal peptidase recognition sites are underlined in 
black.      
 
1.3.5. Tat substrates 
The extent to which Tat is utilised for transport of fully-folded proteins varies in 
different organisms. Gram-positive bacteria generally contain very few substrates; 
for example, B. subtilis expresses two minimal translocases that each only transports 
one substrate (Widdick et al., 2006).However, Streptomyces is an exception in this 
type of bacteria, since it can transport over 100 secretory proteins into the periplasm 
(Joshi et al., 2010; Widdick et al., 2006). Enteric bacteria are different still, 
expressing in the range of Tat 20-30 substrates (Palmer et al., 2010).  
Despite the significant variation in substrate numbers, the reasons why different 
substrates require transport via the Tat machinery is largely unknown; however a few 
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motives have been proposed. Firstly, substrates may non-covalently bind cofactors, 
more specifically metal-sulphur clusters or nucleotide-based cofactors (Berks et al., 
2003), in the cytoplasm prior to export. This offers the advantage that the co-factor 
and substrate do not need to be separately transported into the periplasm (Berks, 
1996). 
Some substrates that lack cofactors may still require Tat translocation due to rapid 
folding kinetics and therefore must be transported fully-folded. An example is E. coli 
proteins AmiA and AmiC that are required for normal cell wall biosynthesis. E. coli 
mutants that lack Tat machinery and therefore unable to correctly localise AmiA and 
AmiC resulted in cells growing in a filamentous morphology since normal cell 
division is prevented (Bernhardt & De Boer, 2003; Ize et al., 2003).  
Interestingly, halophilic archaea secrete a large proportion of their secretome via the 
Tat pathway. It is predicted that use of Tat machinery, and thus full folding of 
substrates in the cytoplasm, avoids the complications of protein aggregation and 
misfolding that arises as a result of high extracellular salt conditions (Pohlschröder et 
al., 2004), or that high internal salt conditions promote cytoplasmic folding of 
nascent polypeptides (Bolhuis, 2002; R. Wesley Rose, 2002).  
Furthermore, cytoplasmic folding would avoid interaction with periplasmic metal 
ions that could otherwise compete for binding site(s) in the protein. For example, the 
bacterial SoxYZ protein Paracoccus pantotrophus that contains an iron-sulphur 





(Sauvé et al., 2007).   
Finally, Tat has been shown to transport heterooligomeric complexes. More 
specifically, some Tat substrates actually lack a Tat signal peptide, yet are able to 
traverse the inner membrane by binding to a partner protein which bears an N-
terminal Tat signal peptide, a mechanism termed “hitch hiking”. These proteins must 
be fully-folded to successfully hitchhike as oligomeric proteins.  
The vast majority of Tat substrates are secretory proteins however some remain 
anchored in the inner membrane via N- or C-terminal transmembrane domains 
(Bachmann et al., 2006; De Buck et al., 2007; Hatzixanthis et al., 2003; Jormakka et 
al., 2002). Recent evidence that used a signal peptide mutant of a native E. coli Tat 
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substrate, YedY, confirmed that Tat is capable of lateral membrane insertion of some 
substrates (Ren et al., 2013).   
1.4. The Tat complex 
In a steady-state situation, the three essential components of the E. coli Tat 
machinery arrange themselves in the inner membrane as a TatBC complex (at 1:1 
stoichiometric ratio) (Bolhuis et al., 2001) and a heterogeneous pool of TatA that is 
expressed at a 20-fold excess over TatBC (Sargent et al., 2001). Briefly, binding of a 
signal peptide-bearing substrate to the Tat machinery, in the presence of a proton 
motive force, triggers the translocation of substrate (Cline & McCaffery, 2007; Cline 
& Mori, 2001) through the large 370-700 kDa heterooligomeric TatABC complex 
(Bolhuis et al., 2001; Oates et al., 2005; Oates et al., 2003) (discussed in more detail 
in section 1.5).  
Early 2D structural analysis of TatABC complexes from E. coli, Agrobacterium 
tumefaciens and Salmonella typhimurium revealed structural conservation of this 
machinery, with the TatABC particles possessing dimensions of approximately 9 – 
13 x 10 nm (Oates et al., 2003). These negatively-stained particles had a central pool 
of stain surrounded by 5-7 stain-excluding densities, each 4 nm wide. A flexible 
modular assembly of this machinery was alluded to since there was a correlation 
between particle size and the number of 4 nm densities in the structure. Since the 
stain excluding region was too small to accommodate a fully-folded protein it is 
sensible to assume that more TatA subunits or TatABC would be needed to create a 
full-sized channel (Oates et al., 2003).      
1.4.1. The TatBC complex 
It is broadly accepted that the TatBC complex serves as the substrate binding site of 
this translocase. Cross-linking data revealed TatC to be the primary interaction site 
between Tat machinery and substrate (Alami et al., 2003; Gerard & Cline, 2006; 
Kreutzenbeck et al., 2007; Maurer et al., 2010; Richter & Brüser, 2005). 
Specifically, it is the N-terminal region of the TatC protein and the first cytoplasmic 
loop that are important in making contact to the signal peptide of the substrate 
(Zoufaly et al., 2012).  
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The exact role of TatB in the substrate binding complex has remained uncertain. This 
is plagued partly by a lack of high resolution structural information. However, recent 
structural NMR data revealed the extended C-terminal region of TatB to exhibit 
significant flexibility relative to the TMH and APH. This flexible region contains 
amino acid residues that have been shown to be in close proximity to the substrate 
during translocation, and they therefore occupy a large conformational space. This 
significant structural plasticity of TatB potentially facilitates the substrate-binding 
complex to adapt for substrates of differing sizes and shapes (Zhang et al., 2014).  
Furthermore, recent cross-linking data has unveiled new insight into the potential 
role of this protein. Data showed that in the absence of TatB, the signal peptide of a 
translocation-incompetent substrate was removed; suggesting that this protein could 
be implicated in preventing the premature cleavage of signal peptides (Frobel et al., 
2012). Also, (Maurer et al., 2010) showed precursors to become surrounded by TatB 
and make contact to its TMH and APH, which were then lost upon translocation; 
suggesting that the interaction between TatB and substrate occurs at an early stage in 
substrate-binding.        
Recent crystal structure data of TatC revealed this protein to possess a “glove-like” 
structure, owed to the TMH5 and TMH6 of this protein being much shorter in length 
than the other TMHs (Ramasamy et al., 2013; Rollauer et al., 2012) (Figure 1.4.1). A 
potential role for this concave region of TatC was further elucidated in light of cross-
linking data showing that the TMH5 and TMH of TatB interact (Rollauer et al., 
2012). Also, this region is rich in aromatic residues which would have the potential 
to bind the lysine residue of the signal peptide consensus motif (SRRxFLK) 
(Ramasamy et al., 2013).   
It remains uncertain about the mechanism of insertion of the signal peptide; however 
there are now numerous studies in favour of a hairpin-like insertion of the signal 
peptide. Firstly, the N-terminus of TatB was found to cross-link to Tat substrates 
prior to translocation (Maurer et al., 2010). Also, mutations in this same region of 
TatB were found to suppress defective translocation of translocation-incompetent 
substrates (Kreutzenbeck et al., 2007; Lausberg et al., 2012). These data demonstrate 
the interaction of the precursor to the trans-side of the inner membrane, which would 
only be possible by a deep insertion of the signal peptide in the inner membrane prior 
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to translocation. The trans-region of TatB has also been demonstrated to strongly 
crosslink to precursors directly (Gerard & Cline, 2006); presenting evidence for deep 





















Figure 1.4.1 Crystal structure of TatC from Aquifex aeolicus  
A – cartoon representation of A. aeolicus  TatC structure coloured in dark blue from the N-
terminus to red at the C-terminus. The position of the bilayer is indicated in grey. A molecule 
of Lauryl Maltose Neopentyl Glycol (LMNG) detergent is shown in purple. The crystal 
structure revealed that transmembrane helices (TMH) 5 and 6 are shorter than the other TMH 
in the TatC protein, which generates a concave region in the TatC structure.  
B – Surface representation of the A. aeolicus TatC structure highlighting the concave 
structure within TatC. Cross-linking data elude to a TatB-accommodating role for this 










45 - 55Å 
110 - 170Å 
Low resolution EM structures of the TatBC complex revealed a hemispherical 
morphology of 11-17 nm in diameter (Tarry et al., 2009) (Figure 1.4.2). The 
presence of an internal cavity was identified, which was too small to accommodate a 
fully-folded substrate, and thus a potential role for signal peptide insertion was 
predicted. Analysis of this reconstruction demonstrated that the dimensions were 
consistent with the presence of 7 copies of TatBC, and thus contain 7 potential signal 
peptide binding site. However, when TatBC was expressed in the presence of Tat 
substrate, interestingly, there were only two copies of a Tat substrate bound at a 
single time. Not only does this support evidence that the preliminary binding site is 
superficially exposed (since the individual substrates protruded out from the TatBC 
complex), and that more than one substrate can bind the substrate-binding complex at 
one time (Ma & Cline, 2010), it presents evidence in favour of a negative 






Figure 1.4.2. Low resolution 3D model of TatBC complexes generated by single particle 
reconstruction 
The low resolution structure shown shows hemispherical TatBC-his complexes that are 11-
17 nm in diameter. The structure possesses a central cavity, which is too small to house Tat 
substrates. The height of the complexes are between 45 and 55Å, which is consistent with 
the thickness of the phospholipid bilayer of the inner membrane (added in grey). This figure 
has been adapted from Tarry et al. (2009).  
 
Until recently highly detailed information in the architecture of the TatBC complex 
was lacking. However, recent photo crosslinking data has shown TatBC oligomers to 
form enclosed chambers consisting of a core of TatB surrounded by outer rings of 
TatC monomers (Blümmel et al., 2015). More specifically, the TMH of each TatB 
protein bridges TMH5 of one TatC and the TMH2 and -4 of an adjacent TatC 
(illustrated in Figure 1.4.3.). These data, in combination with data of Cline et al 
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(Cline, 2015) who showed the movement of the thylakoidal TatA proceeded from 
TatB peripheral position near TMH5 to concave face of TatC (TMH2 and TMH4), is 
consistent with the idea that TatA inserts between TatC monomers consequently 
increasing the diameters of the dome-shaped TatBC complex, thus increasing space 
for internal oligomerisation of TatA and potentially a pore through which the 
substrate can pass (Figure 1.4.3.) (Cline, 2015).      
 
 
Figure 1.4.3. Arrangement of TatBC protein complex in the inner membrane 
Schematic depicting the arrangement of TatABC proteins in the inner membrane before 
(left) and after (right) substrate binding. TatC (green), transmembrane helices (TMH) are 
labelled 1-6. TatA = blue cylinder. TatB = orange cylinder. Upon binding of substrate (green 
circle), the arrangement of the TatABC proteins in the inner membrane changes. The 
arrangement shown is based on the results of numerous cross-linking data of signal peptide 
(labelled RR) to TatB and TatC (Alami et al., 2003; Aldridge et al., 2014; Blümmel et al., 
2015; Gerard & Cline, 2006; Ma & Cline, 2013; Zoufaly et al., 2012). Briefly, TatA moves 
from a peripheral position (near TMH5 of one TatC and the TMH2 and TMH4 of an 
adjacent TatC), to the concave face of TatC, inserting between TatC monomers. This 
increases the internal space of the TatBC complex (where the TatA pore is thought to 
subsequently assemble), creating a channel through which the substrate can pass.  
 
1.4.2. The TatA complex 
The TatA component of the Tat complex in E. coli exhibits significant heterogeneity 
of 100 – 500 kDa, identified Blue Native-polyacrylamide gel electrophoresis (BN-
PAGE). These complexes resolved at 34 kDa intervals, supporting the idea of a 
modular formation of 3 to 4 units of TatA at a time.  
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Class 1 Class 4 Class 8 Class 10 
85-90Å 90-95Å 100-110Å 125-130Å 





Low resolution structures of TatA revealed this protein to form channel-containing 
complexes of varying diameters (Gohlke et al., 2005) (shown in Figure 1.4.4.). The 
complexes ranged from 8.5 – 13 nm in diameter, which accommodates for the 
significant heterogeneity witnessed for TatA by gel electrophoresis. The channels 
ranged from 3 – 7 nm in diameter, which would accommodate even the largest Tat 
substrates. A lid-type feature was also identified on the cytoplasmic side of the inner 
membrane which has been predicted to prevent ion leakage during transport. This 
information forms the biggest support of the most accepted, yet unproven, 
mechanism of Tat translocation: the pore forming model (discussed in section 1.5) 









Figure 1.4.4. Low resolution 3D models of TatA complexes generated by single particle 
reconstruction 
The low resolution 3D models show TatA complexes to possess (detergent-inclusive) 
diameters of 85 – 130Å. The structures possess a channel that is occluded on the cytoplasmic 
face of the inner membrane. The pores are 30 – 70Å in diameter, meaning that even the 
largest Tat substrates can traverse the inner membrane fully-folded. The cytoplasmic-lid is 
proposed to gate entry of the substrate to the translocase. The height of the complexes are 
between 45 and 55Å, which is consistent with the thickness of the phospholipid bilayer of 
the inner membrane (shown in blue). Scale bar = 100Å. This figure has been adapted from 









However such conclusions have been questioned in light of structural data from the 
TatA paralog, TatE. Export assays have shown TatE to functionally substitute for 
TatA in E. coli, supporting efficient translocation of native Tat substrates (Baglieri et 
al., 2012). Low resolution EM structures revealed this protein to form complexes that 
were much smaller and more homogeneous than seen for TatA, which precludes the 
capability of TatE to possess a pore-forming role (shown in Figure 1.4.5). Therefore 
these data question the functional relevance of the TatA heterogeneity, and goes 












Figure 1.4.5. Low resolution 3D model of TatE complexes generated by single particle 
reconstruction 
The low resolution structure shows TatE complexes that are 60-80Å in diameter. The 
structure possesses a central cavity, 25Å in diameter, which is too small to house Tat 
substrates and is occluded at one end. This diameter of this central cavity is smaller than the 
lowest class size of TatA complexes (30Å). The height of the complex is 50Å, which is 
consistent with the thickness of the phospholipid bilayer of the inner membrane. This figure 





Whilst EM structures showed TatA to possess a pore-like feature, we remain 
unaware of what specific structural features of TatA contribute to the pore or the 
cytoplasmic-exposed lid of this complex. Biophysical analyses showed that upon 
oligomerisation of the TatA protein, the highly conserved polar residue at position 8 
of the TMH remains in the middle of the pore and water accessible (Hicks et al., 
2003). Consequently, the pore of the TatA complex would consist of TMHs that are 
only hydrophobic for half the length of a typical membrane. This thinned and 
distorted bilayer within the TatA pore would provide a translocation pathway 
through the Tat machinery (Chan et al., 2011).      
Aside of constituting the pore-forming component of this translocase, TatA has been 
shown to be an early interacting partner with the substrate. These cross-links were 
not obtained in the absence of TatBC, and were sensitive to the PMF; suggesting a 
functional hierarchy of precursor binding exists i.e. TatBC makes contact to substrate 
which then triggers the interaction of TatA (Fröbel et al., 2011). This would be 
consistent with the transient coalescence model of Tat translocation (discussion in 
section 1.5).      
1.5. The Tat mechanism 
As previously mentioned, it is well established that the first interactions between 
substrate and Tat machinery is the substrate precursor binding to the TatBC complex. 
This is subsequently thought to trigger the recruitment of TatA (Cline & Mori, 2001) 
to form the active TatABC translocase though which the substrate can pass. It is at 
this point where our uncertainty in the Tat translocation event arises, owed to our 
inability to “capture” the translocase in any sense i.e. analyse the full translocon 





























Figure 1.5.1.Generalised model for the pore-forming mechanism of the Tat translocase.  
Tat-dependent substrates often require post-translational insertion of a co-factor in the 
cytoplasm (step 1) – to form a fully folded Tat substrate with its exposed twin-arginine-
containing signal peptide (black helix) that will be recognised by the homooligomeric 
TatBC-containing substrate-binding complex (in Gram-negative bacteria step 2). The 
presence of a bound substrate and a proton motive force is thought to trigger the transient 
coalescence of TatA subunits to form the active translocon in the cytoplasmic membrane 
(step 3). The substrate is then exported into the periplasm where it is processed to its mature 
form (step 4).     
 
Whilst we do not yet fully understand the mechanism of Tat translocation, it is clear 
that TatA forms an integral part of the translocation machinery and thus any model 
of Tat translocation varies in their predictions of how TatA is able to permit passage 
of substrate through the Tat machinery. There are two main models for Tat 
translocation: the trap door model and the membrane destabilisation model.  
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1.5.1. Trap-door model 
Low resolution structural data of TatA showed this protein complex to possess 
channels of varying diameters and a cytoplasmic lid (Gohlke et al., 2005), which 
formulated the hypothesis of a trapdoor mechanism of translocation. The authors 
predicted that the walls of the channel were formed by the TMH of TatA and the 
cytoplasmic-exposed APH formed the cytoplasmic lid, which would gate access to 
the translocase and maintain an ionic seal around the substrate (White et al., 2010).       
The ability of TatA to flip its APH into the membrane bilayer from its resting 
position at the cytoplasmic face of the membrane (Gouffi et al., 2004) further 
supports the idea of a trap-door model since this movement would result in a 
hydrophilic coating of the TatA channel enabling passage of substrate through the 
membrane bilayer (Figure 1.5.2.).  
1.5.2. Membrane-destabilisation model 
 
In light of recent structural data of the smaller and more homogeneous E. coli TatA 
paralog, TatE, which showed that this protein forms complexes that are too small to 
constitute a protein-conducting element of a translocase, the functional relevance of 
the TatA heterogeneity was questioned (Baglieri et al., 2012). Additionally, the EM 
structure of a TatA protein from B. subtilis which is smaller and more homogeneous 
than E. coli TatA lacked a channel-like feature. Given the TatAdCd translocase, 
when heterologously expressed in E. coli, is capable of translocating even the largest 
Tat substrate (TorA 94 kDa); the fore-forming property of TatA is questioned.  
 
These data support an alternative mechanism of Tat translocation: the membrane-
weakening hypothesis. Initially proposed by Brüser and Sanders (Brüser & Sanders, 
2003), this model predicts that TatA aggregates in an unordered manner at the 
membrane to form a translocase large enough that would result in the destabilisation 
of the membrane enabling passage of substrate to the periplasmic side of the 
membrane.  
 
Furthermore, the structure of TatAd was further resolved by NMR, again showing 
that the APH was able to partially incorporate into the membrane bilayer (Walther et 
al., 2010); however, in contrast to previous data for TatA, these data suggested that 
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the topology of TatAd is not as flexible as originally anticipated (Gouffi et al., 2004; 
Porcelli et al., 2002; Walther et al., 2010). This implies that the movement of the 
TatA APH into the membrane bilayer would be consistent with a ‘lipid disrupting 
property’ of this protein; and thus support the membrane destabilisation theory of Tat 






























B) Membrane-weakening model 
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Figure 1.5.2. Mechanism of Tat translocation  
Figure adapted from . A substrate bearing an N-terminal signal peptide is targeted to the 
inner membrane and makes contact to Tat machinery. The figure depicts two hypothesised 
mechanisms of translocation across the inner membrane, both of which focus on the TatA 
protein. A) The amphipathic helix (APH) of TatA has a dual topology. In a steady-state 
situation where there is no substrate to traverse the membrane, the APH lies parallel to the 
membrane. However, when a substrate binds to TatBC the APH of TatA flips into the 
membrane to form a hydrophilic pore through which the substrate can pass. B) The dual 
topology of TatA’s APH is a lot less flexible than predicted in the previous model. The APH 
alters orientation to slightly perturb the membrane bilayer, resulting in lipid destabilisation 
and thus membrane weakening. The substrate can then be transported through this disrupted 
lipid patch to gain entry to the periplasm.      
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1.6. Gram-positive Tat systems 
Most of our understanding on the Tat translocase is derived from investigations 
focusing on the Gram-negative system of E. coli, TatABC, which has proven to be a 
good model owed to the conserved features of this system across Gram-negative 
bacteria (Oates et al., 2003). However, recent investigations into the Gram-positive 
organism B. subtilis have yielded significant insight into the potential differences 
between Gram-positive and Gram-negative bacteria.  
All Gram-positive bacteria (expect actinomycetes (Schaerlaekens et al., 2001)), 
contain only tatAC genes (Jongbloed et al., 2004; Pop et al., 2002); indicating a 
fundamental difference compared to Gram-negative Tat systems. B. subtilis contains 
two TatAC-type translocases (TatAdCd and TatAyCy) that operate in parallel yet 
possess different substrate specificities (Jongbloed et al., 2004). TatAdCd is 
expressed under phosphate-limiting conditions (Pop et al., 2002) and is present in the 
inner membrane as a 230 kDa TatAdCd complex, and a separate TatAd complex of 
~270 kDa (Barnett et al., 2008). The situation is mirrored with the constitutively 
expressed TatAyCy (200 kDa), where a separate TatAy complex (200 kDa) is also 
expressed in the membrane (Barnett et al., 2009). The organisation of the tatAC 
genes encoding these proteins is shown in figure 1.3.1 of section 1.3. TatAd and 
TatAy proteins have an almost identical topology to E. coli TatA in the inner 
membrane; although their APH regions are shorter (Hu et al., 2010; Lange et al., 
2007; Müller et al., 2007). Recent NMR studies confirmed this predicted topology of 
TatAd (Walther et al., 2010). Akin to TatC, TatCd and TatCy are predicted to 
contain 6 TMH (Nolandt et al., 2009). The topologies of these Gram-positive Tat 
components are depicted in Figure 1.3.2.      
These complexes are markedly different from their Gram-negative counterparts in E. 
coli, since they are smaller, more homogeneous and lack a TatB component (Barnett 
et al., 2008; Barnett et al., 2009), and it remains questionable whether such 
differences are indications of different mechanisms of Tat translocation between 
Gram-positive and –negative bacteria.  
A lack of TatB is compensated for by the bifunctionality of TatAd and TatAy 
proteins (Barnett et al., 2008). Furthermore, heterologous expression of TatAdCd in 




75 - 90Å 25 - 30Å 
2008). The TatAyCy complex, although not as flexible as TatAdCd, was able to 
transport GFP-tagged substrates (Barnett et al., 2009). Therefore despite these 
systems only possessing a single substrate in their native cellular environment, these 
data clearly show the inherent flexibility of these complexes and suggests that a 
discrete translocase is sufficient to efficiently transport folded substrates.      
The biological relevance of the heterogeneity witnessed in E. coli TatA complexes is 
further questioned in light of EM structural data of the TatAd protein. Detergent-
solubilised TatAd complexes were revealed to be 7.5 – 9 nm in diameter and possess 
cavities of 2.5 – 3 nm which were occluded at the cytoplasmic face of the membrane 
(Gohlke et al., 2005). These features, contrary to those of TatA, were consistent with 
the TatE complex of E. coli (Baglieri et al., 2012), and suggest that TatAd cannot 
form the translocation channel alone. Therefore, an alternative translocation 
mechanism is suggested which involves the coalescence of numerous, homogenous 






Figure 1.6.1. Low resolution 3D model of TatAd complexes generated by single particle 
reconstruction 
The low resolution structure shown shows TatA complexes that are 75-90Å in diameter. The 
structure possesses a central cavity, 25-30Å in diameter, which is too small to house Tat 
substrates. The height of the complex is 50Å, which is consistent with the thickness of the 
phospholipid bilayer of the inner membrane Scale bar = 100Å. This figure has been adapted 
from Baglieri et al. (2012).  
 
A third TatA protein is constitutively expressed in B. subtilis, TatAc. Until recently 
this protein was thought to be functionally redundant since tatAC mutant strains 
failed to show any phenotype (Jongbloed et al., 2004; Jongbloed et al., 2002; 
Tjalsma et al., 2000); however when expressed in E. coli this protein was able to 
functionally substitute for TatA in TatAcCd and TatAcCy; forming fully functional 
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complexes that were capable of translocating endogenous Tat substrates (including 
AmiA, AmiC and TorA) (Monteferrante et al., 2012). It was also able to substitute 
for E. coli TatA and TatB (Beck et al., 2013).  
Available data points to differences in both structure and mechanism of Tat 
machinery between Gram-positive and Gram-negative bacteria. Clearly, more effort 
needs to be employed to extend and deepen our knowledge of Gram-positive Tat 
systems so that our understanding is on par with that of TatABC systems.    
1.7.  Importance of the Tat pathway 
 
1.7.1. A novel antimicrobial target?  
 
Given that bacteria are major contributors to infectious diseases, the rapid increase in 
antibiotic-resistant bacteria over recent years now limits the therapeutic options for 
such diseases. Consequently, the issue of antibiotic-resistant pathogenic bacteria is 
now a major public health concern and now more than ever, do we need to we need 
to source new antibiotics and novel antimicrobial targets.          
 
Tat serves a potential novel antimicrobial target owing to its ability to secrete 
virulence factors to the periplasm of numerous pathogenic bacteria. Such proteins 
would subsequently gain access to secondary protein secretion machinery for export 
across the outer membrane for cell-surface display or gain entry to the extracellular 
medium. Tat has been shown to be required for the virulence of numerous 
pathogenic bacteria including: enterohemorrhagic E. coli O157:H7 (Pradel et al., 
2003), Salmonella enterica (Mickael et al., 2010), Legionella pneumophila (De Buck 
et al., 2005), Pseudomonas syringae (Caldelari et al., 2006), and Agrobacterium 
tumefaciens (Ding & Christie, 2003). Since Tat is not expressed in human or animal 
cells, this machinery has potential as a valuable antimicrobial target.   
 
Some bacterial genomes (E.g. Mycobacterium tuberculosis, Mycobacterium 
smegmatis and Burkholderia pseudomallei) encode β-lactamases which contain Tat 
signal sequences and are translocated by Tat machinery (Rholl et al., 2011; Saint-
Joanis et al., 2006). Several studies have been conducted that impaired the presence 
or functionality of the Tat machinery, in numerous pathogenic organisms such as 
those mentioned, to determine confirm dependence on this translocase for virulence. 
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For example - the signal peptide mutation (RRRK) of Tat-dependent PenA protein 
of B. pseudomallei increased the susceptibility of this bacterium to β-lactam 
antibiotics (McDonough et al., 2005; Rholl et al., 2011; Saint-Joanis et al., 2006). B. 
pseudomallei are Gram-negative bacteria that cause meloidosis in plants and animals 
(Northfield et al., 2002). In humans, without successful antibiotic treatment, 
septicaemia has over a 90% mortality rate (Warner et al., 2007). Likewise, mutation 
of tatABC genes in Mycobacterium tuberculosis increased susceptibility of this 
pathogenic bacterium to β-lactam antibiotics (Saint-Joanis et al., 2006).   
 
Given this evidence, it is sensible to assume that specific inhibitors of the Tat 
machinery could serve as novel antimicrobial compounds, or specifically β-
lactamase inhibitors, that could potentially be used in combination with β-lactam 
antibiotics. Design of such inhibitors is a complicated task owed to the fact that 
currently, there are no high resolution structures available for the Tat components or 
the machinery in its entirety; therefore design of specific Tat inhibitors via molecular 
modelling is a difficult task. (Vasil et al., 2012) developed a titration assay (which 
analysed the ability of the compound’s inhibition to be overcome by increasing the 
levels of Tat expression) to test a library of small molecular weight compounds for 
potential as Tat inhibitors. From over 80,000 initial compounds, 2 were isolated that 
displayed specific Tat inhibition. 
 
Available evidence presents a strong case for the involvement of Tat machinery in 
the virulence of numerous pathogenic bacteria. Whilst our understanding of the full 
extent of this involvement is still at an early stage, there is definitely merit for further 
investigations and investment of designing novel Tat inhibitors.    
 
1.7.2. The biotechnology industry 
 
The ability of the Tat translocase to transport fully-folded proteins into the 
periplasmic space has captured the interest and investment of the biotechnology 
industry, which serves to produce high-value therapeutic proteins. Owing to its rapid 
growth, high yield, easiness of scale-up and cost-effectiveness, E. coli is currently 
used as the host organism for the production of ~30% of therapeutic proteins (Huang 
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et al., 2012). A preferred method of protein purification from these cells is to export 
the recombinant protein into the periplasmic space since this cellular compartment 
contains only ~4% of the total proteome (Pooley et al., 1996), thus simplifying 
purification and downstream processing. To translocate a recombinant protein, a 
signal peptide can be fused to its N-terminus to target it to the inner membrane. Sec 
and SRP pathways require the substrate to be in a partially-unfolded form; however 
many therapeutic proteins fold rapidly in the cytoplasm prior to export or, even if 
they are maintained in a partially unfolded state in the cytoplasm, they fail to 
correctly refold in the periplasm. The Tat system is of interest to the biotechnology 
industry since it circumvents this issue by transporting large, fully-folded proteins 
across the inner membrane, thus simplifying downstream processing.     
Initial studies tested Tat’s capability of transporting a heterologous protein on a large 
scale. Results showed high levels of TorA-GFP export at ~0.35 g.L
-1
 with no large-
scale release of cytoplasmic contents (Matos et al., 2012), confirming this 
translocase’s potential as a viable method of producing therapeutic protein. More 
recent data showed Tat to successfully transport biopharmaceuticals including human 
growth hormone (hGH), interferon α2b and antibody fragments (Alanen et al., 2015). 
Current efforts are focusing on transporting these biopharmaceuticals on a large, 
industrial-relevant scale.   
1.8. Electron microscopy 
Overexpression of recombinant integral membrane proteins often results in low 
expression levels, as is the case with Tat proteins. Consequently, techniques such as 
3D crystallisation are incredibly difficult since they require high yields of highly 
pure protein as starting material. In contrast, electron microscopy requires very little 
starting material for extensive analysis; therefore this investigation used EM as a 
core technique to directly visualise Tat proteins under a variety of experimental 
conditions.   
For clarity in subsequent chapters, the main techniques utilised in this investigation 





1.8.1. Negative staining 
Negative staining is a routine sample preparation technique for biological samples, 
whereby the sample is coated in a thin layer of dried heavy metal salt, to give high 
contrast under the electron microscope. The advantages of this preparation technique 
are: the sample is very resistant to beam-induced degradation; it is a very high 
throughput technique owed to the easiness and rapidity of sample staining. Finally, 
negative staining has proven very useful for analysis of Tat proteins since they are 
very small biological macromolecules (Baglieri et al., 2012; Beck et al., 2013; 
Gohlke et al., 2005; Oates et al., 2003; Tarry et al., 2009), thus analysis via other EM 
preparation techniques such as cryo-EM [reviewed in (Milne et al., 2013)] is very 
difficult as these proteins have very low contrast under the electron beam in ice. 
Therefore, staining with heavy metal salts remains a first vital step in the 
characterisation of Tat proteins.  
1.8.2. Chemical fixation and resin embedding 
Fixation is the first and most crucial step in the preparation of samples for analysis 
under the EM. It serves two crucial purposes: firstly, biological preparation of the 
cells with minimal alteration from living state. Secondly, protection of the sample to 
maintain stability in subsequent preparative conditions (e.g. embedding) and from 
damage induced by irradiation from the electron beam.  
Conventional fixatives include glutaraldehyde and osmium tetroxide. The former, 
owed to the abundance of free aldehyde groups available, rapidly and irreversibly 
fixes samples by cross-linking to proteins; whereas osmium tetroxide binds 
irreversibly to lipids in the sample. Therefore, the combination of these fixatives 
generates optimal contrast under the electron beam (Franke et al., 1969). However, 
antigenicity of the sample is severely diminished since osmium has the potential to 
extract proteins and the high-density cross linking by glutaraldehyde has the potential 
to render many antigenic sites inaccessible to antibody binding (De Paul et al., 
2012). Antigenicity was vital to the latter half of this investigation (discussed in 
section 1.8.3); therefore a gentle fixation regime was adopted which involved low 
percentage of glutaraldehyde fixative and omitted the use of osmium tetroxide.  
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It has been found that many epitopes are sensitive to high concentrations of 
glutaraldehyde (Miller, 1972; Smit et al., 1974); therefore a gentle fixation with 2-
4% formaldehyde and 0.1-1% glutaraldehyde is a sufficient compromise to obtain 
ultrastructural and antigenicity preservation (Tokuyasu, 1984).  
The final step in sample preparation is embedding in resin. Individual plastic 
monomers are slowly and gradually incubated with the sample and polymerised to 
form a solid resin, which provides a protective medium for the sample under the 
electron beam. Mild aldehyde fixation in combination with LR gold resin was used, 
since lightly cross-linked samples enrobed in hydrophilic resins have been shown to 
facilitate access of the labelling agent (antibody) to the antigenic site; thus improving 
the immunogold signal achieved (Philimonenko et al., 2002).     
1.8.3. Immunogold labelling 
Immunogold labelling is a powerful technique for the specific localisation of 
antigenic sites within a biological sample. Identification of the cellular context of a 
particular protein can provide insight into its structure and/or function within the cell.   
In this investigation immunogold labelling was used to unambiguously identify the 
TatA protein of TatABC in E. coli and a heterologous substrate that was transported 
by the same machinery (chapters 3 and 4, respectively). The immunolabelling 
process involved the sequential labelling of the sectioned sample with antibodies 
raised against a specific antigen. This already-labelled sample then undergoes a 
second round of labelling, this time with a gold-conjugated secondary antibody. It is 
the gold particle that generates high contrast under the electron beam, thus enabling 




Figure 1.8.1. Immunogold labelling of Tat-expressing E. coli cells 
Schematic to depict immunogold labelling of resin-embedded, Tat-expressing E. coli cells. 
Serial sections are firstly immunolabelling with a primary antibody raised against a specific 
antigen – in this case – TatA protein. The primary anti-TatA antibody, which was raised in 
rabbit host, was then immunolabelled with a goat anti-rabbit, gold-conjugated secondary 
antibody. The gold particle generates high contrast under the electron beam, thus enabling 
direct identification of protein of interest.  
 
1.8.4. Array tomography 
Derived from the Greek works tomos – to cut or section and graphein – to write, 
array tomography involves the physical, serial sectioning of a resin-embedded 
biological sample. These sections are sequentially imaged under the scanning 
electron microscope (SEM) to obtain 2D electron micrographs which are then 
computationally aligned and reconstructed to generate a 3D volume for visualisation.  
Imaging in this manner avoids the conventional pitfalls of imaging using 
conventional TEM in that the imaging conditions are non-destructive to the sample 
since the electrons do not completely pass through the sample. Also, much larger cell 
volumes can be analysed, such that in this instance, a whole E. coli cell can be 
reconstructed from a single image acquisition.      
The novel combinatorial approach of immunogold labelling of E. coli cells with 
array tomography has enabled us to gain new insight into the 3D localisation and 







1.9. Overall aims and objectives of this investigation 
The overall aim of this investigation was to gain insight into the structure and 
localisation of the Tat translocase.  
The experiments utilised individual Tat proteins and/or complexes from both E. coli 
and B. subtilis, since they are the model organisms for both Gram-negative and –
positive bacteria, respectively; therefore a considerable amount of pre-existing data is 
available to assist in the design of experiments and data analysis. 
To achieve this overall aim, electron microscopy was the main technique used to 
enable visualisation of Tat protein and/or substrates under numerous experimental 
conditions.  
1. Detergent-induced variability  in the appearance of Tat proteins has been reported 
(Porcelli et al., 2002); therefore what is the true extent of detergent contribution to 
the molecular weight and heterogeneity of detergent-solubilised Tat complexes? 
2. Can I develop and fully-optimise a technology that enables the investigator to 
circumvent the used of detergent in the analysis of Tat machinery, and thus analyse 
Tat components in their native cellular environment?  
3. Data using fluorescently-conjugated Tat proteins is to be treated with caution, 
owed to the tendency of these proteins to be inactive or aggregate at the inner 
membrane (Alcock et al., 2013; Ray et al., 2005). The available confocal data does 
not give high-resolution information of the localisation of the particular Tat protein, 
or an appreciation of its 3D localisation in the cell (Alcock et al., 2013; Leake et al., 
2008; Ray et al., 2005; Rose et al., 2013). What is the localisation of particular Tat 
protein in their native cellular environment? Is the localisation dependent on other 
Tat proteins? Given the remarkable feat that this machinery accomplishes, is there a 
higher order of organisation of Tat machinery?  
4. Tat is of interest to the biotechnology industry owed to its ability to transport 
fully-folded proteins into the periplasm (Matos et al., 2012). Tat has been shown to 
successfully transport heterologous biotherapeutics (Alanen et al., 2015). What are 
the limitations to the expression of heterologous proteins in E. coli, specifically by 





















2.0 Materials & Methods 
2.1 Suppliers of chemicals, reagents and materials used 
All reagents and materials were obtained from the companies listed below. 
 
Abcam (UK): Goat anti-mouse (10 nm gold conjugate); Goat anti-rabbit (10 nm 
gold conjugate); Rabbit anti-Strep. 
Agar Scientific (UK): formvar/carbon coated copper grids (300 mesh). 
Antibody Production Services Ltd (UK): Rabbit anti-TatA and Rabbit anti-hGH 
Avanti lipids (USA): Mini extruder and E.coli lipids 
BioRad: Bio-beadTM SM-2 adsorbent,  
GE healthcare (UK): Superdex 200 10/300 GL pre-packed gel filtration column; 
ECL™ detection reagents; Native protein markers for gel electrophoresis and gel 
filtration chromatography; Hybond TM-P PVDF membrane. 
Calbiochem (Germany): n-Dodecyl-ß-D-maltoside (DDM) 
Expedeon (UK): Instant Blue ready-to-use Coomassie® stain. 
Fermentas (UK): Bradford Reagent ready-to-use 
Fisher Scientific (UK): Acetic acid (glacial); Acetone; Ethanol; Formaldehyde; 
Glycerol; Glycine; Hydrochloric acid; Methanol; Sodium chloride; sodium dodecyl 
Sulphate (SDS); Sucrose, and Tris. 
Fuji (Japan): Super RX film. 
Hamilton (Switzerland) 1ml syringes (for extruder) 
IBA (Germany): Buffer E; Strep-tactinTM HRP-conjugate, and Strep-tactinTM 
affinity chromatography resin, Biotin blocking buffer. 
Invitrogen (USA): Mouse anti-His (C-terminal) antibody, Mouse anti-Strep (C-
terminal) antibody. 
Melford (UK): Isopropyl-ß-D-thiogalactoside. 
New England Biolabs (USA): Pre-stained broad range protein markers. 
Premier International Foods (UK): Marvel milk powder. 
Promega (UK) Anti-rabbit-HRP and anti-mouse-HRP conjugates 
Roche applied science (UK): CompleteTM protease inhibitor cocktail tablets. 
Sigma-Aldrich (UK): Ampicillin; L-arabinose; Avidin; Bis-Tris; 
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ß-mercaptoethanol; Bovine serum albumin; C12E9; Ethanol (absolute); Kanamycin; 
Lysozyme; Normal goat sera; Silver nitrate; Sodium cacodylate; Sodium carbonate; 
Sodium thiosulphate; Tannic acid; TEMED; Tricine; Triton X-100, Trizma, 
SPI-Chem™ : Uranyl Acetate 
VWR (UK): 40% Acrylamide solution; Ammonium persulphate; Bromophenol blue; 
Calcium chloride; Disodium hydrogen phosphate; EDTA; Glucose; Magnesium 
chloride; Potassium chloride; Sodium dihydrogen phosphate; Sodium hydroxide 
pellets; Trichloroacetic acid and Tween 20. 




















2.2 Growth and storage of E. coli cells  
2.2.1.E. coli strains used 
The E. coli strains used in this work are presented in table 2.2.1. 
Strain Properties Reference 
MC4100 
F-, araD139, ∆(ara-leu)7696, ∆(lac)x74, galU, 
galK, hsdR2, mcrA, mcrB1, rspL  
Casadaban and Cohen, 
1980 
∆tatABCDE MC4100 ∆tatABCDE, Arar Sargent et al., 1988 
DH5α 
supE44, ∆lacU169 (80lacZ∆M15), hsdR17, 
recA1, endA1, gyrA996, thi-1, relA1 
Sambrook et al., 1989 
Table 2.2.1.  Bacterial strains used 
All bacterial strains used in this work, the relevant properties and initial reference 
where they were first used are outlined in the table above.  
 
2.2.2. E. coli plasmids used 
The E. coli plasmids used in this work are presented in table 2.2.2. 
Construct Properties Reference Source 
TatAyCy_S 
pBAD24 + B. subtilis TatAyCy-Strep 
in ΔtatABCDE 







pBAD24 + E. coli TatABC-Strep in 
ΔtatABCDE 







pEXT22 + E. coli TatABC-Strep in 
ΔtatABCDE 





TatA_h pBAD24 + E. coli TatA-his in MC4100 







pET23 + TorA signal peptide human 
growth hormone-6His in MC4100 





pHAK77 As pHAK14 but with substitution of Alanen et al., Heli Alanen 
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A39L in TorAsp in MC4100 2015 (University of 
Kent) 
Table 2.2.2. Bacterial plasmids used 
All bacterial plasmids used in this work, the relevant properties and initial reference 
where they were first used are outlined in the table above.  
 
2.2.3. LB supplements 
 
Luria Broth (LB) media (10 g/L NaCl, 10 g/L bactotryptone and 5 g/L yeast extract) 
was supplemented with ampicillin (100 μg/μl) with pBAD24; kanamycin (50 μg/μl) 
with pEXT22 and/or pET23.   
 
2.2.4. Competent Tat cells 
 
The E. coli strains listed in table 2.2.1. were inoculated in 5 ml LB media and 
cultured overnight at 37
o
C with shaking (220 rpm). The overnight pre-culture was 
then diluted 1/10 into fresh LB and cultured for 3hr at 37
o
C with shaking. Cells were 
harvested via centrifugation at 3000 g for 10 min. Cells were resuspended in 10 ml of 
0.1 M MgCl2 and incubated on ice for 10 mins before harvesting as previous. Cells 
were resuspended in 1 ml 0.1 M CaCl2 and incubated on ice for 30 min. Once 
competent, the cells remain viable for 24 hours.   
 
2.2.5. Transformation of E. coli cells 
 
100 µl of competent E. coli cells were incubated with ~100 ng of DNA on ice for 30 
min before mixing. After an additional 15 min incubation, the competent cells were 
subjected to heat shock: the cells were incubated at 42
o
C for 1 min and then 
immediately placed back on ice for 2 min.    
 
2.2.6. Storage of E. coli cells  
 
Glycerol stocks of E. coli cultures were prepared by mixing 2 parts liquid culture 
with 1 part 50% (v/v) glycerol and placed immediately on dry ice. Once frozen, the 






2.3 Protein expression and purification  
2.3.1. Cell culture and induction of plasmids 
 
A 5ml overnight pre-culture of E. coli cells containing the appropriate plasmid, was 
used to inoculate (at 1/100 dilution) fresh LB media, and cultured to OD600 of 0.1-
0.2. At this OD, cells were induced with 0.1 mM IPTG and cultured until they 
reached stationary phase (OD600 0.6-0.8). For cells containing the pBAD plasmid, 
induction occurred upon addition of 200 µM arabinose until the cells reached mid-
exponential growth phase (OD600 0.6-0.8).   
 
2.3.2. Fractionation of the E. coli cell 
 
E. coli cells were fractionated into periplasm, cytoplasm and membrane fractions 
using the lysozyme/cold osmotic shock method (Randall and Hardy 1986). Cells 
(transformed with the appropriate plasmid), were cultured in 10 ml LB media and 
induced with 1 mM arabinose (or 1 mM IPTG) and cultured until mid-exponential 
growth phase. Cells were harvested via centrifugation at 6000 rpm for 20 min at 4
o
C, 
and resuspended in 1 ml disruption buffer (100 mM Tris-acetate pH 8.2, 500 mM 
sucrose and 5 mM EDTA). The periplasmic fraction was obtained by adding 
lysozyme (20 µg/ml) to this resuspension and kept on ice for 5 min. 1 ml of ice-cold 
dH2O was then added to introduce osmotic pressure; resulting in lysis of the E. coli 
outer membrane. 40 µl of 1M MgSO4 was added at the same time to inhibit enzyme 
activity. The resulting spheroblasts were harvested by centrifugation at 4000 g for 1 
min. The periplasm (supernatant fraction) was collected, and pellet resuspended in 
0.5 ml wash buffer (50 mM Tris-acetate pH 8.2, 2.5 mM EDTA) and centrifuged at 
4000 g for 1 min. The washed pellet was resuspended in 1 ml sonication buffer (50 
mM Tris-Acetate pH 8.2) and sonicated for 3 cycles at 8 microns per cycle, for 10 
secs with 30 sec intervals. The broken cell membranes were separated from the 
cytoplasm by ultracentrifugation at 70,000 rpm for 35 min (Beckman TLA 100.3). 
The resulting membranes were resuspended in 0.5 ml solubilisation buffer (20 mM 
Tris-HCl pH 8.0, 10% Glycerol, 50 mM NaCl and 1% DDM) for a minimum of 1 hr 
at 4
o




2.3.3. Membrane isolation and solubilisation for Tat purification  
For a 0.5 L culture, the Tat-expressing E. coli cells were harvested by centrifugation 
at 6000 rpm for 20 min at 4
o
C. The cells were resuspended in 24 ml pre-chilled 
disruption buffer (100 mM Tris-acetate pH 8.2, 500 mM sucrose and 5 mM EDTA) 
with 1 protease inhibitor tablet (Roche) added to the suspension. The E. coli outer 
membrane was disrupted using 1 mg/ml of lysozyme, followed by immediate 
addition of 24 ml ice-cold dH2O. Finally 1ml of 1M MgSO4 was added to the 
suspension. The resulting spheroblasts were harvested by centrifugation at 4000 g for 
15 min at 4 
o
C and resuspended in 10 ml sonication buffer (50 mM Tris-acetate pH 
8.2 and 2.5 mM EDTA). The membranes were broken by 4 sonication cycles of 30 
secs at 10 microns (with 1 min interval between each cycle). The membranes were 
separated from the cytoplasm by ultracentrifugation at 70,000 rpm for 35 min at 4 
o
C 
(Beckman TL80.6 rotor). The resulting membrane pellet was solubilised in 10 ml 
solubilisation buffer (20 mM Tris-HCl pH 8.0, 10% glycerol, 50 mM NaCl and 2% 
DDM) overnight at 4 
o
C.  
2.3.4. Export assays of Tat substrates in E. coli cells  
E. coli cells (transformed with the appropriate plasmid), were cultured in 1L LB 
media and induced with 1 mM arabinose (or 1 mM IPTG) and cultured for 3 hours. 
At appropriate intervals (i.e 1 hr, 1hr 15 min, 1hr 30 – 3hrs) the optical density of the 
culture was measured at 600 nm. 10 ml of culture was removed from the flask and 
harvested by centrifugation at 6000 rpm for 20 min at 4
o
C. Each cell pellet was 
normalised against OD600 = 10, (e.g.  OD600 of 0.6), then resuspended in 0.6 ml 
disruption buffer (and later sonication and solubilisation buffers). E. coli cells were 
fractionated into periplasm, cytoplasm and membrane fractions using the 
lysozyme/cold osmotic shock method (Randall and Hardy 1986).  The same protocol 







2.4 Protein chromatography  
2.4.1. Purification using anion exchange Q-sepharose chromatography 
5 ml of Q-sepharose resin (GE healthcare) was equilibrated in 10 ml of equilibration 
buffer (20 mM Tris-HCl pH 8.0, 50mM NaCl and 10% Glycerol). A solubilised 
membrane sample from a 0.5 L culture of E. coli (overexpressing the protein of 
interest), was applied to the Q-sepharose column and flow through was collected. To 
remove loosely bound material the column was washed 5X each with 5ml of wash 
buffer (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 10% Glycerol and 0.02% DDM). 
The protein was eluted in 5X 2 ml elutions using high-salt elution buffer (20 mM 
Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol and 0.02% DDM). To neutralise the 
high-salt condition (by reducing final salt concentration to 150 mM), the elutions 
were eluted directly into 2ml of no salt buffer (20 mM Tris-HCl pH 8.0, and 0.02% 
DDM). 
 
2.4.2. Affinity tags 
For the purification and detection of recombinant proteins, C-terminal tags were 
sued. Either the 10 amino acid Strep-tag II (IBA, Germany) or a hexa-histidine tag 
were used where stated, denoted by –s or –h, respectively. 
2.4.3. Purification using a Streptactin
TM
-Sepharose affinity chromatography 
Solubilised membranes were incubated with 1µM avidin for a minimum of 30 min 
prior to loading onto the Streptactin column to prevent non-specific binding of 
biotinylated proteins. Prior to sample loading, the Streptactin resin was equilibrated 
with 2 column volumes (CVs) of equilibration/wash buffer (20 mM Tris-HCl pH 8.0, 
150 mM NaCl and 0.02% DDM). Blocked, solubilised membranes were applied to 
the Streptactin resin and flow through collected. Unbound proteins were washed 
from the column by washing with 5 CVs (5X 4ml) of equilibration/wash buffer. 
Finally, the Strep-tagged proteins were eluted from the column, in 10X 1ml elutions, 
using the elution buffer (20 mM Tris-HCl, 150 mM NaCl, 2.5 mM desthiobiotin and 
0.02% DDM).  
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2.4.4. Purification using a Talon
TM
 affinity chromatography 
Talon affinity chromatography was used to purify his-tagged proteins. 10 ml of 
Talon resin was equilibrated with 10 ml (1 CV) of equilibration buffer (20 mM Tris- 
HCl pH 8.0, 400 mM NaCl, 5 mM imidazole and 0.02% DDM) and left rotating 
overnight at 4
o
C. The resin was separated from the equilibration buffer by 
centrifugation at 2000 rpm for 5min. A solubilised membrane sample or pooled Q-
sepharose elutions were gently mixed with the Talon resin and left rotating for ~4 hr 
at 4
o
C. The slurry of protein sample/Talon resin was poured into a plastic gravity 
column and allowed to settle. The flow through was then collected from the column. 
The column was washed in 6 CVs of buffer 1 (equilibration buffer) and then eluted 
with 2.5 CV of elution buffer (20 mM Tris-HCl pH 8.0, 400 mM NaCl, 150 mM 
imidazole and 0.02% DDM). Each elution fraction was 0.5 ml.   
 
All fractions from either Streptactin or Talon affinity columns were separated by 
SDS-PAGE and visualised by Western blot. Peak fractions were pooled and 
concentrated using: 30 kDa VivaSpin concentrators for TatAyCy and TatABC 
complexes; and 5 kDa cut off for TatAd. 
      
2.4.5. Gel-filtration chromatography 
Size-exclusion chromatography was used as the final purification step to isolate Tat 
proteins, and an analytical tool to estimate the mass of protein complexes. A 
Superdex200 10/300 GL column (protein separation range: 10-600 kDa) was used 
with an ÄKTA purifier FPLC system (GE healthcare), operated by the UNICORN® 
v.4.00 software. The column was equilibrated with 2 CVs of gel filtration (GF) 
buffer (20 mM Trizma-HCl pH 7, 150 mM NaCl +/- 0.02% DDM). The concentrated 
protein sample was centrifuged at 10000 rpm for 10 min prior to loading onto the 
column. Sample separation was performed at 0.5 ml/min and the elution volume was 
collected in 0.5 ml fractions. Between sample runs, the column and loading loop was 
washed in 2 CVs of GF buffer. Resin purity and column performance was 
maintained by a daily cleaning protocol: 2 CV dH2O, then 2 CVs 0.5 M NaOH then 




2.4.6. Gel filtration calibration 
Calibration of the Superdex200 column was performed using proteins of known 
molecular mass to generate a standard curve for molecular weight estimation. Blue 
dextran was used to estimate the column void volume (Vo) (the volume at which all 
matter too larger to enter the resin is eluted). The protein standards and their elution 








Protein standard Ve 
(ml) 
Ve/Vo 
669 669000 Thyroglobulin 9.30 1.13 
440 440000 Ferritin 10.92 1.32 
158 158000 Aldolase 12.87 1.56 
66 66000 Albumin 14.03 1.70 
   Vo  
2000 2000000 Blue Dextran 8.25  
Table 2.4.1. Elution volumes of protein standards on Superdex200 
Protein standards with their molecular weight and corresponding elution 
volume (Ve) are shown. The void volume (Vo) of the Superdex200 column 
was shown to be 8.25 ml. A linear plot of Ve/Vo is used to estimate the 
molecular weight of unknown protein sample.  
 
2.5. Protein electrophoresis 
 
2.5.1. SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Gel electrophoresis was used to resolve protein samples. It was performed using the 
C.B.S vertical gel system and a uniform running buffer (25 mM Tris, 250 mM 
glycine and 0.1% SDS). SDS-PAGE gels consisted of a 17.5% resolving gel (17.5% 
acrylogel, 375 mM Tris-HCl pH 8.8, 0.1% APS and 0.06% TEMED) and 4% 
stacking gel (4% acrylogel, 125 mM Tris-HCl pH 6.8, 0.1% SDS, 0.6% APS and 
0.06% TEMED). Protein samples were prepared by diluting aliquots 1:1 with 2x 
loading dye (125 mM Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 0.02% bromophenol 
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blue and 5% β-mercaptoethanol) and heated at 70oC for 5 minutes. Gels were run at 
35 mA for ~2 hr 15 mins (until the blue dye from had reached the bottom of the gel).   
 
2.6. Protein detection 
 
2.6.1.Silver staining  
 
Having resolved proteins by SDS-PAGE, the gel was incubated in fixer solution 
(50% acetone, 1.25% trichloroacetic acid and 0.015% formaldehyde) for 15 minutes 
at room temperature. Fixer was washed off with 3x 5 min washes in dH2O. The gel 
was washed for a further 5 mins in 50% acetone, followed by 1 minute incubation in 
0.02% (w/v) sodium thiosulphate enhancer solution. Enhancer solution was removed 
by washing in dH2O for 5 min. Staining of the gel followed, by an 8 min incubation 
in staining solution (0.25% (w/v) silver nitrate and 0.4% formaldehyde (v/v)). 
Protein bands were visualised by developing the gel in developing solution (0.2 mM 
sodium carbonate, 0.004% sodium thiosulphate (w/v) and 0.015% formaldehyde). 
Once the bands were visible, developing was stopped by rinsing the gel in 1% acetic 
acid. Finally, the gel was rinsed in water.      
 
2.6.2. Coomassie staining   
 
SDS-PAGE gels were incubated with ~50 ml of Instant Blue Coomassie stain for at 
least 1 hr before washing with dH2O until background is clear.  
 
2.6.3. Protein transfer to PVDF membranes 
 
Once proteins had been resolved on a SDS-PAGE gel, they were transferred to a 
PVDF membrane using a semi-dry Western blotting system (Sigma, UK). Two 
sheets of Whatman paper soaked in transfer buffer (A Towbin transfer buffer was 
used: 25 mM Tris, 192 mM glycine and 20% methanol [Towbin et al., 1979]) and 
placed on the pre-wet positive electrode. A methanol-soaked PVDF membrane was 
then layered on top of the Whatman paper, followed by the gel. Finally, two more 
pieces of buffer-soaked Whatman paper were placed on top ensuring no air bubbles 
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remained in the stack. The blotter was closed, completing contact between the 




Once proteins have been transferred to a PVDF membrane it is blocked overnight in 
a solution of 5% (w/v) dried milk in PBS-T (or 3% BSA for strep-tagged proteins) at 
4
o
C. Membranes were then rinsed in PBS-T prior to the addition of 20 ml of the 
appropriate primary antibody (see table 2.6.1.) for 1 hr at room temperature (RT). 
For StrepII-tagged proteins, the membranes were blocked in biotin-blocking buffer 
(1:10000 dilution) before adding the anti-Strep-HRP antibody for 2 hours. For other 
primary antibodies, the post-incubation with antibody, the membranes were washed 
frequently for 1 hour in PBS-T. Then, the appropriate secondary HRP-conjugated 
antibody (table 2.6.1.) was incubated with the membrane for 1 hour at RT. Finally, 
all membranes were washed frequently in PBS-T for at least 1 hour at RT. 
Immunoreactive bands were detected using ECLTM detection reagents according to the 
manufacturer’s instructions. X-ray films were developed using an AGFA Curix 60 automatic 
developer as directed by the manufacturer’s instructions.  
 
Antibody Dilution Source 
Mouse anti-his (C-terminal) 1:10000 Invitrogen, USA 
Mouse anti-strep II HRP conjugate 1:10000 IBA, Germany 
Anti-TatA 
1:6000 Colin Robinson  
(University of Kent) 
Anti-hGH  
1:20000 Colin Robinson  
(University of Kent) 
Anti-rabbit IgG HRP conjugate 1:10000 Promega, USA 
Anti-mouse IgG HRP conjugate 1:10000 Promega, USA 
Table 2.6.1. Antibodies used in this investigation 
List of antibodies used in Western Blotting protocol, alongside working dilution and 







2.6.5. Estimation of protein concentration  
 
Estimation of protein concentration was achieved using Bradford’s reagent 
(Fermentas) as per the manufacturer’s instructions: 20 µl of protein sample mixed 
with 1 ml of room-temperature Bradford’s reagent. Assay readings were recorded at 
595 nm after 5 min incubation. Standard curves were prepared using BSA dilutions.  
 
2.7. Protein reconstitution in liposomes 
2.7.1. Liposome preparation  
1 ml (~25 mg) of chloroform-dissolved E. coli polar lipids (Avanti) was dried in a 50 
ml round-bottom flask using gentle nitrogen airflow (flask incubated in 60
o
C 
waterbath). Residual solvents were removed by placing the remaining thin lipid film 
under a vacuum overnight. The lipid film was hydrated in nitrogen-saturated 
liposome buffer (20 mM Tris-HCl pH 8 and 150 mM NaCl) to give a 2 mg/ml lipid 
solution for 4-6hr with gentle agitation to form multilamellar vesicles. Once fully 
hydrated, the lipid layer was subjected to 5 cycles of freeze-thaw. The liposomes 
were extruded through a 600 nm (3 X) and 200 nm (20 X) membranes, forming 
uniform 200 nm liposomes.   
2.7.2. Protein reconstitution  
The liposomes were subjected to 0.12% Triton-X-100 disruption via incubation for 
15 min, whilst rotating. Protein was added to 2mg liposomes at differing ratios 
(lipid:protein – 1:1, 60:1 and 90:1) and further incubated for 45 min at room 
temperature for the protein to be incorporated. Detergent was removed via the 
addition of SM2 Biobeads: 30 mg of wet Biobeads were added gradually to the 1 ml 
liposome mixture and incubated at RT for 30 min. An additional 60 mg of beads 
were added and incubated for a further 1 hr. A final 60 mg of biobeads were added 
and rotated overnight at 4
o
C. The liposome solution was extracted from the Biobeads 
and concentrated by ultracentrifugation at 55,000 rpm for 1.5 hour (Beckman TLA 





2.8 Atomic Force Microscopy 
all atomic force microscopy (AFM) work was carried out by Cvetelin Vasilev 
(University of Sheffield).  
2.8.1. Sample preparation 
Purified proteoliposome sample was diluted in imaging buffer (10 mM Tris pH 7.4, 
120 mM KCl, 0.02% DDM) and 40 µl was deposited onto a freshly cleaned mica 
surface, which is attached to an AFM sample support. Protein was left to adsorb onto 
the mica surface for ~15 min. The sample was then rinsed 3X with imaging buffer, 
and imaged under the AFM tip.  
2.8.2. AFM measurements 
PeakForce QNM mode was operated on a Multimode 8 AFM instrument. The 
microscope was connected to a 15 µm E-scanner and a NanoScope Vcontroller 
(Bruker). NanoScope software (v8.15, Bruker) was used for data collection. 
OriginPro (v8.5.1, Origin Lab Corp.) software was used for data processing and 
analysis. All measurements were collected in imaging buffer at room temperature 
using BL-AC40TS probes (Olympus). Z-modulation amplitude was set to 20-24 nm, 
with the frequency set to 2  kHz. Tip-sample force was maintained between 60 – 80 
pN.   
2.8.3. Preparation of Wet Bio-beads SM-2 
Biobeads SM-2 are adsorbent beads that capture detergent molecules. Biobeads (1 
mg) are prepared for detergent extraction by washing in methanol for 15 min with 
rotation at RT. The methanol is discarded and a further 16 ml is added to the same 
beads and washing continued for 30 min. Residual methanol was removed by 
multiple washes in 30 ml dH2O for 30 min. Finally, the beads were equilibrated in 
liposome buffer (20 mM Tris-HCl pH 8.0 and 150 mM NaCl) until ready to use.      
2.8.4. Sucrose density gradient centrifugation (SDGC) 
Sucrose density gradient was used to separate protein and liposomes given their 
differing densities. A sucrose gradient is prepared by: adding 400 µl 60% sucrose (in 
20 mM Tris-HCl pH 8.0 and 150 mM NaCl buffer) to 200 µl liposome solution (final 
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sucrose concentration is 40%); then 2 ml of 20% sucrose (in 20 mM Tris-HCl pH 8.0 
and 150 mM NaCl buffer) is layered on top. The final layer is 0% sucrose/400 µl 
liposome buffer. The gradient is subjected to ultracentrifugation at 55,000 rpm 
(Beckman TLA 100.3) for 1.5 hr at 4
o
C. Low-density liposomes shall resolve in the 
upper layers of the sucrose gradient, yet the unincorporated proteins will remain at 
the bottom sucrose layers.       
2.9. Analytical ultracentrifugation 
Analytical ultracentrifugation experiments (AUC) were conducted in a Beckman 
Optima XL-A analytical ultracentrifuge equipped with absorbance optics using a 
60Ti rotor. Sedimentation equilibrium experiments were performed at 7000 rpm -
12000 rpm for purified TatAyCy complexes. Data was collected at 230 and 280 nm 
in step scan mode using a separation of 0.001 cm. Five readings were averaged for 
each scan, and a baseline scan was taken at 360 nm to correct for optical 
imperfections. Readings were taken at 6hr intervals until no difference could be 
detected between consecutive scans. The equilibrium distributions from three 
different loading concentrations (10, 20 and 50 µg/ml) were globally analysed using 
single species fit model in SEDPHAT software  (Schuck, 2005). Solvent density was 
adjusted to that of DDM detergent by adding 29% (w/v) sucrose. Measurement of 
buffer density was measured to 1.01 g/mL using a density meter (Anton Paar 
DSA5000).         
2.10 Electron microscopy 
2.10.1. Sample preparation 
2.10.1.1. Sample preparation for negative staining 
20 µl aliquots of purified protein sample (previously stored at -20oC) were used for 
each imaging session. Any dilutions and/or washes were performed using the GF 
buffer (20 mM Trizma-HCl, 150 mM NaCl) +/-0.02% DDM detergent. All solutions 





2.10.1.2. Glow discharge 
A hydrophilic surface of carbon-coated grids was generated by glow discharging. 
Glow discharge was performed with an EMtech K100x unit, running at 3x10
-1 
mbar 
and 25ma for 15 seconds of negative discharge in air.  
2.10.1.3. Touching drop gridding method  
4 µl of protein sample was pipetted onto a freshly glow-discharged Formvar/carbon 
coated copper grid (300 mesh), for 1 min. Washing excess sample off the grid was 
achieved by touching the grid to the convex face of a 8 µl drop of GF buffer for ~10 
secs with gentle agitation. Post-washing, excess liquid was removed from the grid by 
blotting with filter paper. This process of washing and blotting was repeated again. 
Next, the grid was washed for ~10 secs in an 8 µl drop of uranyl acetate stain (1 or 
2% (w/v)) before blotting and staining in a fresh drop of uranyl acetate for 20 secs. 
The grid was blotted for a final time and then left to air dry for ~10 min before 
insertion into the electron microscope. This protocol is an adaptation of a previously 
published method (Rubinstein, 2007) using a Parafilm® drop support and 
Whatman® paper for blotting.   
2.10.1.4. Cryogenic plunging of biological samples 
7 µl of biological sample was pipetted onto a glow-discharged lacey carbon grid and 
allowed to adsorb for 1 min. Lacey carbon grids were used since they contain 
irregularly-shaped holes in the carbon layer in which vitreous ice can form. After 1 
min, both sides of the grid are blotted for 5 secs with filter paper. Immediately after 
blotting, the sample is plunged into liquid ethane to freeze in vitreous ice. An in-
house pneumatic plunge system was used for this plunging step.   
2.10.1.5. Chemical fixation of E. coli cells 
Following immediate induction with 100 uM arabinose, 1L of E. coli cells 
(overexpressing his-tagged TatA [TatA-his] or strep-tagged TatABC [TatABC-
strep]), were cultured to an OD600 of ~0.6. Bacterial cells were harvested via 
centrifugation at 6000 rpm for 20 minutes. The cell pellet was divided into aliquots 
(the cell volume no larger than an equivalent of 100 µl), and resuspended in 0.5 ml 
aldehyde fixative(s) (prepared in dH2O) of varying concentrations. An equal volume 
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of low melting temperature agarose was added to the sample and re-suspended 
quickly. Samples were centrifuged at 15000 rpm for 1 min and placed onto ice for 
10-15 minutes until the agarose had set. Once set, the agarose plug was extracted and 
any agarose lacking bacterial cells was trimmed and discarded. The remaining 
agarose-enrobed cells were sliced to pieces no larger than 1 mm
3
. The specimen 
cubes were resuspended in fresh 0.5 ml aldehyde fixative overnight (o/n) at 4°C. The 
following day, cells were centrifuged at 2000 rpm for 2 mins. Aldehyde supernatant 
was discarded and cell pellet resuspended and subsequently rotated in 0.15 M sodium 
cacodylate/HCl buffer pH 7.4 (now termed cacodylate buffer) for 10 minutes at 4°C. 
A total of 5 washes were conducted.   
2.10.1.6. Heavy metal staining of E. coli cells: Osmium tetroxide and Tannic 
acid staining 
Post-washing of chemically fixed E. coli cells, cells were quenched via washing in 
cacodylate buffer containing 0.1 M glycine for 1 hour (2x 30 mins) at 4°C. To stain, 
cells were resuspended in 2% osmium tetroxide for 2 hours at room temperature 
(RT). Cells were then rinsed in 3x 5 min in cacodylate buffer. This was followed by 
a second staining of 1% buffered Tannic acid (TA) for 1 hour at 4°C. Washing of the 
cells was again necessary in cacodylate buffer for 1x 5 min and 1x 10 min period at 
RT. The E. coli cells were then dehydrated in an ethanol series (70% -100%) for a 
period of 2 hrs. The cells were then embedded in LR-Gold resin (London Resin 
Company Ltd.; Berkshire, UK).    
2.10.1.7. Heavy metal staining of E. coli cells: Tannic acid and Uranyl acetate 
staining    
The protocol was identical to section 2.1.2; however instead of osmium tetroxide 
followed by TA, 1% buffered TA was used followed by 1% aqueous uranyl acetate 
(UA) at 4°C in darkness.  Also- the washing after the first staining period was dH2O 
instead of cacodylate buffer.  
2.10.1.8. Heavy metal staining of E. coli cells: The ‘Berrymann’ method 
This method used fixative: 1% glutaraldehyde, 4% formaldehyde,  0.2% picric acid 
and 0.5 mM in 0.1M phosphate buffer, pH 7.4 for fixation of E. coli cells. Removal 
of phosphates was necessary following quenching of the sample(s). Staining 
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consisted of solely 2% buffered (0.1 M maleate-sucrose, pH 6.5) UA at 4°C in 
darkness. 
2.10.1.9. Infiltration of resin 
Ethanol was removed via centrifugation at 2000 rpm for 2 minutes. The following 
rotating incubations at 4°C were conducted:  
 1:1 LR gold:ethanol, 1 hr 
 7:3 LR gold:ethanol, 1 hr 
 100% LR gold, 1hr  
 100% LR gold, o/n 
 100% LR gold + 0.5% benziyl (polymerisation initiator), 1 hr 
 100% LR gold + 0.5% benziyl, 1 hr 
 100% LR gold + 0.5% benziyl, o/n 
Sample was then transferred into 0.5 ml Eppendorf with fresh 100% LR gold +0.5% 
benziyl and left to stand for ~1 hr so that the E. coli cells deposited at the bottom of 
the Eppendorf. Samples were then polymerised via exposure to UV light for ~ 72 
hours at 4°C.  
2.10.1.10. Serial sectioning of resin blocks for imaging under the EM       
A glass knife was used to ‘square-off’ the resin block (using an ultramicrome 
[Ultracut E, Reichert-Jung; Vienna, Austria]), providing a flat 0.5 mm
2
 surface which 
could then be sectioned. Using the same microtome and a diamond knife, ultrathin 
(50 nm) serial sections were cut. Using a metal loop, these sections were transferred 
to either: carbon-coated (~80 nm thickness) glass coverslips (13 mm diameter) for 
scanning EM work, or 200-mesh carbon-coated copper grids (Agar Scientific, 







2.10.2. Immunolabelling of serial sections  
2.10.2.1. Optimised immunolabelling procedure for unambiguous identification 
of overexpressed TatA-his and TatABC-strep in the E. coli inner membrane  
Using the touching-drop method serial sections were blocked in TBS/T buffer 
(0.24% Tris (w/v), 0.8% NaCl (w/v) and 0.1% Tween-20 (v/v))  pH 8.4 containing 
1% BSA (w/v) and 4% normal goat sera (v/v) (Abcam Plc, Cambridge UK) for 30 
min at RT. Grids/Glass coverslips were directly transferred to a 10µl drop of primary 
antibody ((table 2.9.1.) (diluted in TBS/T buffer + 1% BSA (w/v)) for 2hrs at RT. 
Sections were washed (with blotting with filter paper in between) for 3x 2 min with 
TBS/T buffer + 1% BSA at RT. Incubation with secondary antibody (diluted in 
TBS/T buffer + 1% BSA (w/v)) followed (table 2.9.1.) for 1hr at RT. Sections were 
washed for 3x 10 min with TBS/T+BSA buffer at RT, followed by 4x 3min washes 
in dH2O at RT. Finally, grids were allowed to air dry before insertion into the EM.  
2.10.2.2. Berryman immunolabelling procedure 
Using the touching-drop method serial sections were blocked in TBS buffer (0.24% 
Tris (w/v) and 0.8% NaCl (w/v))  pH 7.5 containing 1% BSA (w/v) for 30 min at 
RT. Grids/Glass coverslips were directly transferred to a 10µl drop of primary 
antibody (table 2.9.1.) (diluted in TBS buffer) for 1hr at RT. Sections were washed 
(with blotting with filter paper in between) for 5x 3 min with TBS buffer at RT. 
Incubation with secondary antibody (diluted in TBS buffer) followed (table 2.9.1.) 
for 1hr at RT. Sections were washed for 5x 3 min with TBS  buffer at RT, followed 
by 5x 3min washes in dH2O at RT. To fix antibodies in place, sections were 
incubated in 2% aqueous glutaraldehyde for 5 min at RT. Counterstaining to improve 
section contrast was performed by staining sections in 2% aqueous osmium tetroxide 
for 5 min at RT. Residual stain was washed off sections by washing for 5x 3min with 
dH2O at RT. Further staining in lead citrate for 3 min at RT followed, with removal 
of excess stain achieved by washing sections in dH2O for 1x min. Finally, sections 





2.10.2.3. Optimised immunolabelling procedure for the unambiguous 
identification of overexpressed Tat substrate (TorAspHGH) in E. coli 
To identify the Tat substrate in the E. coli cell, the anti-hGH antibody was used 
(table 2.9.1.). The same methodology applies as (§2.10.2.1.), however a different 
TBS/T buffer was used: (0.24% Tris (w/v), 2.5% NaCl (w/v) and 2% Tween-20 
(v/v))  pH 8.4.     
Antibody Host Dilution Source 
anti-His Mouse 1:20 Life Technologies, UK 
anti-Strep Mouse 1:20 IBA, Germany 
anti-Strep Rabbit 1:20 Abcam plc, UK 
anti-TatA Rabbit 1:20 Colin Robinson, Kent 
University 
anti-hGH Rabbit 1:1000 Colin Robinson, Kent 
University 
Anti-rabbit IgG  
pre-adsorbed (10-nm gold) 
Goat 1:10 Abcam plc, UK 
Anti-mouse IgG  
pre-adsorbed (10-nm gold) 
Goat 1:10 Abcam plc, UK 
Table 2.9.1. Antibodies used for immunolabelling of serial sections with their 
optimised working dilution and source.  
2.10.3. Transmission electron microscopy (TEM)     
2.10.3.1. JEOL 2010F TEM 
200 kV JEOL transmission electron microscope with a field emission gun electron 
source, operating a Gatan Ultrascan™ 4000 CCD camera with a pixel size of 14 µm.  
2.10.3.2. Imaging software 
The microscope was controlled via the FasTEM software suite (ver.3) and the CCD 





2.10.3.3. Density profiling 
The Density Profile tool in Digital Micrograph software (ver.1.81.78) was used to 
measure particle diameter in the electron micrographs.  
2.10.4. Scanning electron microscopy (SEM) 
2.10.4.1. JEOL 7401F SEM 
A cryo-scanning electron microscope with a field emission electron source. The “in-
lens” solid state back scatter detector provides ultimate resolution with low kV 
performance.  
2.10.4.2. Imaging software 
The microscope was controlled by SEMSupporter software (SiFi), which also 
enabled the acquisition of image montages from each serial section.       
2.10.5. Computational reconstruction 
2.10.5.1. Alignment of image stack 
SiFi Panorama Mapping module in SEM supporter software was used to manually 
refine alignment of montage stack. The greyscale of the images was reset for each 
montage to make refinement of alignment easier in later steps. In eTomo software 
(IMOD (Kremer et al., 1996)), Align Serial Sections/Blend Montages tab was 
selected and the relevant .mrc image stack uploaded. Midas module was used to 
further manually refine montage alignment; correcting for magnification, stretch and 
rotation. Under the ‘Make Stack’ tab in Align Serial Sections, Global Alignments 
was selected, and Make Aligned Stack option selected to generate aligned volume 
stack.  
2.10.5.2. Segmentation of aligned image stack for generation of volume image 
Following alignment using Midas, the Z-stack was opened using 3DMod (set to 
Model). The first Z-plane was selected, and the first bacterium centred, ensuring it 
filled the screen. A new Object was created for each bacterium.     
For each Z-plane (1 to 20), the perimeter of a single E. coli bacterium was manually 
traced. Any immunogold labels were each marked as single points in each contour. 
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Points were edited and deleted as necessary to make sure that the contour matched 
the visible perimeter as accurately as possible. Once the contour was complete, any 
immunogold labels were each marked in a new Object as separate contours. The 
perimeter tracing and gold-point marking was repeated for each Z-plane until all 
were successfully contoured.   
The contours were stitched together using the meshing feature in 3DMod. Mesh One 
was used to generate the surface for each bacterium. The final model was saved and 
exported into UCSF Chimera for visualisation.  
2.10.6. Quantification of immunogold 
2.10.6.1. Multi-random sampling approach to quantifying immunogold  
Having sampled randomly and selected the optimal operating magnification of 
12,000X on the JEOL 2010F TEM, raw gold counts were retained as numerical 
frequency distributions from 200 randomly imaged E. coli (from 2 biological and 2 
technical replicates) and assigned to one of the two compartments: inner membrane 
and cytoplasm. A compromise between precision of intracellular location, or more 
specifically- inner membrane localisation, and noise of the EM image was achieved 
by counting any gold particle within a 25 nm radius of the inner membrane.   
2.10.6.2. Statistical evaluation of immunogold distributions  
Raw gold counts were used to construct a numerical frequency distribution table. 
Observed numbers of gold particles in each compartment were compared by use of 
contingency table analysis with ‘g’ groups (arranged in columns) and ‘c’ 
compartments (arranged in rows). This analysis generated predicted gold particles 
and, hence, partial chi-squared values, for each group and each compartment. 
Comparison of the total chi-squared value against a Chi-squared table determined 
whether the null hypothesis (of no difference in immunolabelling between TatA-












Chapter 3:  
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Bacillus subtilis contains two discrete Tat systems that operate in parallel, yet 
possess different substrate specificities (Jongbloed et al., 2006): TatAyCy and 
TatAdCd (Jongbloed et al., 2004). Reminiscent of the situation in E. coli, the 
TatAyCy system is comprised of two types of membrane protein complexes: 
TatAyCy and TatAy that have been reported to form ~200 kDa complexes (as judged 
by gel filtration chromatography) (Barnett et al., 2009; van der Ploeg et al., 2011). 
Likewise, TatAdCd exists as a ~230 kDa complex (Barnett et al., 2008) , alongside a 
separate and discrete TatAd complex of ~160 kDa (Barnett et al., 2008) .  
In addition to differences in size, composition and organisation,  the smaller 
TatAdCd and TatAyCy systems, which possess discrete, homogeneous TatA 
complexes, were found to translocate E. coli Tat substrates in the range of 63 kDa to 
85 kDa (Barnett et al., 2008; Barnett et al., 2009). This further complicates the 
translocation process, since these data argue against the pore-forming model of Tat; 
instead suggesting a primary translocon that is flexible in accepting substrates of 
different sizes (Robinson et al., 2011). There remains a lack of knowledge regarding 
the structural properties of TatAyCy and TatAdCd, which will assist in the 
elucidation of the Tat mechanism in Gram-positive bacteria.   
Previous published structural information has largely focused on individual Tat 
constituents: TatE, TatAd and TatA (Baglieri et al., 2012; Beck et al., 2013; Gohlke 
et al., 2005); whereas structural information on entire Tat complexes is severely 
lacking. Pursuit of a 3D reconstruction of TatABC, TatAyCy or TatAdCd is limited 
by several factors. Firstly, the interaction of the Tat constituents at the inner 
membrane is transient and it is therefore difficult to capture the active translocase at 
the membrane. Also, the small size of the Tat complexes makes it difficult to obtain 
electron microscopy images of sufficiently high contrast and information content to 
average for computational reconstructions. This is further complicated by the known 
heterogeneity of the Tat machinery since thousands of particles would have to be 
classified to gain enough structural data to represent the entire size range of the 
protein complex. The latter difficulties do not make it impossible to generate a 3D 
reconstruction – low resolution reconstructions of TatA were resolved despite 
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significant heterogeneity of  8.5 nm to 13 nm (Gohlke et al., 2005) – however it is 
vital to thoroughly characterise the sample prior to pursuit of a 3D reconstruction.  
Given the aforementioned evidence suggesting a difference in Tat mechanism 
between Gram-positive and Gram–negative bacteria (Baglieri et al., 2012; Beck et 
al., 2013), I decided to conduct preliminary 2D structural characterisation of the 
TatAyCy complex.  
Initial results presented in this chapter demonstrate the use of EM to unambiguously 
identify the detergent-solubilised TatAyCy complexes. This is necessary when 
analysing a detergent-solubilised protein since lipid/detergent micelles are also 
present in the purified sample. These need to be identified so that they can be 
excluded from subsequent structural analysis. Size distribution analysis confirmed 
that TatAyCy protein-detergent complexes (PDCs) are 12-14 nm in diameter. This 
required further analysis to investigate whether this heterogeneity is intrinsic to the 
TatAyCy complex or an artefact of detergent solubilisation.  
Analytical ultracentrifugation (AUC) (in collaboration with Dr David Scott, 
Research Complex, Harwell) was used to gain a detergent-free molecular weight of 
TatAyCy. This technique involves the application of a centrifugal force to a 
macromolecule in solution. Over time the solute will move towards the bottom of the 
cell and start to sediment. Simultaneously the process of diffusion opposes the 
sedimentation and eventually these two processes reach a state of equilibrium, thus 
the solute does not move (Figure 3.2.8.). Therefore, the concentration of the solute 
increases exponentially towards the bottom of the cell. This distribution is dependent 
on the buoyant molecular weight of the solute (molecular weight of the sample 
corrected by a buoyancy factor due to displaced solvent). Measurement of 
concentrations at different points leads to the determination of molecular weight of 
solute. Data from several experiments (run at different speeds, loading 
concentrations and measured at different wavelengths) are examined simultaneously 
to obtain the most accurate molecular weight possible.    
AUC revealed a true molecular weight of TatAyCy to be 101 kDa, excluding 
detergent contribution. However, further analysis revealed that this protein is 
heterogeneous. This is the first time that TatAyCy has been analysed in such manner, 
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and these results bear implications for future structural studies on this complex, and 
the Tat mechanism of Gram-positive bacteria.   
3.2 Results 
3.2.1. Affinity chromatography of TatAyCy 
Preliminary characterisation of TatAyCy complexes required a highly pure sample. 
Affinity chromatography was performed using a C-terminal strep tag on the TatCy 
component of the TatAyCy complex. As described in Materials and methods 
(§2.4.3.), solubilised membranes from E. coli cells overexpressing TatAyCy were 
applied to an equilibrated Streptactin™ affinity column (that specifically binds the 
strep-tag on TatCy). Bound proteins were eluted from the column and analysed by 
SDS-PAGE and blotting using antibodies to strep-tag on TatCy. The results are 
presented in Figure 3.2.1.  
Strep-tagged proteins were detected in all wash fractions, implying that they bound 
to the column only weakly. The tightly bound TatCy-strep specifically eluted from 
the column over elution fractions 2-5. Silver staining of SDS-PAGE gel confirmed 
that TatAy had co-eluted with the TatCy complex (middle panel, Figure 3.2.1.). 
There are very few other migrating bands present on the gel, indicating a good level 
of purity of these isolated TatAyCy complexes after application to just a single 







Figure 3.2.1. Affinity chromatography of WT TatAyCy-strep 
SDS-Polyacrylamide gel electrophoresis analysis of purified TatAyCy-strep. E. coli 
membranes were isolated from ΔtatABCDE cells expressing WT TatAyCy-strep from the 
pBAD plasmid and solubilised in DDM.  Solubilised membranes were applied to a 
StrepTactin column as described above. The column flow-through (FT), wash fractions (W1-
5) and elution fractions (E1-5) were analysed by Coomassie staining (A) and silver-stain (B). 
The same samples were immunoblotted with antibodies against the Strep-tag on TatCy(C). 
Positions of TatAy and TatCy are indicated on the left-handside of the figures and 





3.2.2. Gel filtration chromatography of TatAyCy complex 
Affinity purified TatAyCy was subjected to size exclusion chromatography for 
further purification to obtain a homogeneous complex for EM analysis. Purified 
TatAyCy was applied to a gel filtration column and eluted in 0.5 ml fractions (Figure 
3.2.2.). Peak fractions were immunoblotted with antibodies against the strep-tag on 
the TatCy protein (Figure 3.2.2., B). The blot shows TatCy strep eluting in 11 
fractions between 8 and 14 ml. By using a calibration curve (generated from elution 
profiles of soluble standards), the mass of the TatCy complex (in 0.02% DDM 
detergent) can be estimated to be ~320 kDa. This is similar to previous molecular 
weights reported for the same complex in DDM detergent (Patel et al., 2014). 
Fractions 15-24 were pooled and concentrated to a final concentration of 85 µg/ml. 
An aliquot of this final sample was resolved by SDS-PAGE and silver stained 
(Figure 3.2.2., C). The blot shows a pure fraction of a TatAyCy complex which will 



































Figure 3.2.2. Size exclusion chromatography of WT TatAyCy-strep 
Purified TatAyCy is a 320 kDa complex. (A) Affinity purified TatAyCy-strep was applied to 
a 24ml Superdex 200 (HR 10/300) gel filtration column as described in Materials and 
Methods and eluted in 0.5 ml fractions. Absorbance was measured at 230 nm (solid line) and 
280 nm (dotted line). Peak elution fractions (14-26 / 7ml-13ml) were immunoblotted using 
antibodies against the strep-II tag on TatCy. (B) The TatCy immunoblot shows the presence 
of TatCy in all peak fractions. (C) Fractions 15-24 were pooled and concentrated to a final 
concentration of 85µg/ml. Silver stain of the pooled fraction shows the presence of TatAy 
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3.2.3. Electron microscopy of TatAyCy complexes  
3.2.3.1 Optimisation of sample preparation for imaging of TatAyCy under the 
TEM 
With the aim of gaining preliminary structural insight into the TatAyCy complex, 
TEM was employed to analyse particles of purified protein-detergent complexes 
(PDC) of TatAyCy.  
Membrane proteins are notorious for low yields of purification. Therefore electron 
microscopy was deemed an appropriate technique for the preliminary structural 
characterisation of TatAyCy complexes, as only a few microliters of sample are 
required for analysis. Optimisation of sample preparation was required to minimise 
the number of contaminating aggregates and obtain an even spread of particles in the 
field of view. Both of these affect the level of staining that a particular PDC receives 
and consequently the contrast of particles under the electron beam. 
Initial viewing of the concentrated gel filtration fractions containing pure, detergent-
solubilised TatAyCy complexes revealed a sample containing a dense lawn of 
roughly-spherical TatAyCy particles and a large number of aggregates (large white, 
irregularly sized bodies) (Figure 3.2.3., A, yellow circles). In an attempt to minimise 
the number of aggregates, the washing of the sample, after being adsorbed to a 
copper grid, was increased. Results showed the density of particles decreased, yet the 
aggregates remained (Figure 3.2.3. B). Further optimisation by increasing dilution to 
25X minimised the number of aggregates (Figure 3.2.3. C), and increased staining 
time of this sample with 2% uranyl acetate increased particle contrast (Figure 3.2.3., 



































Figure 3.2.3 Electron micrographs of purified 
WT TatAyCy-strep under various sample 
preparation conditions  
The concentrated gel filtration fractions (15-24 
Figure 3.2.2.) containing pure, detergent-solubilised 
WT TatAyCy-strep was diluted in GF buffer 
(+0.02% DDM) and adsorbed onto an EM grid for 
TEM particle analysis.  
Sample dilution and staining + washing were 
sequentially altered to optimise particle density and 
contrast under the electron beam.  
A) 5X dilution, 2x 10 second stain (2% UA) and 2x 
10 sec wash (GF buffer + 0.02% DDM). B) 
Increased washes: 2x 30 sec wash.  C) Increased 
dilution: 25X dilution. D) Increased staining: 2 x 25 
sec (2% UA). E) Increased dilution: 60X dilution.  




Figure 3.2.4. Electron micrograph of purified WT TatAyCy-strep in optimal sample 
preparation conditions 
The peak gel filtration fraction (B4) containing pure, detergent-solubilised WT TatAyCy-
strep was diluted in GF buffer (+0.02% DDM) and adsorbed onto an EM grid for TEM 
particle analysis. A 25X dilution in GF buffer (+0.02% DDM), 3x 25 sec 2% UA stain and 
2x 30 sec washes in GF buffer (+0.02% DDM) gave the optimal particle density and density 
contrast under the electron beam. The micrograph shows a lawn of spherical protein-









Increasing the dilution of the sample to 60X in an effort to eradicate the aggregates 
drastically altered the appearance of the protein, since particles appeared 
significantly smaller. The stability of a solubilised protein depends on the 
protein:detergent (P:D) ratio. At higher detergent concentrations lipids distribute 
themselves amongst the detergent micelles, resulting in the formation of a 
heterogeneous mixture of lipid/detergent and protein/detergent micelles. With 
increased detergent concentration, delipidation occurs and solubilisation no longer 
increases. The removal of lipid head groups from a PDC alters stability of the PDC 
and thus the solubilised protein. Therefore, the 60X dilution of the TatAyCy protein 
(solubilised in 0.02% DDM) is evidence of this effect. A lowered protein 
concentration increased detergent ratio, clearly decreasing the stability of the 
TatAyCy PDC and causing it to disassemble (Figure 3.2.3., E).   
The optimised sample of DDM-solubilised TatAyCy is shown in Figure 3.2.4. A 
heterogeneous population of circular TatAyCy-detergent complexes was observed. 
Aggregates could not be completely removed from the sample. However, to avoid 
disturbing the P:D ratio and thus the stability of the observed PDCs, minimising the 
number of aggregates was deemed to be sufficient.  
Further analysis of these particles revealed the full extent of TatAyCy heterogeneity 
(Figure 3.2.5.). The diameters of 400 randomly selected TatAyCy particles from 
independent purifications was measured (Figure 3.2.5., C). Results showed that 
particles as small as 7 nm in diameter and in excess of 20 nm were present. 
Quantification of these measurements showed that 12-14 nm particles were the most 
abundant. Interestingly, the 12-14 nm particles (magnified in boxes for clearer 
observation) exhibited a similar density pattern: the central density across all of the 
particles shows a “W-shaped” pattern (Figure 3.2.5., B). Given that the particles have 
been negatively stained (i.e. stain is most dense where there is no sample), this W-
shaped density profile is consistent with the presence of a central cavity/pore-like 
feature in the complex. Similar staining profiles have been observed previously for 
TatAd and TatE components of the B. subtilis and E. coli Tat systems, respectively, 
whose later reconstructions revealed the presence of a pore/cavity-like feature 
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Figure 3.2.5. Size distribution analysis of WT TatAyCy-detergent complexes under the 
electron microscope 
A) Electron micrograph of heterogeneous TatAyCy-detergent complexes. The peak gel 
filtration fraction (B4) containing pure, TatAyCy-strep was diluted in GF buffer (+0.02% 
DDM) and adsorbed onto an EM grid for TEM particle analysis. The micrograph contains 
spherical protein-detergent complexes of varying diameters. B) Density profiling (using 
Digital Micrograph software) of the WT TatAyCy complexes shows a “W-shape” profile 
indicating a stain-excluding region in the particle. C)  400 randomly selected particles had 
their diameters measured using ImageJ software to gauge the most abundant particle 
diameters. Magnification = 40000X. Scale bar = 100 nm  
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3.2.3.2 Preliminary characterisation of TatAyCy particles under the EM 
The next stage was to ensure that the 12-14 nm particles are definitely detergent-
solubilised TatAyCy complexes and not just detergent micelles, since any subsequent 
structural analysis on this complex would have to encompass the entire size 
distribution of the TatAyCy complexes. Serial dilutions of the purified TatAyCy 
protein were prepared for size-distribution analysis. As previously described, 400 
TatAyCy particles were randomly selected from each dilution and its diameter was 
measured. Results are shown in Figure 3.2.6.       
The amount of protein in each sample halves with respect to the previous and the 
concentration of DDM detergent remains constant (2.3X above the CMC); therefore 
PDCs are still able to form, just at a lowered frequency. If the 12-14 nm diameter 
range is a true reflection of TatAyCy size, these particles should be the most 
abundant in the sample.  
Such a trend is observed in Figure 3.2.6: particle density is reduced as dilutions 
increase. Data also shows that for each dilution, the most abundant particle diameter 
was in the range of 12-14 nm. Interestingly, as the dilution increased from 1:10 to 
1:40, the most abundant particle diameter increased in size from 12 to 14 nm, 
respectively (Figure 3.2.6., green bar on histogram). This is most likely due to the 
detergent ratio increasing relative to the amount of protein with each dilution. An 
increase in detergent ratio could result in more detergent molecules being 





























Figure 3.2.6. Size distribution analysis of serially diluted heterogeneous WT TatAyCy-detergent 
complexes under the electron microscope.    
Left: Electron micrographs of TatAyCy sample. The peak gel filtration fraction (B4) containing pure, 
detergent-solubilised WT TatAyCy-strep was serially diluted (1:10, 1:20 and 1:40) in  GF buffer 
(+0.02% DDM) and adsorbed onto an EM grid for TEM particle analysis. The micrograph contains 
spherical protein-detergent complexes of varying diameters. Right: 400 randomly selected particles 
had their diameters measured using ImageJ software to gauge the most abundant particle diameters for 
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Whilst 12-14 nm particles were the most abundant, there were also other particle 
sizes visualised. PDCs are not the only components present in the sample. When a 
protein is solubilised in detergent, there will be lipid-detergent micelles lacking 
protein incorporation. It is important to identify which particles these are and 
consequently confirm the extent of the heterogeneity of the TatAyCy complex. 






























































































Figure 3.2.7. Size distribution analysis of buffer-only sample under the electron microscope.   
A) Electron micrograph of detergent-only sample. Gel filtration buffer (+0.02% DDM) was adsorbed 
onto an EM grid for TEM analysis. The micrograph contains spherical detergent complexes of varying 
diameters. B) Density profiling (using Digital Micrograph software) of the detergent complexes shows 
varying profiles, not consistent with a “W-shape” profile. C)  400 randomly selected particles had 
their diameters measured using ImageJ software to gauge the most abundant particle diameters. 
Magnification = 40000X. Scale bar = 100 nm  
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EM analysis revealed a lawn of heterogeneous spherical particles (Figure 3.2.7., A) 
magnified in boxes for clearer observation). Quantification of particle size showed 
that, compared to the TatAyCy-detergent sample (Figure 3.2.5.), the most abundant 
particles had smaller diameters in the range of 8-11 nm (Figure 3.2.7 C). This shift in 
size distribution is likely attributable to the lack of protein incorporation into the 
detergent-micelles.    
However, 12-14 nm particles were still present in the sample, albeit at a much lower 
frequency than in TatAyCy-containing samples (1.7X, 1.9X and 3.2X, respectively). 
Surface density analysis of these particles revealed that they exhibit a different 
average surface profile compared to TatAyCy-containing samples: the detergent-only 
samples lack the characteristic “W-shaped” profile. Instead surface density exhibits a 
more evenly shaped profile, lacking any deep stain-excluding regions like those 
observed in the TatAyCy sample. This profile could be explained by the fact that 
detergent micelles would have a more uniform surface density surface owed to the 
lack of protein incorporation.  
Data presented this far provides evidence for spherical TatAyCy detergent-
solubilised complexes to exhibit diameters of 12-14 nm. However, the observed 
increase in particle diameter with increasing dilutions demonstrates how alteration of 
protein/detergent ratio can alter complex size. Therefore, it remains questionable 
whether the observed heterogeneity is an intrinsic property of the TatAyCy complex 
or a consequence of detergent solubilisation. Confirmation of an intrinsic 
heterogeneity could provide insight into the translocation mechanism of a Tat system 
from Gram-positive bacteria.  
3.2.4. Analytical Ultracentrifugation of purified TatAyCy  
Whilst we know that detergent solubilisation contributes to the molecular weight of a 
protein upon the formation of PDCs, thus increasing the size of the protein when 
visualised under the electron microscope, it is unclear what the exact contribution of 
the detergent is. Also, regarding TatAyCy protein, we do not know whether the 12-
14 nm particle heterogeneity is an inherent property of this protein complex, or an 
artefact of detergent solubilisation. Therefore, analytical ultracentrifugation (AUC) 
was employed to find the true molecular weight of the TatAyCy complex, and 




AUC is an extremely versatile technique for the quantitative analysis of 
macromolecules in solution. Sedimentation equilibrium (SE) was performed on 
purified, detergent-solubilised TatAyCy particles.  
 
20 µl of highly pure TatAyCy (Figure 3.2.2., C) (10-50 ug/ml) was spun at 7000, 
10000, and 12000 rpm until the measured (absorbance at 230 and 280 nm) 
concentration profile remained unchanged for at least 24 hours (§2.7 methods 
section). Density matching of the detergent-containing solvent was necessary to 
make the DDM neutrally buoyant. This was achieved by the addition of 29% sucrose 
(w/v) to the buffer. Global analysis (simultaneous analysis data measured at varying 
concentration and speeds) of the SE data was performed using SEDFIT and 
SEDPHAT software (Schuck, 2005). Results presented in Figure 3.2.9 presents SE 
data for the TatAyCy molecule, showing concentration as a function of position 
within the cell as monitored by absorbance at 230 and 280 nm (Figure 3.2.9, top and 






































Figure 3.2.8. Schematic representation of sedimentation equilibrium of biological 
macromolecules  
Upon application of centrifugal force the solute begins to sediment towards the bottom of the 
cell (white arrows). Simultaneously, this process is opposed by diffusion (black arrows). 
Eventually a point of equilibrium is reached and the solute no longer moves in the cell. The 
resulting concentration gradient of the solute increases exponentially towards the bottom of 
the cell (black line). Measurement of concentration at different points leads to the 
























































Figure 3.2.9 Sedimentation equilibrium analysis of purified TatAyCy complexes 
Sedimentation equilibrium (SE) profile of 10-50 µg/ml TatAyCy purified in buffer 
containing 0.02% DDM. A molecular weight of 101 kDa was determined from fitting data at 
rotor speeds of 7000 rpm (red circle), 10000 rpm (green square) and 12000 rpm (blue 
triangle). Absorbance measurements of SE experiments were taken at 230nm and 280nm.  
The continuous lines represent best fits described single ideal species model of SEDPHAT 












































































Figure 3.2.10 Sedimentation equilibrium analysis reveals TatAyCy behaves as a non-
ideal species in solution 
A plot of ln(abs) vs. r
2
 for purified TatAyCy complexes revealed the complex to possess 
properties of a non-ideal solute. A single species would exhibit a linear concentration 
distribution. Absorbance data measured at 230 nm (A) and 280 nm (B) failed to yield a 





Analysis of this profile via fitting a single species model revealed the TatAyCy 
protein complex to exhibit a detergent-free molecular weight of approximately 101 
kDa. The goodness of fit of this model is judged by two parameters. First are 
residuals which are the difference between each experimental data point and the 
corresponding point on the calculated curve from the model. Residuals for both 230 
nm and 280 nm (Figure 3.2.9, bottom panel of each graph), are randomly distributed 
about point zero which is an indication of a relatively good fit for this particular 
model. The second parameter that tests for goodness of fit- Chi-squared analysis- 
mirrors this finding since statistical analysis of the residual points relative to the 
fitted model by the SEDPHAT software gave a value of Chi-squared value of 4 (a 
score of 1.0 would be a perfect fit). 
 
Qualitative analysis of the SE data at 230 nm shows data points that fit the model 
well. This is indicated by a good overlay of individual data points to the fitted model 
(straight lines for each speed). As expected, the absorbance of the sample at 280 nm 
was virtually zero due to a lack of aromatic amino acids which would otherwise 
absorb UV light at this wavelength.  
 
Given the heterogeneity revealed by EM analysis, data was replotted with the natural 
log of absorbance versus radius
2
. In this type of plot, if a single species is present it 
should generate a straight line whose slope is proportional to its mass. Results are 
presented in figure 3.2.10. At 230 nm (Figure 3.2.10 A), whilst the overall trend 
would appear to be linear, a significant proportion of the residuals are non-linear 
(highlighted in red circles). In light of previous data from this sample at 280 nm 
(Figure 3.2.10 B), it is unsurprising that there are a significant number of non-linear 
residuals at this wavelength.     
 
The identification of the TatAyCy sample exhibiting behaviour akin to a non-ideal 
species warrants further investigation into the full identification of species present. 
There appears to be a deviation from the 101 kDa molecular weight calculated by the 
single-species fit model of SEDPHAT software. Only upon identifying the different 
species present will the correct molecular weight range be determined (discussed in 





Most structural studies on the Tat system have focused on components from the 
Gram-negative bacterium, E. coli (Gohlke et al., 2005; Ramasamy et al., 2013; 
Rollauer et al., 2012; Tarry et al., 2009; Zhang et al., 2014a; Zhang et al., 2014b). 
However in light of recent evidence elucidating differences in Tat mechanism 
between Gram-positive and Gram-negative bacteria (Baglieri et al., 2012; Beck et 
al., 2013), structural insight into the Tat machineries from Gram-positive bacteria 
has potential to elucidate further details. The data presented in this chapter represents 
the first experimental evidence for an inherent heterogeneity of the TatAyCy 
complex from B. subtilis. Additionally, AUC data suggested that the average, 
detergent-free molecular weight of this complex was ~100 kDa.  
Previous purifications of the TatAyCy complexes have yielded molecular weights of 
~300 kDa (this study – Figure 3.2.2.) and 200 kDa (Barnett et al., 2008). These 
molecular weights were predicted from gel filtration chromatography purifications of 
TatAyCy that had utilised different detergents for solubilisation from the inner 
membrane, namely: DDM and digitonin. These are non-ionic detergents that each 
form large micelles of 70 kDa (Smith & Pickels, 1940; VanAken et al., 1986).  
Despite the same micellar molecular weight of these detergents, significantly 
different TatAyCy-detergent molecular weights were predicted. Clearly there are 
varying contributions of the number of detergent monomers to the PDC. This 
highlights the significant and varying contributions a detergent can make to the 
overall molecular weight of a PDC and consequently the value of obtaining true 
molecular weights of insoluble proteins.    
Given that the predicted 100 kDa value is smaller than the detergent-inclusive 
weights mentioned above, and the residuals of the fitted model and chi-squared 
goodness of fit analyses demonstrated a reasonably good fit, it seems that this 
predicted molecular weight of TatAyCy is feasible.  
Since this is the first AUC study on entire Tat complexes, true molecular weight data 
for other complexes is lacking; nor has there been much characterisation of the 
TatAyCy complex prior to this study. A 100 kDa complex size would not 
accommodate for many copies of TatAy and TatCy proteins given their individual 
molecular weights: 6 kDa and 28.4 kDa, respectively. Hypothetically- if the 
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substrate-binding complex contained a 1:1 stoichiometric ratio of TatA and TatC 
components (akin to the situation in E. coli (Bolhuis et al., 2001; Oates et al., 2003)), 
then the TatAyCy complex would contain only approximately 3 copies of TatAyCy 
protomers. This is very different to the situation in E. coli where low resolution EM 
structures of the TatBC substrate binding complex alluded to a complex arrangement 
consisting of 7 copies of TatBC (Tarry et al., 2009).    
This makes the mechanism of transport of the TatAyCy complex more intriguing, 
given that such a small complex is capable of transporting not only its native 
substrate in B. subtilis (YwbN 45 kDa), but also Tat-precursor-tagged GFP substrates 
(native to E. coli) when heterologously expressed in E. coli (Barnett et al., 2009). 
Perhaps such arrangement of TatA and TatC protein could be a reflection of a 
difference in Tat complex composition between Gram-positive and Gram-negative 
bacteria? 
To add further validation to this predicted detergent-exclusive molecular weight, 
additional AUC SE experiments should be conducted on TatAyCy that has been 
purified in a different detergent, to establish whether the same molecular weight is 
predicted.        
The most supported – yet still unproven – hypothesis for Tat translocation is the pore 
forming mechanism. The key factors in this model (which predicts that TatA is the 
pore-forming element of the translocase (Gohlke et al., 2005)) are the size and 
heterogeneity of the Tat components. It is the heterogeneity exhibited by the TatA 
components which explains how fully-folded substrates of varying sizes are able to 
traverse the inner membrane without ion leakage. However- this model is 
complicated by the finding that TatAdCd and TatAyCy (when heterologously 
expressed in E. coli), are capable of transporting TatABC substrates between 63 kDa 
and 82.6 kDa (Barnett et al., 2009). Furthermore, in light of evidence that TatAd 
lacks a pore large enough to support translocation (Beck et al., 2013), it suggests that 
a different model of Tat translocase exists in Gram-positive bacteria, which is 
sufficiently flexible to transport a wide range of substrates. For example, there could 
be coalescence of relatively homogeneous TatA-type complexes to TatAC 




The finding that the TatAyCy complex is a non-ideal species alludes to the idea that 
this complex possesses heterogeneity. However, since detergent (despite being 
neutrally buoyant), is still present we are unable to rule out the possibility that the 
detergent molecules are influencing the structure of the TatAyCy complex.  
Given the small size of the TatAyCy complex, which as explained above would not 
accommodate many copies of TatAy and TatCy proteins, it remains unknown how 
TatAyCy complexes are able to permit the translocation of non-native substrates in 
E. coli. If TatAyCy was confirmed to possess an inherent heterogeneity, this 
flexibility explain how this complex is capable of transporting substrates other than 
its endogenous YwbN (45 kDa) (Barnett et al., 2009). It could be possible that 
different numbers of TatAy monomers (from the pool of TatAy in the inner 
membrane (Barnett et al., 2009) could be recruited to the main substrate-bound 
TatAyCy complex. Additional recruitment of TatAy, creating a larger TatAyCy 
complex, would cause greater perturbation to the inner membrane for transport of 
larger Tat substrates. However this is speculation and additional investigations would 
have to be conducted to confirm the intrinsic heterogeneity of the TatAyCy complex 
to determine what the true size range of this complex is, and how each species 
present in solution differs.   
Sedimentation velocity (SV) is a technique that can address this question. Unlike SE, 
this technique relies on the application of a high centrifugal force to a macromolecule 
in solution which causes it to sediment towards the bottom of the cell. This process is 
information-rich since proteins of different sizes and components will exhibit 
different sedimentation profiles. Therefore this technique is able to separate samples 
according to size, shape and density; and consequently determine the oligomeric 
state of a heterogeneous membrane protein sample (Dorwart et al., 2010). For 
example, insight into the different sizes of oligomeric TatAyCy complexes would 
reveal the true molecular weight range for this complex. Furthermore, based on the 
differences in molecular weight between each oligomeric complex, the relative 
contributions of each TatAy or TatCy proteins could be inferred.    
The data presented in this chapter revealed a small detergent-free molecular weight 
of the TatAyCy complex in vitro and the importance for structural characterisation of 
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detergent-solubilised membrane proteins, prior to pursuit of 3D reconstructions, was 
demonstrated.   
The increase of Tat complex size upon alteration of P:D ratio highlights the 
variability that detergent solubilisation can have on the structure of a solubilised 
protein. Such variability does not reside solely with TatAyCy, a striking difference in 
Tat behaviour between native and detergent solubilised states has been reported for 
TatA. Despite evidence showing that TatA complex formation requires the TatBC 
complex in the inner membrane (Alcock et al., 2013), detergent-solubilised TatA 
forms complexes even when expressed in the absence of Tat components (Porcelli et 
al., 2002), suggesting that extraction of TatA from the inner membrane using 
detergents induces the polymerisation of the TatA proteins. Therefore, data derived 
from detergent solubilised proteins should be treated with caution.     
Due to heterogeneity and difficulty in distinguishing detergent-solubilised complexes 
a 3D reconstruction of TatAyCy complexes was not pursued. Results presented in 
this chapter reiterate the need to circumvent the use of detergents in this field of 
research. Therefore, the remainder of findings presented in this thesis have 
endeavoured to analyse the Tat machinery and/or its substrates avoiding the use of 












Chapter 4:  
Attempted reconstitution of 
















4.1 Introduction   
Results presented in the previous chapter highlighted the variability that detergent 
solubilisation can have on the structure of an insoluble protein. Such variability has 
also been observed for the TatA protein of E. coli (Porcelli et al., 2002), where 
detergent-solubilised TatA protein formed complexes even when expressed in the 
absence of other Tat components (TatB and TatC), which are compulsory for Tat 
complex assembly (Mori & Cline, 2002). These data highlight the caution that 
should be taken when analysing data from detergent-solubilised proteins.  
The mechanism of Tat translocation is still very much unsolved, and approaches to 
elucidate how this system accomplishes the remarkable feat of transporting fully-
folded proteins will undoubtedly involve structural analysis of Tat constituents. To 
obtain high-value, unambiguous information we need to circumvent the use of 
detergent-solubilisation for structural analysis. Therefore, the results presented in this 
chapter demonstrate the attempted reconstitutions of the TatAyCy system of B. 
subtilis into liposomes. Structural analysis of the TatAyCy-incorporated liposomes 
by atomic force microscopy (AFM) has the potential to elucidate topological details 
of this Tat complex in a lipid bilayer. Insight into the arrangement of a Tat complex 
in the inner membrane would add to our understanding of the mechanism of a Tat 
system from a Gram-positive bacterium.       
Liposomes are spherical vesicles that contain a single lipid bilayer and are therefore 
able to serve as a mimic of the phospholipid bilayer of the cytoplasmic membrane of 
bacteria. Reconstitution of proteins into liposomes is a complicated task, which 
contains many parameters that are each vital to the success of the reconstitution. 
Therefore the approach to find the optimal reconstitution for a given membrane 
protein has long been entirely empirical.      
There is an abundance of literature covering the formation of bacterial membrane 
protein proteoliposomes, detailing the diverse approaches to successful protein 
reconstitution into a liposome bilayer. The vast majority of these consist of a 
detergent-mediated approach since a detergent has already been used to extract the 
protein of interest from its native phospholipid bilayer. Therefore, the reconstitution 
process involves the incubation of a purified detergent-solubilised membrane protein 
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with liposomes. This approach was adopted in this study to attempt the reconstitution 
of TatAyCy into liposomes (Figure 4.2.2).       
No published data exists on the reconstitution of whole Tat complexes into 
liposomes. The data presented in this chapter show, for the first time, the attempted 
reconstitution of TatAyCy complexes into liposomes; highlighting several 
parameters that are vital for successful reconstitution. Additionally, the analysis of 
TatAyCy proteoliposomes under the AFM tip is presented. AFM work was 
performed by Dr Cvetelin Vasilev (University of Sheffield).   











4.2 Results  
4.2.1. Affinity purification of TatAyCy for reconstitution into lipid bilayers  
Affinity purification of TatAyCy complexes was necessary to obtain a highly pure 
sample of a Tat complex for reconstitution into a phospholipid bilayer. Affinity 
chromatography was performed using a C-terminal strep tag on the TatCy 
component of the TatAyCy complex. As described in Materials and methods 
(§2.4.3.), solubilised membranes from E. coli cells overexpressing TatAyCy were 
applied to an equilibrated Streptactin™ affinity column (that specifically binds the 
strep-tag on TatCy). Bound proteins were eluted from the column, and consequently 
analysed by SDS-PAGE and immunoblotting using antibodies to the strep-tag on 
TatCy. The results are presented in Figure 4.2.1.   
Weakly-bound Strep-tagged proteins were eluted from the column in the first wash 
fraction. The tightly bound TatCy-strep specifically eluted from the column over 
fractions 2-5 (Figure 4.2.1., A+B). Silver staining of the SDS-PAGE gel confirmed 
that TatAy had co-eluted with the TatCy complex (Figure 4.2.1., B). The purity of 
these isolated TatAyCy complexes after application to just a single column is 
highlighted, since aside from the TatAy and TatCy bands, there are very few other 
migrating bands present on the gel.      
Given the high purity of the TatAyCy complexes, and the fact that additional 
purification steps are likely to increase the dilution of the sample, a single affinity 
purification step was deemed sufficient to purify TatAyCy-strep before reconstitution 
into liposome vesicles. Therefore, elution fractions 2-5 were pooled and concentrated 



























  7 
B) 






Figure 4.2.1. Affinity chromatography of TatAyCy-strep 
E. coli membranes were isolated from ΔtatABCDE cells expressing WT TatAyCy-strep from the 
pBAD plasmid and solubilised in DDM.  Solubilised membranes were applied to a StrepTactin 
column as described above. The column flow-through (FT), wash fractions (W1-5) and elution 
fractions (E1-5) were analysed by Coomassie staining (A) and silver-stain (B). The same 
samples were immunoblotted with antibodies against the Strep-tag on TatCy(C). Positions of 
TatAy and TatCy are indicated on the right-handside of the figures and molecular-weight 
markers on the left.   
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4.2.2. Reconstitution of purified TatAyCy into liposome vesicles  
To reconstitute purified TatAyCy complexes into a membrane mimetic, liposomes 
were used. Liposomes are small, spherical artificial vesicles formed from 
phospholipids in aqueous solution and serve to mimic the native cellular environment 
of a lipid bilayer. An E. coli polar lipid extract was used to produce liposomes since 
an environment of similar physiological condition to that in vivo will be provided.  
Multi-lamellar liposomes were formed upon hydration of a thin film of E. coli lipids, 
which were then subjected to 5 cycles of freeze-thaw to form large multi-lamellar 
liposomes. These liposomes were subsequently extruded through membranes, 
possessing pores of 600 nm and 200 nm, for a total of 30 cycles, to obtain a 
homogeneous population of single lamellar vesicles.  
Once liposomes were formed, the next stage was to make them amenable to protein 
reconstitution. The most successful and frequently used strategy to achieve this is 
using a detergent-mediated approach (Figure 4.2.2.), since membrane proteins are 
extracted from their lipid bilayer and purified in the presence of detergents.  
 
The approach adopted in this study is outlined in Figure 4.2.2. The liposome bilayer 
was destabilised by the addition of 10% Triton-X-100; a detergent that is commonly 
used for this purpose (Helenius & Simons, 1975). Upon increasing concentration of 
Triton detergent, the liposomes undergo structural changes and a subsequent phase 
transition from a lamellar structure to phospholipid-detergent micelles (Lichtenberg 
et al., 2013). At the end of the incubation with Triton-X-100, the phospholipids are 
completely solubilised into mixed micelles. Purified TatAyCy was then introduced 
into the disrupted liposome solution (Figure 4.2.2., strep 2) and incubated with the 
mixed micelles.   
 
To drive protein reconstitution into the micelle bilayer, excess detergent was 
removed by incubation with SM2 Biobeads. Biobeads contain small pores that 
capture excess detergent molecules, and it is this removal that drives the process of 




Given the significant number of parameters to be optimised for an individual 
membrane protein reconstitution, different reconstitution procedures have yielded 
proteoliposomes of many different sizes and compositions. Therefore the best 
approach is to empirically determine the optimal conditions for the protein of 
interest. One parameter is the lipid-to-protein ratio (henceforth denoted L:P).  
Depending on required use of the proteoliposomes, the density of reconstituted 
protein may vary, which could influence the amount of protein to be added into the 
reconstitution mixture and consequently the L:P ratio. The initial reconstitution 
attempt used a L:P ratio of 60:1 and was performed as described in §2.7 of Materials 
and Methods. The TatAyCy proteoliposomes were separated from Biobeads and 
concentrated by ultracentrifugation. The resulting liposome pellet was resuspended 













Figure 4.2.2. Schematic of proteoliposome formation 
Schematic to illustrate the protocol adopted for the formation of TatAyCy-containing proteoliposomes. Liposomes were produced by extrusion 
through 100 nm pores (step 1). Addition of Triton-X100 destabilised the liposomes (indicated by dashed lines) to enable protein incorporation 
when incubated with a detergent-solubilised Tat sample (blue circles [detergent micelle] containing orange/purple rectangles [Tat complexes]) 
(step 2). Detergent extraction from the solution mixture (by Biobeads) drives the formation of Tat-containing proteoliposomes (step 3). 
 
 
1. Destabilisation of liposomes 
with Triton-X-100 detergent 
+ detergent 
2. Incubation of destabilised liposomes with 
detergent-solubilised Tat complexes 
+ - detergent 
3. Detergent removal (by Biobeads) 
to produce proteoliposomes 
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4.2.3. Sucrose density gradient centrifugation of TatAyCy liposomes  
To evaluate the effectiveness of protein reconstitution, sucrose density gradient 
centrifugation was used. This technique separates particles based on their densities, 
and is therefore capable of separating free protein from that which is reconstituted 
into liposomes. The sucrose gradient was prepared as shown in Figure 4.2.3., A. The 
liposome sample was suspended in the 40% sucrose layer at the bottom of the 
centrifuge cell, with 20%, 10% and 0% deposited on top. Upon application of a 
centrifugal force, proteoliposomes should float to the meniscus of the 20% layer; 
whereas free protein that does not reconstitute into liposomes will aggregate at the 
bottom of the cell (Figure 4.2.3., A, right-hand-side).      
Aliquots from each layer were resolved by SDS-PAGE and the presence of TatAyCy 
was detected by immunoblotting against the strep-tag on TatCy. The results of 
protein reconstitution at 60:1 L:P ratio show that whilst some TatAyCy aggregated at 
the bottom of the cell (Figure 4.2.3, B), some appeared to incorporate into liposomes, 
being present in higher sucrose layers of 10% and 20%. The difference in final 
position in the cell is owed to the size of the liposomes: smaller liposomes will have 
a lower density and thus resolve in lower percentages of sucrose.  
The negative control sample, of empty liposomes, contained no protein detected by 
Western blotting, but the liposomes still floated to the middle 20% layer indicated by 
a cloudy meniscus in the centrifuge tube.       
Despite the partial success of protein reconstitution at 60:1 ratio, preliminary AFM 
analysis reported that the liposome sample (which resolved at the 20% sucrose 
layer), contained large lipid patches with no protein. Since I endeavoured to 
reconstitute a sufficient amount of TatAyCy into liposomes for structural analysis via 
AFM, the amount of protein reconstituted needed to be greatly increased. Therefore, 
reconstitution was repeated but with a L:P ratio of 1:1. The reason for adding fewer 
lipids per unit of protein at this stage was in attempt to increase the efficiency of 
reconstitution: it is possible that at the previous L:P ratio (60:1), there was not 
enough protein to form densely packed Tat proteoliposomes. Results of this 
reconstitution are shown in Figure 4.2.3., C. The Western blot shows that all of the 
TatAyCy had aggregated at the bottom of the cell, remaining in the 40% sucrose 


















Figure 4.2.3. Analysis of protein incorporation into liposomes. 
A) Successful protein incorporation into liposomes was analysed by sucrose density gradient 
centrifugation. Proteoliposome samples were applied to a sucrose gradient (0-40%) and 
centrifuged at high speeds (50000 rpm). Proteoliposomes should resolve in lower sucrose 
regions (0-20%) due to their greater buoyancy, whereas non-incorporated protein will 
aggregate at the bottom of the cell in the 40% layer. Control liposomes (lacking protein 
incorporation) were used to confirm liposome formation (indicated by a cloudy meniscus – 
not shown); hence lack of immunolabelling in the (-) lane of B and C. Aliquots from each 
layer were resolved by SDS-PAGE and TatAyCy protein identified by Western blotting 
using anti-Strep antibody. B) Western Blot to show results of protein reconstitution at lipid-
to-protein ratio of 60:1. Some protein incorporated into liposome vesicles, yet a large 
proportion aggregated at the bottom of the cell. C) Western Blot of reconstitution at 1:1 ratio. 



























































4.2.4. Cryo-EM of TatAyCy liposomes  
To check whether liposomes were definitely being formed, and whether attempted 
protein reconstitution under the given conditions (§2.7.2) hindered liposome 
formation, aliquots from the negative liposome control and the liposomes in the 20% 
layer of the 60:1 reconstitution were imaged by cryo-EM. Results showed that both 
samples contained liposomes (Figure 4.2.4.). 
Despite undergoing multiple extrusions through a 100 nm membrane, both samples 
contained a heterogeneous population of unilamellar vesicles that possessed 
diameters in the range of ~30 nm to 140 nm. This heterogeneity could affect the 
distribution of reconstituted protein in the liposomes resulting in a low protein 
density; and thus difficult AFM analysis. Furthermore, most of the liposomes are 
unilamellar, with the odd exception of bilamellar vesicles (Figure 4.2.4, yellow 
circles). The presence of such vesicles would not hinder structural analysis under the 















Figure 4.2.4. Digital electron micrographs of liposomes +/- the reconstitution of TatAyCy protein visualised by cryo-EM 
Freshly formed liposomes +/- TatAyCy protein were cryogenically frozen and imaged under the EM. The presence of liposomes in both samples confirmed 
their successful formation. The presence of protein (top row) did not alter the stability of the liposomes or their formation since both samples were stable 
under the EM. Largely, unilamellar vesicles were formed with a few multilamellar vesicles present in solution (highlighted in yellow circles). The liposomes 
were heterogeneous in size, ranging from ~30 to 140 nm (size indicated in representative particles). Images were taken at 40000X mag on a JEOL UK 2010F. 




































4.2.5. Purification of TatAd for reconstitution into lipid bilayers  
Given the unsuccessful reconstitution of TatAyCy protein into liposome vesicles, a 
smaller and more homogeneous Tat protein, TatAd-his (Beck et al., 2013), was 
purified for reconstitution into liposomes to determine whether these properties aided 
protein reconstitution.   
A two-step purification procedure of TatAd-his was performed to reduce the amount 
of contaminating proteins onto the affinity column. Initially, solubilised membranes 
from E. coli cells overexpressing TatAd-his were applied to an equilibrated ion 
exchange column (Q-sepharose column). Bound proteins were eluted from the 
column by an increasing gradient of salt concentration. All fractions were analysed 
by SDS-PAGE and immunoblotted using antibodies to the TatAd protein itself. The 
results are presented in Figure 4.2.5.. TatAd was present in all fractions of the Q-
sepharose column (Figure 4.2.5., B and C). Elution fractions 2-5 were pooled and 
concentrated, and subsequently applied to an equilibrated Talon column. Weakly-
bound his-tagged proteins were eluted from the column in washes 1-3. Tightly-bound 
his-tagged proteins were eluted in fractions 1-5, with most TatAd-his eluting in 
fractions 3-5 (Figure 4.2.5., C).            
Coomassie staining of the Talon column elutions confirmed the presence of other 
minor migrating proteins; however TatAd was in definite excess. The presence of 
minor contaminant proteins will not hinder protein reconstitution; although they 
would introduce ambiguity when analysing the sample under the AFM. However, 
this part of the experiment aimed to test whether protein properties influence 







Figure 4.2.5. Purification of TatAd-his 
E. coli membranes were isolated from ΔtatABCDE cells expressing TatAd-his from the 
pBAD plasmid and solubilised in DDM. Solubilised membranes were first applied to a Q-
sepharose column. Elution fractions 2-5 (E2-E5) were pooled, concentrated and applied to a 
Talon column. The column flow-through (labelled FT), wash fractions (labelled W) and 
elution fractions (labelled E) of the Q-sepharose and Talon column were analysed by 
Coomassie staining (A) and silver-stain (B). The same samples were immunoblotted with 
antibodies against the TatAd protein. Positions of TatAd are indicated on the left-handside of 
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4.2.6. Sucrose density gradient centrifugation of TatAd liposomes  
To evaluate the effectiveness of protein reconstitution, sucrose density gradient 
centrifugation of the TatAd-reconstituted liposomes was performed as described 
previously (§4.2.3). The L:P ratio was reverted back to 60:1 since a 1:1 ratio resulted 
in all of the TatAyCy aggregating at the bottom of the cell (Figure 4.2.6.). Also, the 
parameter change in this part of the investigation was the protein (TatAd instead of 
TatAyCy). Reconstitution showed evidence of liposomes floating up to the 20% 
layer. Results of Western blot analysis for the detection of TatAd indicated that most 
of the protein had successfully reconstituted into liposomes and resolved at the 20% 
layer. However, some did not reconstitute and aggregated at the bottom of the cell. 
Some non-specific binding was also witnessed. AFM analysis of the proteoliposomes 
that resolved in the 20% sucrose layer, akin to TatAyCy proteoliposomes 
reconstituted at the same ratio, was reported to contain large lipid patches with no 









































Figure 4.2.6. Analysis of successful TatAd incorporation into liposomes  
Western Blot to show results of TatAd reconstitution at lipid:protein ratio of 60:1. 
Aliquots from each layer of a sucrose gradient were resolved by SDS-PAGE and TatAd 
protein identified by Western blotting using an anti-TatAd antibody. Some non-specific 
binding was detected. A proportion of TatAd was incorporated into liposome vesicles 
indicated by TatAd detection in the 20% sucrose layer. Some TatAd had also aggregated 
and remained at the bottom of the cell in the 40% layer. Control liposomes (lacking 
protein incorporation) were used to confirm liposome formation (indicated by a cloudy 





4.2.7. Further optimisation of Tat protein reconstitution 
Given the lack of success with protein reconstitution for both TatAyCy and TatAd at 
60:1 and 1:1 L:P ratios, further optimisation was conducted whereby numerous 
parameters were sequentially altered, including type of lipid, choice of detergent and 
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Figure 4.2.7 Optimisation of Tat reconstitution by alteration of numerous experimental 
parameters. 
Table detailing which parameters were altered in attempt to increase Tat protein 
reconstitution into liposomes. Three main factors were sequentially altered: the lipid type 
(either DOPC lipid, or E. coli polar lipid extract) (orange shading), the lipid:protein ratio 
(blue shading) and the presence of octylglucoside (OG) for liposome destabilisation (samples 
E and F).  
Lower L:P ratios were examined in light of data showing that bacterial membrane 
proteins reconstituted more efficiently at L:P ratios (Parmar et al., 1999). Also, in 
addition to E. coli polar lipid extract, DOPC lipids were used to prepare liposomes. 
This is because DOPC has only a single lipid composition and therefore will provide 
a flatter bilayer under the AFM. Any perturbations can be attributed more 
confidently to protein in the lipid bilayer. Finally, in samples that showed signs of 
reconstitution, octylglucoside (OG) was used instead of Triton-X-100, which is 
another detergent frequently used in detergent-mediated reconstitution. OG has a 
high CMC (23 mM) which slows the, usually rapid, rate of detergent removal by the 
Biobeads. This more gentle treatment, may aid protein reconstitution. Once prepared 






4.2.8. AFM analysis of TatAyCy proteoliposomes 
Reconstitution of TatAyCy into liposomes was performed under different 
experimental conditions (Figure 4.2.7. A-F), and subsequently analysed for protein 
reconstitution using AFM. Samples that contained liposomes prepared from E. coli 
polar lipid extract were examined first (Figure 4.2.7. A and B). Results are shown in 
Figure 4.2.8.  
The green arrows indicate equivalence points between AFM view (left-hand-side) 
and the measured height in the sample (right-hand-side). In both samples, the green 
arrow is positioned at a point where the lipid bilayer ends and the mica surface is 
exposed; hence the true sample height can be measured. AFM analysis revealed that 
both samples (L:P 0.3:1 [top panel] and 0.5:1 [bottom panel]) contained a sample 
height of 5 nm, which is consistent with an empty lipid bilayer surface. Additionally, 
these 5 nm surfaces had a significant lateral dimension of ~ 600 nm in both samples, 
consistent with a vast empty lipid deposition on the mica surface. Therefore, protein 
reconstitution was largely unsuccessful. A 10 nm feature was identified that 
protruded from the lipid bilayer surface in the 0.55:1 sample; however this was the 
only one identified; and therefore deemed unreliable.        
Furthermore, reconstitutions of TatAyCy into liposomes that were prepared from 
DOPC lipid, at 0.3:1 and 0.55:1 L:P ratios (Figure 4.2.7. C and D) were unsuccessful 
since- similar to the previous AFM data, the sample contained vast empty lipid 
patches that were 5 nm in height and up to 1 µm wide in lateral space (Figure 4.2.9). 
Very large features, approximately 20 nm in height were also identified in the 
liposome sample (Figure 4.2.9., bottom panel, right-hand-side), which are too large 
to be individual proteins and are therefore most likely unopened liposomes or protein 
aggregates.    
Despite the above samples (Figure 4.2.7. C and D) failing to reconstitute TatAyCy 
protein, they were easier to analyse under the AFM tip compared to liposomes which 
were prepared from E. coli polar lipid extract. More specifically, the lipid bilayer of 
the liposomes made from DOPC lipids could be clearly distinguished from the 
surrounding substrate surface. Therefore, reconstitution of liposomes produced from 
this lipid was repeated; although in an attempt to eliminate the presence of large 
aggregates and promote protein reconstitution, OG detergent was used instead of 
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Triton-X-100. Results are presented in Figure 4.2.10. These proteoliposome samples 
contained protein-like features that were 10-12 nm in height (top and middle panel). 
A control sample of empty liposomes contained features that were distinguishably 
larger in height (~18 nm), which are likely to be liposomes aggregates. 
The lateral dimensions of the protein-like features are difficult to reliably measure 
owed to an inherent artefact of AFM analysis termed, ‘profile broadening’. This is 
effect arises due to tip-sample convolution. More specifically, the tip of the AFM 
that makes contact to the sample is not a perfect point, it is rounded, and thus any 
AFM image is a convolution of the shape of the probe and the shape of the sample. 
The effect of this is that the protruding feature is measured wider than its true width. 
Whereas, the height measured in Z-axis is high resolution, and if the particles are 
assumed to be roughly spherical, this measurement would correspond to the diameter 
of the feature. 
Despite these 10 – 12 nm protein-like features being distinct from those in negative 
control samples, they were not abundant within the sample. Therefore, improving the 
quantity of Tat protein being reconstituted into liposomes remains important future 
work. A high density of Tat protein in liposome bilayer is important to reliably 


































Figure 4.2.8.  TatAyCy reconstitution into liposomes (of E. coli polar lipid extract) 
TatAyCy proteoliposomes (orange surface on left-hand-side panels) were adsorbed onto mica 
surface (blue surface on left-hand-side panels) for topography analysis under the atomic force 
microscope (AFM) tip. Randomly-selected cross-sections (red line) were measured with the AFM 
and examined for protein reconstitution.  
Top panel: TatAyCy protein reconstituted at a lipid-to-protein ratio (L:P) of  0.3:1 was 
unsuccessful. AFM measurements (right-hand-side) showed largely vast flat areas that are 
approximately 5 nm in height, which are attributable to empty lipid surfaces. Scale bar =  
500 nm.    
Bottom panel: TatAyCy protein reconstituted at a L:P ratio of  0.55:1 was unsuccessful.  Again, 5 
nm empty lipid bilayer was largely detectable. A 10 nm protrusion was detected (labelled, right-
hand-side); however this was the only one in the sample.  Scale bar = 500 nm.  
The green arrows indicate equivalence points between AFM view (left-hand-side) and the 

























5 nm 5 nm 
Figure 4.2.9. TatAyCy reconstitution into liposomes (of DOPC lipid) 
TatAyCy proteoliposomes (orange surface on left-hand-side panels) were adsorbed onto mica 
surface (blue surface on left-hand-side panels) for topography analysis under the atomic force 
microscope (AFM) tip. Randomly-selected cross-sections (red line) were measured with the 
AFM and examined for protein reconstitution.  
Top panel: TatAyCy protein reconstituted at a lipid-to-protein ratio (L:P) of  0.3:1 was 
unsuccessful. AFM measurements (right-hand-side) showed largely vast flat areas that are 
approximately 5 nm in height, which are attributable to empty lipid surfaces. Scale bar = 1 µm.    
Bottom panel: TatAyCy protein reconstituted at a L:P ratio of  0.55:1 was unsuccessful.  Again, 
a 5 nm empty lipid bilayer was largely detectable. 20 nm protrusions were frequently detected, 


























































 18 nm 
Figure 4.2.10. Octylglucoside-meditated TatAyCy reconstitution into liposomes of DOPC 
lipid.  
TatAyCy proteoliposomes (orange surface on left-hand-side panels) (which have been 
reconstituted using octylglucoside detergent instead of Triton-X-100) were adsorbed onto mica 
surface (blue surface on left-hand-side panels) for topography analysis under the atomic force 
microscope (AFM) tip. Randomly-selected cross-sections (red line) were measured with the 
AFM and examined for protein reconstitution.  
Top panel: TatAyCy protein reconstituted at a lipid-to-protein  ratio (L:P) of  0.3:1. AFM 
measurements (right-hand-side) showed protrusions that are approximately 10 nm in height, 
consistent with the presence of a protein reconstituted in the lipid bilayer. Scale bar = 1 µm. 
Middle panel: TatAyCy protein reconstituted at a L:P ratio of  0.55:1. AFM measurements 
(right-hand-side) showed protrusions that are approximately ~12 nm in height, consistent with 
the presence of a protein reconstituted in the lipid bilayer. Scale bar = 1 µm. 
Bottom panel: control sample of empty liposomes. This sample was found to possess 
protrusions from the lipid bilayer of ~18 nm in height, consistent with the presence of protein 




The results presented in this chapter are the first experimental data for the attempted 
reconstitution of a Tat protein complex into liposomes; therefore the approach used 
has been entirely empirical. A detergent-mediated approach was used to attempt to 
optimise the reconstitution of TatAyCy into liposomes (Figure 4.2.2).  
The lack of success in forming TatAyCy-rich proteoliposomes can be attributed to 
the latter process of reconstitution. Use of cryo-EM to visualise Tat proteoliposomes 
in their native state confirmed that liposomes were being successfully made, and that 
their stability was not affected by attempted TatAyCy-protein reconstitution. The 
small size of the liposomes, if there was successful protein reconstitution, would 
offer a higher protein density, which is better for AFM analysis where a high density 
of protein in a lipid bilayer is desired.  
During the reconstitution process, numerous parameters proved to be influential on 
protein incorporation and its analysis. First was the L:P ratio: the ratio of amount of 
lipid relative to the amount of protein. This ratio is important since it determines 
whether a sufficient amount of protein is present in order to efficiently reconstitute 
into a detergent-saturated liposome. Insufficient protein or lipid can result in inactive 
or aggregated protein which prevents investigation into protein functionality, and/or 
it can cause ambiguity in structural analysis, as seen in this investigation (discussed 
later in this section). Owing to the vast range of ratios possible, and variety in 
properties of the protein to be reconstituted, this parameter is determined empirically 
for each protein.  
Reconstitutions at 60:1 and 1:1 L:P failed to produce liposomes that contained any 
protein-like features. A further reduction in the amount of lipid (0.3:1 and 0.55:1), in 
combination with alteration of detergent used for reconstitution (OG versus Triton-
X-100), produced proteoliposomes, which contained protein-like features of 10-12 
nm that were detectable under the AFM. Clearly this ratio requires further 
optimisation, and for TatAyCy, lower L:P ratios resulted in, albeit in very low 
quantities, protein reconstitution into liposomes.  
Another important variable is choice of detergent. Two were used in this 
investigation: Triton-X-100 (low CMC – 0.17 mM) and OG (high CMC – 23 mM). 
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Both of these are routinely used in detergent-mediated reconstitution, and what is 
most important is the rate as which these detergent molecules are removed from the 
sample to drive proteoliposome formation. Samples that were subjected to OG-
mediated detergent reconstitution, instead of Triton-X-100, contained protein-like 
features that were detected by the AFM. SM2 Biobeads have been shown to rapidly 
remove both of these detergents efficiently, irrespective of initial conditions (Lévy et 
al., 1990; Paternostre et al., 1988). Therefore, it would seem that the use of a 
detergent with a high CMC favours detergent-mediated protein reconstitution when 
using hydrophobic beads. It is likely that slower removal of a detergent minimises 
the chances of protein aggregation, which would prevent efficient protein 
reconstitution. Despite this, high-density reconstitution of TatAyCy was still 
unsuccessful. Perhaps slower removal of the OG detergent would favour 
reconstitution of all protein complexes. 
The choice of lipid was a final parameter that influenced ambiguity of AFM data. 
DOPC is a bilayer lipid that will form fluid lamellar bilayers (Seddon et al., 2004). 
Given that it consists of only a single lipid type, this detergent had the potential to aid 
AFM analysis, since any perturbations in the lipid bilayer should be much less 
ambiguous than the E. coli polar lipid extract, which possesses 3 different types of 
phospholipid. AFM analysis demonstrated that, for liposomes prepared from DOPC 
lipid, any protrusions from the lipid bilayer could be clearly discerned from mica 
surface and/or the surrounding bilayer; thus the 10-12 nm protein-like features 
detected upon the use of OG in the final reconstitution attempt could be clearly 
distinguished from the surrounding liposome bilayer and from those detected in the 
negative control sample.     
In light of data from the first chapter of this thesis that showed TatAyCy in protein-
detergent complexes to possess diameters of 12-14 nm, it is feasible that the particles 
of 10-12 nm diameter identified in this investigation would be consistent with 
TatAyCy lacking contribution of detergent. However, these particles were not 
abundant and therefore the data is too ambiguous to continue with for detailed 
topography analysis of the TatAyCy-proteoliposomes; therefore an alternative, more 














Chapter 5 - TatA complexes exhibit 
a marked change in organisation 












Substrates are targeted to the Tat machinery via an N-terminal signal peptide 
(Chaddock et al., 1995; Stanley et al., 2000). At the inner membrane the substrate 
binds to a TatBC complex (Ma & Cline, 2013; Tarry et al., 2009), which triggers the 
recruitment of a separate TatA complex (Alami et al., 2003; Mori & Cline, 2002) to 
form the active translocase through which the substrate can pass. The precise 
mechanism of translocation is, however, poorly understood and the full translocation 
system has not been characterised.  
 
It has been proposed that TatA contributes to the translocation process by weakening 
the membrane, or by forming a transient pore. Electron microscopy generated low-
resolution structures of detergent-solubilised TatA protein, which showed TatA to 
exist as large, homo-oligomeric complexes that possess a cavity-like feature of 
varying diameter (Gohlke et al., 2005). These data provide support for a role of TatA 
protein as the pore-forming element of the Tat machinery. However, similar studies 
on the TatA paralog, TatE, which can functionally substitute for TatA, and TatAd of 
B. subtilis which can also substitute for TatA showed these complexes to be much 
smaller and more homogeneous than TatA (Baglieri et al., 2012; Beck et al., 2013). 
Therefore, the biological significance of TatA heterogeneity (as a consequence of 
sample preparation) remains unclear.   
 
Alternatively, it has been proposed that once TatA protein is recruited to TatBC 
complex it could serve as a nucleation point for additional TatA proteins (Alami et 
al., 2003; Mori & Cline, 2002). Cross linking data has shown that the number of 
cross-links between TatA proteins increases under transport conditions (Dabney-
Smith et al., 2006), which is consistent with the idea that substrate binding to the Tat 
machinery triggers polymerisation of TatA protein. This in turn would alter the 
immediate environment of the phospholipid bilayer to permit passage of substrate 
through the inner membrane (Brüser & Sanders, 2003; Cline & McCaffery, 2007; 
Dabney-Smith et al., 2006; Greene et al., 2007). However, the precise oligomeric 
state of the TatA protein varies in cell membranes and detergent micelles (Alcock et 
al., 2013; Gohlke et al., 2005; Leake et al., 2008; Porcelli et al., 2002), which 
suggests that data from detergent-solubilised complexes are not necessarily a true 
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reflection of what is occurring in the protein’s native cellular environment. 
Furthermore, cross-linking data are unable to define the distribution of TatA proteins 
within a given complex.  
 
The distribution of Tat complexes within the membrane is another area that has been 
difficult to analyse with accuracy. Efforts to investigate the distribution of the two 
Tat complexes (TatA and Tat(A)BC) have utilised Tat proteins tagged with 
fluorescent proteins, and there is evidence that the TatB and TatC proteins retain 
activity with C-terminal fluorescent tags (Ray et al., 2005). This study concluded that 
these proteins were uniformly distributed when expressed at low levels, although a 
separate study proposed that Tat complexes exhibit a polar localisation (Berthelmann 
& Brüser, 2004). However, analysis of TatA is more difficult. One study used GFP-
tagged TatA to analyse the oligomeric state of TatA complexes in the membrane 
(Leake et al., 2008), but another (Ray et al., 2005) showed that a TatA-GFP fusion is 
prone to proteolysis and release of mature-size TatA. Since even low levels of TatA 
can support translocation activity, this finding means that it is not possible to 
determine whether TatA-GFP fusions proteins are active. It has therefore been 
difficult to reliably gauge TatA protein distribution and/or localisation in two 
dimensions.  
 
Analysis of the 3-dimensional distribution of Tat complexes within cells is even 
more problematic. Despite the advent of super-resolution light microscopy bringing 
opportunity to analyse bacterial protein distribution with high resolution (Bakshi et 
al., 2012; English et al., 2011; Greenfield et al., 2009), there still remains a lack of 
visualisation of protein distribution in 3D space. The image acquisition required for 
techniques such as PALM (photoactivated localisation microscopy) requires 
hundreds of thousands of X-Y images for every 1 µm deep focal plane; with a 
resulting trade-off between sample density and image acquisition time (Lidke & 
Lidke, 2012). Coupled with the above questions regarding TatA-GFP activity, this 
means that care must be taken when considering light microscopy-based approaches 
to study Tat localisation. 
 
In this study we have sought to bypass such problems through the use of electron 
microscopic approaches in which native, unmodified TatA proteins are investigated. 
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I have developed the novel combinatorial approach of array tomography (Micheva et 
al., 2010; Micheva & Smith, 2007) (a high-throughput proteometric imaging 
method) (in collaboration with Andrew Yarwood, JEOL UK) (Figure 5.2.1), with 
immunogold labelling, to obtain a 3D volume image of E. coli; unveiling the 
unambiguous distribution of TatA protein in the inner membrane. This is the first 
time that this organism has been analysed using this technique.  
 
Our data show that a proportion of TatA is uniformly distributed in the plasma 
membrane, whether TatA is over-expressed on its own or together with TatBC. 
However, another fraction of TatA forms a linear cluster along the membrane in a 
TatBC-dependent manner, suggesting a mode of organisation not observed before. 
Despite the data not resolving any of the native structure of the Tat machinery, it 
does show the localisation and distribution of a Tat component that has been 
visualised in 3D space, in situ – afirst for the Tat field.  
 
Given the ability to unambiguously identify TatA in the inner membrane, the polarity 
of this protein was investigated. Localisation of specific proteins to the cell poles – 
the ends of rod-shaped cells – is integral to the spatial organisation of a bacterium’s 
proteome. Such regions play key roles in a multitude of cellular processes including: 
virulence, cellular differentiation and cell cycle progression (Treuner-Lange & 
Søgaard-Andersen, 2014). Therefore, knowledge of whether a particular protein 
localises to the cell poles is not only an essential question in bacterial cell biology, 
but can also provide insight into the functionality of the specific protein and its 
interaction partners. Existing data on whether the TatA protein exhibits a polar 
localisation remains dubious (Berthelmann & Brüser, 2004; Ray et al., 2005; Ridder 
et al., 2009; Rose et al., 2013). Data presented in this chapter provides evidence for a 








5.2.1. Chemical fixation and heavy metal staining of E. coli cells for visualisation 
under the electron microscope 
To capture a ‘snap shot’ of E. coli cells (overexpressing TatA or TatABC) with 
minimal alteration from living state, chemical fixation was required to preserve and 
protect the biological sample. Subsequent staining with heavy metal salts was 
necessary to impart high contrast to the cells for visualisation under the 
scanning/transmission electron microscope (Figure 5.2.1).   
Glutaraldehyde was the initial choice of fixative since it is the most frequently used 
fixative that cross-links proteins efficiently and irreversibly (Melan, 1999). A dual 
staining approach was used to maximise sample contrast. Osmium tetroxide (OT) 
and tannic acid (TA) was the first staining protocol tested since osmium has been 
shown to impart substantial contrast; particularly in lipid-dense regions 
(Wigglesworth, 1975). However this staining combination produced resin blocks that 
were very brittle (Figure 5.2.2, panel C) and therefore almost impossible to section. 
The fragile consistency of the resin block was an indication of unsuccessful staining 
and resin embedding of the E. coli cells. Unsurprisingly, these cells had poor contrast 
under the SEM (Figure 5.2.2., panel A).   
TA has been used as a less severe alternative to osmium tetroxide for the staining 
lipids in cells (Berryman, 1990), and was therefore used in combination with uranyl 
acetate (UA) (a conventional heavy metal stain). The combination of TA and UA 
produced resin blocks that were uniformly stained (Figure 5.2.2, panel D), sectioned 
well and had good contrast under the SEM (Figure 5.2.2, panel B). 
Having optimised a staining protocol and perfected the technique of cutting ultrathin 
serial sections (Figure 5.2.3., A), the next stage was to optimise the immunolabelling 
of the sections for the unambiguous identification of TatA or TatABC (Figure 5.2.1., 
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Figure 5.2.1. Overview of the Array Tomography process. 
Array tomography is an 8-step technique that results in a volume image of the sample studied, in this 
case an E. coli bacterium. Fixation was necessary to biologically preserve the E. coli cells, and 
staining generated contrast under the electron beam (Step 1). Embedding in a resin forms a solid 
medium that enables the sample to be imaged in the microscope (Step 2). This requires the E. coli 
bacteria to be cut using a diamond knife (Step 3). Ultrathin (50 nm) serial sections were transferred to 
a flat, conductive surface for visualisation under the scanning electron microscope (SEM) (Step 4). 
The protein of interest shall be identified by exploiting the presence of a specific antigen i.e. TatA 
protein (Step 5). Imaging the ribbon under the SEM (Strep 6) generates an image stack (Step 7) that is 




















Figure 5.2.2. Optimisation of staining protocol to ensure sufficient contrast of E. coli under the 
electron beam  
E. coli cells overexpressing TatA and TatABC were chemically fixed and stained in either osmium 
tetroxide and TA (A) or TA and UA (B). The latter generated greater contrast of the cells under the 
SEM (JSM-7500F field emission SEM, 3,000X mag, scale bar= 1 um). (A)-stained resin blocks were 
brittle and therefore very difficult to cut (C- middle image). (B)-stained resin blocks (D) cut well with 















































Figure 5.2.3. Electron micrograph of sectioned E. coli 
A: Electron micrograph of E. coli cells stained with tannic acid and uranyl acetate. The cells have 
good internal contrast with cytoplasmic and cell wall features clearly distinguishable. Image taken on 
JEOL 7401-F at 5000X mag. Scale bar = 2.5 µm.   
B: The E. coli bacterium shown has been sectioned through a latitudinal axis with a diamond knife. 
The outer (OM – yellow line) and inner membrane (IM – white line) can be clearly distinguished as a 
result of heavy metal staining. Gold particles within 25 nm radius of the section shown (white circle) 
shall be considered as bound to the inner membrane of E. coli. Image taken on JEOL 2010 TEM at 








5.2.2. Optimisation of immunolabelling for the unambiguous identification of 
TatA protein in E. coli 
Given that the labelling procedure involves binding of a primary antibody to a gold-
conjugated secondary antibody, the electron-dense particle visualised under the EM 
may not necessarily be localised in the immediate vicinity of the inner membrane. 
van Weering (van Weering, 2010) elucidated that this “structure” of primary + 
secondary + 10 nm gold is ~25 nm diameter. Therefore the region considered to be 
of inner membrane localisation has a 25 nm radius (Figure 5.2.3., B, white circle). 
The immunolabelling procedure (§2.10.1.2) consists of many variables, each of 
which requires optimisation to ensure optimal antibody labelling of desired antigen. 
The first variables to be tested in this study were: Tris- or phosphate-containing 
buffer; +/- presence of detergent and +/- blocking of sample prior to antibody 
incubation.    
E. coli cells overexpressing TatA-his or TatABC-strep (hereafter denoted TatA and 
TatABC) were immunolabelled with each of the above variables changed separately. 
E. coli cells lacking any Tat machinery (∆tatABCDE; hereafter denoted ∆tat) were 
used as controls for non-specific binding. A second negative control was TatA- or 
TatABC-overexpressing cells immunolabelled with the primary antibody omitted 
(hereafter denoted (-)).   
Cells immunolabelled with PBS and PBS/T buffers yielded higher gold counts versus 
TBS and TBS/T samples (Figures 5.2.4. to 5.2.7.); however, there is clearly more 
gold in the negative controls of these phosphate-containing samples and thus more 
non-specific binding. Since gold is bound in both of the negative controls, it is 
unclear which of the antibodies are binding non-specifically to the sections, or 
whether both are.    
The orange asterisk in the blocked PBS/T sample (Figure 5.2.4., bottom row, (+)) 
highlights the presence of UA crystals that have formed upon reaction with 
phosphate ions in the buffer. These hinder immunogold labelling, and are therefore 
another justification for omitting phosphate from buffer conditions.  
The non-specific binding in the Tris-containing samples (Figure 5.2.6 and 5.2.7), 
albeit in very low quantity, is mostly in the non-blocked TBS Δtat control where 
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there is gold bound at the inner membrane (yellow-dashed area) and on the resin 
(green circle). 
Blocked TBS/T samples contained the least amount of non-specific binding and 
retained a sufficient number of gold particles in the TatA overexpressing sample 
without any significant signs of gold clustering (Figure 5.2.6., bottom row).   
The next step in optimisation focused on increasing the antigenicity of the E. coli 
cells, whilst retaining sufficient internal contrast. A staining procedure was 
developed that was shown to improve both antigenicity and contrast at the inner 
membrane (Berryman, 1990). When this protocol was tested on TatA overexpressing 
E. coli cells (Figure 5.2.8., top row), an increased contrast at the inner membrane 
only occurred upon additional heavy metal counter-staining with lead citrate (Figure 
5.2.8., top row, left versus middle panel). However compared to previous imaging 
results, this level of contrast was attainable without this altered staining protocol. 
Also, the overall antigenicity of these samples was not markedly improved. In fact- 
binding at the inner membrane was lacking and the control sample highlighted the 
capability of the secondary antibody to bind non-specifically (Figure 5.2.8).  
To determine whether the lack of gold was attributable to the alteration of staining or 
immunolabelling procedure, the same “Berryman-stained cells” were 
immunolabelled using the blocked, TBS/T method optimised in this study (Figure 
5.2.8., bottom row). Again, gold was lacking and there were signs of clustering 
(green circle), which is likely due to alteration in cell preparation/staining. Not only 
did the “Berryman” preparative technique drastically reduce antigenicity, any 
increase in membrane contrast was negligible.  
What is apparent so far is the presence of cytoplasmic-bound gold. Despite this 
localisation of TatA being reported previously (Berthelmann et al., 2008), TatABC 
overexpressing cells were analysed in parallel, since TatC is more hydrophobic than 
TatA given the six transmembrane helices as opposed to one (§1.3.3). Therefore, we 
would expect (in line with its calculated membrane localisation), TatABC to reside 



















Figure 5.2.4. Electron micrographs of E. coli cells, overexpressing TatA, subjected to immunogold labelling with alteration of numerous parameters 
Chemically fixed and stained E. coli cells overexpressing TatA [labelled (+)] were immunogold labelled to detect the presence of his-tagged proteins. Controls: cells that had 
Tat machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. Preliminary optimisation of immunolabelling utilised different 
buffers (PBS or TBS), +/- the presence of 0.1% Tween-20 detergent and +/- blocking of the sections. There was significant non-specific binding at the inner membrane and 
cytoplasm in each of the controls. Orange asterisk highlights formation of uranyl acetate crystals. Images were taken on a JEOL 2010 TEM at 12,000X mag. Scale bar = 200 
nm. 







































Figure 5.2.5. Electron micrographs of E. coli cells, overexpressing TatA, subjected to immunogold labelling with alteration of numerous parameters 
Chemically fixed and stained E. coli cells overexpressing TatA [labelled (+)] were immunogold labelled to detect the presence of his-tagged proteins. Controls: cells that had 
Tat machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. Preliminary optimisation of immunolabelling utilised different 
buffers (PBS or TBS), +/- the presence of 0.1% Tween-20 detergent and +/- blocking of the sections. There was significant non-specific binding at the inner membrane and 











































Figure 5.2.6. Electron micrographs of E. coli cells, overexpressing TatA, subjected to immunogold labelling with alteration of numerous parameters 
Chemically fixed and stained E. coli cells overexpressing TatA [labelled (+)] were immunogold labelled to detect the presence of his-tagged proteins. Controls: cells that had 
Tat machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. Preliminary optimisation of immunolabelling utilised different 
buffers (PBS or TBS), +/- the presence of 0.1% Tween-20 detergent and +/- blocking of the sections. Use of Tris buffer reduced the amount of non-specific binding. Green 
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Figure 5.2.7. Electron micrographs of E. coli cells, overexpressing TatA, subjected to immunogold labelling with alteration of numerous parameters 
Chemically fixed and stained E. coli cells overexpressing TatA [labelled (+)] were immunogold labelled to detect the presence of his-tagged proteins. Controls: cells that had 
Tat machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. Preliminary optimisation of immunolabelling utilised different 
buffers (PBS or TBS), +/- the presence of 0.1% Tween-20 detergent and +/- blocking of the sections. Use of Tris buffer reduced the amount of non-specific binding. An 
absence of tween increased non-specific binding to resin (green circles).  Yellow circle = inner membrane-bound gold. Images were taken on a JEOL 2010 TEM at 12,000X 








































Figure 5.2.8. Alteration of E. coli cell fixation and staining to enhance contrast and antigenicity.  
E. coli cells overexpressing TatA were fixed in 1% glutaraldehyde/4% formaldehyde and subjected to pre-embedding staining of uranyl acetate and subsequent post-
embedding staining of osmium tetroxide (Berryman staining- both rows). The Berryman immunolabelling method (top row) lasted less than 3 hours, avoided use of detergent 
and +/- counterstaining with lead citrate. Counterstaining marginally increased the contrast of the outer and inner membranes (Left versus right, white-dashed boxes, top row). 































































































































To confirm TatA and TatABCs localisation(s), E. coli cells overexpressing either 
TatA-his or TatABC-strep were fractionated into periplasmic, cytoplasmic and 
membrane fractions and immunoblotted using the same primary antibodies as in the 
immunogold labelling (Figure 5.2.9). Results showed a lack of His6-tagged proteins 
in the cytoplasm of TatA overexpressing cells and unsurprisingly, both regions of 
∆tat cells (Figure 5.2.9., top panel). These data confirm that the abundance of 
cytoplasmic gold seen in both cell types is non-specific. Whereas, TatC-strep was 
detected in both the membrane and cytoplasm of TatABC overexpressing cells 
(Figure 5.2.9., bottom panel). The fact that TatA-his was not detected in the 
cytoplasm of TatA-overexpressing cells could be a reflection anti-Strep having a 
much higher affinity than anti-his hence why it is detecting TatC in the cytoplasm; or 





























Figure 5.2.9. Cytoplasmic and inner membrane fractions of E. coli cells (overexpressing TatA or 
TatABC) immunoblotted for the detection of his/strep-tagged proteins.   
E. coli cells overexpressing TatA (top) and TatABC (bottom) were fractionated into cytoplasmic and 
membrane fractions. The fractions were resolved by SDS PAGE and immunoblotted to detect for the 
presence of his/strep-tagged proteins. The control was E. coli cells that have had Tat machinery 
knocked-out (∆tat). Top panel: anti-his antibody identified overexpressed TatA only the membrane 
fraction of TatA overexpressing cells. Bottom panel: anti-strep antibody identified overexpressed 




















In a continued effort to decrease non-specific binding, both TatA and TatABC -
overexpressing samples were immunolabelled with increasing dilutions (1:5, 1:10 
and 1:15) of anti-his and anti-strep antibody, respectively.    
In both samples, an expected decrease in amount of gold upon increasing dilutions of 
primary antibody was seen (Figures 5.2.10 and 5.2.11). In samples overexpressing 
TatA or TatABC (denoted (+)), there was an abundance of gold particles in the 
cytoplasmic region, with little at the inner membrane. The ∆tat cells had gold bound, 
albeit in lower quantities than (+) samples, at all dilutions. This was minimised with 
1:20 dilutions. The (+) samples immunolabelled without primary antibody (denoted 
(-)) both bound gold, demonstrating that the secondary antibody is binding non-
specifically. Therefore, the 1:20 dilution of the primary antibody was selected as the 
optimal dilution in further experiments, with additional efforts required to minimise 
non-specific binding of gold in both samples.     
The next avenue of optimisation was to increase the pH of the TBS/T buffer from 7.2 
to ~8.2 (Figure 5.2.12). An increase in pH reduces charge attraction of negatively-
charged gold particles to positive sample components. Both (+) samples had binding 
at the inner membrane (Figure 5.2.12. yellow-dash circles). Whether this had 
changed relative to previous samples was indistinguishable via qualitative analysis. 
Gold still bound non-specifically in ∆tat cells, so much that they were 
indistinguishable from the (+) samples; more so for cells overexpressing TatABC. 
Gold binding to the (-) samples shows that the secondary antibody is also binding 




















Figure 5.2.10. Electron micrographs of E. coli cells, overexpressing TatA, immunolabelled with varying concentrations of primary antibody  
E. coli cells overexpressing TatA were immunolabelled using an anti-his primary antibody at 1:5, 1:10 and 1:20 dilutions from stock. Controls: cells that had Tat machinery 
knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)].1:20 was the optimal primary antibody concentration since non-specific binding 


























Figure 5.2.11. Electron micrographs of E. coli cells, overexpressing TatABC, immunolabelled with varying concentrations of primary antibody  
E. coli cells overexpressing TatABC were immunolabelled using an anti-strep primary antibody at 1:5, 1:10 and 1:20 dilutions from stock. Controls: cells that had Tat 
machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)].1:20 was the optimal primary antibody concentration since non-


























Figure 5.2.12.Electron micrographs of E. coli cells immunolabelled with buffers of increased pH  
During immunolabelling of cells overexpressing either TatA or TatABC, the pH of the wash buffer was increased from 7.2 to 8.4 in an attempt to minimise non-specific 
binding. Controls: cells that had Tat machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. In both cell types, non-specific 
binding remained in both controls (∆tat) and (-). Yellow-dash indicates binding at inner membrane. Red-dash indicates binding in cytoplasmic regions. Green circle highlights 


















Despite changing numerous variables such as buffer pH, primary antibody 
concentrations etc., there is still extensive non-specific labelling of Δtat and (-) 
cells by the primary and gold-conjugated secondary antibodies.  
To address these issues individually, increasing percentages of goat sera (1%, 2% 
and 4%) were included in the blocking buffer to eradicate non-specific binding of 
secondary antibody (Figure 5.2.13 and 5.2.14) to TatA and TatABC overexpressing 
cell. For both samples, only at 4% goat sera was the gold binding in the (-) samples 
eradicated.  
Non-specific binding of primary antibody to ∆tat cells remained, thus giving false 
positives in (+) samples. Avidin was added in the blocking buffer of TatABC 
overexpressing cells in attempt to stop biotinylated proteins binding non-specifically 
to the anti-strep antibody (Figure 5.2.15). However, the non-specific binding 
increased with more gold bound in ∆tat and (-) samples. Clustering/aggregation of 
































Figure 5.2.13. Electron micrographs of E. coli cells, overexpressing TatA, blocked with differing 
percentages of normal goat sera. 
Having been blocked in buffer containing 1, 2 or 4% normal goat sera, E. coli cells overexpressing 
TatA were immunolabelled using an anti-his primary antibody. Controls: cells that had Tat machinery 
knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. 
Yellow-dash = inner membrane binding. 4% goat sera was the optimal concentration of goat sera 
since it minimised non-specific binding in (∆tat) and (-) cells. Images were taken on JEOL 2010F 
































































Figure 5.2.14. Electron micrographs of E. coli cells, overexpressing TatABC, blocked with 
differing percentages of normal goat sera. 
Having been blocked in buffer containing 1, 2 or 4% normal goat sera, E. coli cells overexpressing 
TatABC were immunolabelled using an anti-strep primary antibody. Controls: cells that had Tat 
machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled 
(-)]. Yellow-dash = inner membrane binding. 4% goat sera was the optimal concentration of goat sera 
since it abolished non-specific binding of secondary antibody [bottom row, (-)]. Images were taken on 





















































Figure 5.2.15. Electron micrographs of E. coli cells, overexpressing TatABC, blocked with an addition of 1% avidin   
E. coli cells (overexpressing TatABC) were blocked in buffer containing 4% normal goat sera and 1% avidin and subsequently immunolabelled using an anti-strep primary 
antibody. Controls: cells that had Tat machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)].Yellow-dash = inner 
membrane binding. Red-dash= cytoplasmic binding. Green= clustering of immunogold. The presence of 1% avidin worsened the non-specific binding in light of the increase 
in gold in both (∆tat) and (-) samples. Clustering of the gold was noticeable. Images were taken on JEOL 2010F TEM at 12,000X magnification. Scale bar = 200 nm.
(+) (∆tat) (-) 
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Next, in attempt to improve antigenicity retained at the end of the chemical fixation 
and staining process (and thus gold binding at the inner membrane), TatA and 
TatABC overexpressing cells were prepared in varying concentrations of fixatives 
(§2.10.1.5). Disappointingly, each new fixative failed to improve antigenicity in both 
TatA and TatABC samples such that the (+) and ∆tat samples were indistinguishable 
by eye (Figures 5.2.16 and 5.2.17).  
From results obtained so far, it is clear that the despite the alteration of numerous 
variables, the primary antibodies used to label TatA and TatABC overexpressing 
cells are not suitable for immunogold labelling studies of acrylic sections. Therefore 
different primary antibodies were tested.  
Fractionation of TatABC overexpressing cells and immunoblotting with a different 
anti-Strep antibody showed TatC-strep to reside solely within the membrane, and 
∆tat cells to lack any strep-tagged proteins in either compartment (Figure 5.2.18). 
The corresponding EM micrographs (Figure 5.2.20) show that there was no 
difference in amount of gold bound to (+) samples, and gold still bound in 
considerable amounts to the ∆tat cells. Therefore the second anti-strep antibody did 
not produce significant differences in abundance or localisation of gold binding. 
TatA was detected only in the cytoplasm and membrane of TatA overexpressing 
cells (Figure 5.2.19). Electron micrographs of these cells immunolabelled with anti-
TatA show a marked improvement in the amount of gold in (+) samples versus ∆tat. 
However, non-specific binding was not completely eradicated since gold bound the 
inner membrane of ∆tat cells (Figure 5.2.21). 
In order to maximise antigenicity, TatA overexpressing cells were prepared in 
different fixatives and immunolabelled using the anti-TatA antibody. A small 
sampling study was conducted, whereby 50 randomly imaged E. coli had their raw 
gold counts counted. A multi-stage random sampling approach was adopted for 
unbiased sampling of E. coli cells (Figure 5.2.22). Each gold was assigned to the 
membrane or cytoplasmic region of the cell (Figure 5.2.23) Results show that the 
second fixative provided the highest ratio of gold at the membrane between (+) and 
∆tat cells. There were 8.57X more gold at the membrane of each (+) cell compared 
to ∆tat. Therefore this fixative was used for all subsequent preparations of TatA 





























Figure 5.2.16. Electron micrographs of E. coli cells, overexpressing TatA, that have been 
chemically fixed in different combinations of aldehyde. 
E. coli cells, overexpressing TatA, were immunolabelled using an anti-his primary antibody. Fixative 
1: 0.5% glutaraldehyde/2% formaldehyde. Fixative 2: 0.25% glutaraldehyde/4% formaldehyde. 
Fixative 3: 2% glutaraldehyde/2% formaldehyde. Controls: cells that had Tat machinery knocked-out 
[labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled (-)]. Yellow-dash = 
inner membrane binding. Red-dash = cytoplasmic binding. None of the fixatives improved 
antigenicity. Each fixative had low gold density. Images were taken on JEOL 2010F TEM at 12,000X 



































































Figure 5.2.17.Electron micrographs of E. coli cells, overexpressing TatABC, that have been 
chemically fixed in different combinations of aldehyde. 
E. coli cells, overexpressing TatABC, were immunolabelled using an anti-strep primary antibody. 
Fixative 1: 0.5% glutaraldehyde/2% formaldehyde. Fixative 2: 0.25% glutaraldehyde/4% 
formaldehyde. Fixative 3: 2% glutaraldehyde/2% formaldehyde. Controls: cells that had Tat 
machinery knocked-out [labelled (∆tat)] and (+) cells that had the primary antibody omitted [labelled 
(-)]. Yellow-dash = inner membrane binding. Red-dash = cytoplasmic binding. None of the fixatives 
improved antigenicity. Each fixative had low gold density. Images were taken on JEOL 2010F TEM 




















































Figure 5.2.18. Cytoplasmic and membrane fractions of E. coli cells (overexpressing TatABC) 
immunoblotted for the detection of strep-tagged proteins using a different anti-Strep antibody.   
E. coli cells overexpressing TatABC were fractionated into cytoplasmic and inner membrane 
fractions. The fractions were resolved by SDS PAGE and immunoblotted to detect for the presence of 
strep-tagged proteins. The control was E. coli cells that have had Tat machinery knocked-out (∆tat). 
Strep-tagged TatABC was identified in only the membrane fraction of (+) cells.    













Figure 5.2.19. Cytoplasmic and membrane fractions of E. coli cells (overexpressing TatA) 
immunoblotted for the detection of TatA protein using anti-TatA antibody. 
E. coli cells overexpressing TatA were fractionated into cytoplasmic and inner membrane fractions. 
The fractions were resolved by SDS PAGE and immunoblotted to detect for the presence of TatA 
protein. The control was E. coli cells that have had Tat machinery knocked-out (∆tat). TatA protein 



































Figure 5.2.20. Electron micrographs of E. coli cells, overexpressing TatABC, immunolabelled using a different primary antibody 
E. coli cells, overexpressing TatABC, were immunolabelled using a new anti-strep primary antibody. Controls: cells that had Tat machinery knocked-out [labelled (∆tat)] and 
(+) cells that had the primary antibody omitted [labelled (-)].IBA was the provider of the first anti-strep antibody (top row). Abcam was the provider of the second anti-strep 
antibody (bottom row). Both antibodies had the same final concentrations of 50 ug/ml. Yellow-dash = inner membrane binding. Red-dash = cytoplasmic binding. The ‘new’ 
Abcam antibody did not produce significant differences in abundance or localisation of gold binding. Images were taken on JEOL 2010F TEM at 12,000X magnification. 
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Figure 5.2.21. Electron micrographs of E. coli cells, overexpressing TatA, immunolabelled using a different primary antibody 
E. coli cells, overexpressing TatA, were immunolabelled using a anti-TatA primary antibody. Controls: cells that had Tat machinery knocked-out [labelled (∆tat)] and (+) 
cells that had the primary antibody omitted [labelled (-)]. Despite the anti-TatA antibody binding non-specifically to (∆tat) cells, the cells were distinguishable from (+) cells 
since they had less gold bound at the inner membrane. No gold bound to (-) sample showed that any non-specific binding in other samples was attributable to primary 




























Figure 5.2.22. Schematic depicting the multi-stage random sampling process of E. coli cells 
overexpressing TatA cells.  
E. coli specimens are sampled in a hierarchical fashion commencing at the liquid culture stage. Of the 
two cultures grown, one shall be randomly selected and only 0.5L of that chosen culture shall be 
harvested for subsequent processing. Since the orientation of E. coli within the resin block cannot be 
controlled, the cellular structures exposed upon sectioning with diamond knife are absolutely random. 
When under the TEM the top section shall be imaged first and work in a serpentine fashion 
throughout the sections until 200 E. coli are imaged. The sampling experiment shall also be conducted 


























Figure 5.2.23. Small-scale sampling of anti-TatA labelled E. coli cells that have been chemically fixed in different combinations of aldehydes. 
E. coli cells, overexpressing TatA, were immunolabelled using an anti-TatA primary antibody. Fixative 1: 0.5% glutaraldehyde/2% formaldehyde. Fixative 2: 0.25% 
glutaraldehyde/4% formaldehyde. Fixative 3: 2% glutaraldehyde/2% formaldehyde. Controls were cells that had Tat machinery knocked-out (∆tat). Raw gold counts were 
taken from 50 randomly imaged E. coli and assigned to one of two cell compartments: inner membrane or cytoplasm. Total gold count was determined and consequently, the 
approximate gold per cell and gold per inner membrane of each cell was calculated (rows 3 and 5 of table). Quantitative data confirmed fixative 2 retained the best 
antigenicity since it had the most gold in the inner membrane of each cell (electron micrographs, middle).  
 Fixative 1 Fixative 2 Fixative 3 
 TatA Δtat TatA Δtat TatA Δtat 
E. coli 50 50 50 50 50 50 
Total gold count 107 25 166 25 102 21 
Approx. gold per cell 2.14 0.5 3.32 0.5 2.04 0.42 
Total gold at inner 
membrane 
27 11 60 7 29 5 
Approx. inner 
membrane gold per 
cell 
0.54 0.22 1.2 0.14 0.58 0.1 
Difference in amount 















The anti-his and anti-strep antibodies were not good enough for pursuit of 
array tomography with immunogold labelled E. coli cells, since they bound non-
specifically to the sections. In contrast, small-scale sampling studies revealed the 
anti-TatA antibody to unambiguously identify TatA.      
 
5.2.3. TatA exhibits a uniform distribution in the inner membrane of E. coli in 
cells overexpressing only TatA 
 
The distribution of TatA was examined in wild type cells over-expressing TatA. 
Again, ∆tat cells were used as controls for non-specific binding. We first analysed 
cytoplasmic and membrane fractions to determine the proportion of TatA in the 
cytoplasm, by immunoblotting cell fractions. The data are shown in Figure 5.2.19, 
with cells over-expressing TatA. The vast majority of the TatA is found in the 
membrane fraction as expected. A small proportion (about 10%) is found in the 
cytoplasm, as observed in previous studies (Berthelmann et al., 2008). As expected, 
no signal was obtained in blots of ∆tat cells.  
 
Immunogold labelling was conducted to identify and localise the Tat complex in E. 
coli cells. Our aim was to achieve unambiguous identification of TatA protein in the 
inner membrane through immunogold labelling of E. coli cells overexpressing TatA. 
Firstly, the level of non-specific antibody labelling was assessed by comparing the 
level of gold binding between TatA-overexpressing cells and cells that do not 
express Tat machinery (∆tat). The images were examined for the presence of gold 
particles and these were then classified according to their location.  
 
Figure 5.2.25 (montage) shows representative images. The TatA-overexpressing cells 
(fixed in 0.25% glutaraldehyde/4%formaldehyde (fixative 2)) exhibit a pattern of 
gold labelling that is predominantly around the periphery and magnification of these 
images (not shown) confirmed that these particles were almost entirely in the inner 
membrane. A smaller number of particles are evident in the cell interior (Figure 
5.2.24 and 5.2.25, red circles). Analysis of ∆tat cells shows the presence of a small 
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number of gold particles in the cytoplasmic region with hardly any in the membranes 
(Figure 5.2.24.). These data confirm that the antibody is able to detect TatA with a 
high degree of specificity. As further controls, TatA-expressing cells were 
immunolabelled with the primary antibody omitted (Figure 5.2.24, labelled (-)), and 
TEM analysis showed that these cells lacked any gold binding; confirming that non-
specific binding seen in ∆tat cells was attributable to the primary antibody. Finally, 
the same cell type was immunolabelled with a gold conjugated-secondary antibody 
directed towards a different animal species (Figure 5.2.24, (-)2). TEM analysis 
showed only unlabelled E. coli cells, confirming that the cells do not have a non-





















Figure 5.2.24. Electron micrographs of E. coli cells, overexpressing TatA, immunogold-labelled 
following primary antibody detection against TatA protein. 
E. coli cells overexpressing TatA, were immunolabelled using a primary antibody raised against the 
TatA protein [labelled (+)].Controls: cells that had Tat machinery knocked-out [labelled (∆tat)]; (+) 
cells that had the primary antibody omitted [labelled (-1)], and (+) cells immunolabelled using a 
different secondary antibody [labelled (-2)]. Raw gold counts were taken from 200 randomly imaged 
E. coli from 2 separate resin blocks. Gold was assigned to either inner membrane compartments 
(yellow-dotted) or cytoplasm (red-dotted) for subsequent statistical analysis. Images were taken on 




















Figure 5.2.25. Montage of electron micrographs of E. coli cells, overexpressing TatA, immunogold-labelled following primary antibody detection against TatA 
protein. E. coli cells overexpressing TatABC were immunolabelled using a primary antibody raised against the TatA protein. The montage gives an overview of E. coli cells 
sectioned at different angles. TatA protein was found to exhibit a uniform distribution in the inner membrane (yellow circles) with some gold found in the cytoplasm (red 
circles). Images were taken on JEOL 2010F TEM at 12,000X magnification. Scale bar = 200nm. 
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Raw gold counts were collected from 200 randomly sampled, immunolabelled E. coli 
TatA-overexpressing and Δtat E. coli cells. Gold particles were assigned to either 
cytoplasmic or inner membrane compartments. Quantification of the gold particles 
(Figure 5.2.26.) shows that the average number of gold particles per compartment in 
TatA-overexpressing cells was 1.57 per cell in the cytoplasm and 0.99 per cell in the 
inner membrane, whereas Δtat cells bound approximately 0.595 in the cytoplasm and 
0.075 particles in the membrane per cell, respectively (Figure 5.2.26, B). The 
labelling of the membrane bound TatA is thus highly specific; the inner membrane of 
TatA-overexpressing cells contains 13.2x more gold particles than the membrane of 
∆tat cells. To confirm a statistical difference in immunogold labelling between these 
cells at the cytoplasm and inner membrane, Chi-squared analysis of the raw gold 
count data was conducted; for a total chi-squared value of 35.25 and 1 degree of 
freedom, P was less than 0.005. This confirms that the gold labelling distributions 
between the two cells types are significantly different. 
 
Importantly, the gold particles are randomly distributed within the membrane, with 
no evidence for a preferential localisation within the E. coli cell. The TatA is 
overexpressed to a considerable extent and is therefore in massive excess over the 
endogenous TatBC complex, and therefore TatA on its own has no intrinsic 
preference for a specific location in the membrane. 
 
Analysis of the distribution of gold particles in the cytoplasm shows the presence of 
1.57 and 0.595 particles in the TatA-overexpressing and Δtat cells, respectively. 
Since the particle number in Δtat cells represents nonspecific binding, and assuming 
that the level of nonspecific binding in the 2 cell types is identical, this indicates that 
TatA-overexpressing cells contain an average of 0.975 particles per cell in the 
cytoplasm, which is approximately the same number as in the inner membrane. Some 
of these particles can be attributed to genuinely cytoplasmic TatA, as shown in the 
blots in Figure 5.2.19., but the particle count for the cytoplasmic TatA is still 
surprising because blots showed the majority of TatA to be in the membrane fraction. 
It is unclear why the gold particle count is so high in the cytoplasm of these cells and 
this observation bears further examination. Therefore, the approach provides highly 
specific detection of TatA in the membrane fraction, whereas labelling of 












Figure 5.2.26. Quantitative analysis of raw gold counts of E. coli cells immunogold labelled with primary antibody detection against TatA protein.   
E. coli cells overexpressing TatA, were immunolabelled using a primary antibody raised against the TatA protein. Controls were cells that had Tat machinery knocked-out 
[labelled (∆tat)].  A: Raw gold counts were taken from 200 randomly imaged E. coli from 2 separate resin blocks. Gold was assigned to either inner membrane or cytoplasm 
compartment. The approximate number of gold at the inner membrane and cytoplasm of each cell was calculated, and subsequently the difference between the two cell types. 
B: The difference in average number of gold particles at the cytoplasm or inner membrane of each cell type is shown. Error bars: CI of 2xSE. C: Statistical analysis of raw 
gold counts. Values represent observed and (expected) numbers of 10 nm gold particles in the two different cell types. For a total chi-squared of 35.36 and 1 degree of 
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E. coli  200 200 
Raw Gold count TOTAL 512 132 
Raw Gold count at inner 
membrane 
198 15 
Approx. inner membrane gold per 
cell 
0.99 0.075 
Difference in the amount of gold 
at the inner membrane per cell 
0.99 / 0.075 = 13.2X 
Subcellular 






198 (169.3) 15 (43.66) 213 4.850 18.81 
Cytoplasm 314 (342.6) 117 (88.34) 431 2.397 9.297 













5.2.4. Increased expression of TatBC protein alters the distribution of TatA 
protein in the inner membrane of E. coli 
The distribution of TatA complexes was also examined in cell overexpressing the 
TatABC operon. This approach was taken so that we could test whether the presence 
of stoichiometric levels of the TatBC complex affects the distribution of TatA 
complexes. Fractionation of E. coli cells overexpressing TatABC mirrored the results 
of previous data showing that TatA is present within the cytoplasmic and membrane 
fraction of these cells (Figure 5.2.29.). These cells were then immunolabelled with 
anti-TatA antibody. Analogous to previous immunolabelling experiments, Δtat cells 
served as important negative controls. These cells showed gold binding, albeit very 
little, at the cytoplasmic and inner membrane regions (Figure 5.2.27). Representative 
images are shown in Figure 5.2.28 (montage), with the quantified data shown in 
Figure 5.2.30. The data show that TatABC-overexpressing cells bound on average 
1.25 gold particles per cell in the cytoplasm and 0.85 particles at the inner 
membrane, whereas Δtat cells bound approximately 0.60 particles per cell in the 
cytoplasm and 0.075 particles in the membrane. The data thus show that the TatABC 
cells bind approximately 11.3x more gold at the inner membrane than do Δtat cells, 
again confirming that the technique is able to detect the TatA with high specificity in 
these cells. The overall levels of TatA are fairly similar: 0.85 particles per cell in 
TatABC-overexpressing cells and 0.99 in TatA-overexpressing cells bound, which 
shows that expression of TatBC does not increase the levels of TatA in the 
membrane.  
Chi-squared analysis confirmed a statistical difference in immunogold labelling 
between TatABC-overexpressing and Δtat cells in both the cytoplasm and inner 
membrane: for a total chi-squared of 39.2 and 1 degree of freedom, P<0.005. 
Mirroring the findings of TatA-overexpressing cells, evidence for non-specific 
binding of the TatA antibody was found, since TatABC-overexpressing cells bound 
1.25 particles per cell in the cytoplasm, while Δtat cells bound 0.59 particles. This 
again, is contrary to the relatively low levels of cytoplasmic TatA observed on the 





















Figure 5.2.27. Electron micrographs of E. coli cells, overexpressing TatABC, immunogold-
labelled following primary antibody detection against TatA protein. 
E. coli cells overexpressing TatABC, were immunolabelled using a primary antibody raised against 
the TatA protein [labelled (+)].Controls: cells that had Tat machinery knocked-out [labelled (Δtat)]; 
(+) cells that had the primary antibody omitted [labelled (-1)], and (+) cells immunolabelled using a 
different secondary antibody [labelled (-2)]. Raw gold counts were taken from 200 randomly imaged 
E. coli from 2 separate resin blocks. Gold was assigned to either inner membrane compartments 
(yellow-dotted) or cytoplasm (red-dotted) for subsequent statistical analysis. Images were taken on  




















Figure 5.2.28. Montage of electron micrographs of E. coli cells, overexpressing TatABC, immunogold-labelled following primary antibody detection against TatA 
protein. E. coli cells overexpressing TatABC were immunolabelled using a primary antibody raised against the TatA protein. The montage gives an overview of E. coli cells 
sectioned at different angles. TatA protein was found to exhibit a uniform distribution in the inner membrane (yellow circles) with some gold found in the cytoplasm (red 

































Figure 5.2.29. Cytoplasmic and membrane fractions of E. coli cells (overexpressing TatABC) 
immunoblotted for the detection of TatA protein.   
E. coli cells overexpressing TatABC were fractionated into cytoplasmic and inner membrane 
fractions. The fractions were resolved by SDS PAGE and immunoblotted to detect for the presence of 
TatA protein. The control was E. coli cells that have had Tat machinery knocked-out (Δtat). Anti-
TatA antibody identified TatA protein in both the cytoplasm and membrane of TatABC over-













































































Figure 5.2.30. Quantitative analysis of raw gold counts of E. coli cells immunogold labelled with primary antibody detection against TatA protein.   
E. coli cells overexpressing TatABC, were immunolabelled using a primary antibody raised against the TatA protein. Controls were cells that had Tat machinery knocked-out 
[labelled (Δtat)].  A: Raw gold counts were taken from 200 randomly imaged E. coli from 2 separate resin blocks. Gold was assigned to either inner membrane or cytoplasm 
compartment. The approximate number of gold at the inner membrane and cytoplasm of each cell was calculated, and subsequently the difference between the two cell types. 
B: The difference in average number of gold particles at the cytoplasm or inner membrane of each cell type is shown. Error bars: CI of 2xSE. C: Statistical analysis of raw 
gold counts. Values represent observed and (expected) numbers of 10 nm gold particles in the two different cell types. For a total chi-squared of 39.2 and 1 degree of  
freedom, P<0.005 (indicated by +++ on the graph); hence the two labelling distributions are significantly different.   
 
TatABC Δtat 
E. coli  200 200 
Raw Gold count TOTAL 420 132 
Raw Gold count at inner 
membrane 
170 15 
Approx. inner membrane gold per 
cell 
0.85 0.075 
Difference in the amount of gold 
at the inner membrane per cell 
0.85 / 0.075 = 11.3X 
Subcellular 






170 (140.2) 15 (44.74) 185 6.309 19.78 
Cytoplasm 250 (279.7) 119 (89.25) 369 3.163 9.914 













With increased expression of TatBC proteins, immunogold labelling showed the 
TatA protein to exhibit a uniform distribution around the periphery of the cell in 
most cells, as shown in Figure 5.2.28. However, in 4% of the cells (4 cells out of 100 
imaged) the distribution of TatA protein altered in the inner membrane, with a 
clustering of gold clearly observed (Figure 5.2.31). This distribution was not 
observed in any of the TatA-overexpressing cells. Quantitation of the number of 
TatA clusters in independently-sampled TatA-overexpressing and TatABC-
overexpressing cells confirmed that the presence of clusters in the latter cell type was 
statistically significant (Figure 5.2.32).   
 
Due to the nature of TEM analysis, the images are 2D projections; we do not have 
any idea of whether this clustering is consistent with an extension of TatA in the 























Figure 5.2.31. Electron micrographs of E. coli cells, overexpressing TatABC, immunogold-
labelled following primary antibody detection against TatA protein. 
A) E. coli cells overexpressing TatABC, were immunolabelled using a primary antibody raised 
against the TatA protein [labelled (+)].Controls: cells that had Tat machinery knocked-out [labelled 
(Δtat)]; (+) cells that had the primary antibody omitted [labelled (-1)], and (+) cells immunolabelled 
using a different secondary antibody [labelled (-2)]. With increased expression of TatBC, the 
localisation of the TatA protein altered in approximately 1 in 25 of cells. TatA protein appeared to 
cluster along the inner membrane (highlighted in yellow). Images were taken on JEOL 2010F TEM at 



























Figure 5.2.32 Statistical analysis of clustering of TatA in the inner membrane of E. coli.  
E. coli cells overexpressing TatA or TatABC were immunolabelled using a primary antibody 
raised against TatA protein. Top panel: count data for the presence of gold clustering along 
the inner membrane was collected from 100 randomly imaged E. coli (from 5 independently 
prepared samples). Subsequently the average number of clusters per cell was calculated for 
each cell type (top graph). Error bars: CI of 2xSE. Bottom panel: statistical analysis of count 
data. Values represent observed and (expected) numbers of TatA clustering in the inner 
membrane. For a total chi-squared of 5.18 and 1 degree of freedom, P<0.01 (indicated by ++ 
on graph); hence the labelling distribution of TatA clustering is significantly different 







Cluster 0 (2.23) 4 (1.76) 4 2.23 2.83 
Non-cluster 100 (97.7) 75 (77.23) 175 0.05 0.06 







































5.2.5. The TatA protein of the Tat complex does not exhibit a polar localisation 
Given that a protocol to unambiguously identify TatA in the inner membrane of  
E. coli had now been optimised; the polarity of the TatA protein was investigated. 
TatA-YFP was not found to localise to any sub regions of an E. coli cell (Leake et 
al., 2008), whereas a later study using a TatA-GFP construct found TatA foci 
(complexed with TatB-mCherry) to have a tendency to move to the cell poles  (Rose 
et al., 2013). Whether the Tat complex or any of its constituents exhibits such 
localisation remains dubious since TatA-XFP fusions have been shown to be inactive 
(Alcock et al., 2013; Leake et al., 2008; Ray et al., 2005).    
 
Raw gold counts were taken from 200 randomly-sampled E. coli cells that had been 
longitudinally cross-sectioned (to ensure inner membrane of a polar localisation was 
captured). Gold was assigned to either a polar or non-polar localisation. A polar 
region was defined at the point in which the cell wall is non-linear (Figure 5.2.33., F, 
yellow dashed lines). The TatA protein was found to localise in the entire periphery 
of the cell (Figure 52.33., yellow circle), with no distinct polarity witnessed. 
Clustering of the TatA protein was found in both polar and non-polar locations 
(Figure 5.2.33., red circle). 638 TatA-bound gold was identified, over 70% (454) of 
which was NOT localised to the poles of the cell (Figure 5.2.34). T-test analysis 
confirmed a statistically significant difference between these cellular regions 





















Figure 5.2.33. Electron micrographs of E. coli cells, overexpressing TatABC, immunogold-labelled following primary antibody detection against TatA protein to. 
E. coli cells overexpressing TatABC, were immunolabelled using a primary antibody raised against the TatA protein [labelled (+)].Raw gold counts were taken from 200 
randomly imaged E. coli (from 2 separate resin blocks) that had been longitudinally cross-sectioned. Gold was assigned to either polar or non-polar localisation. No polar 
localisation of TatA protein was apparent. Yellow circle = inner membrane binding. Blue circle = cytoplasmic localisation. Red ellipse = clustering at inner membrane. 
Images were taken on JEOL 2010F TEM at 12,000X magnification. Scale bar = 200 nm. 
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Figure 5.2.34. Quantitative analysis of raw gold counts of immunogold-labelled E. coli cells to 
determine polarity of Tat complex. 
E. coli cells overexpressing TatABC were immunolabelled using a primary antibody raised against the 
TatA protein. Raw gold counts were taken from 200 randomly imaged E. coli (from 2 separate resin 
blocks) that had been longitudinally sectioned. Gold was assigned to either polar or non-polar 
localisation. The TatA protein does not appear to possess a polar localisation, with only 29% of gold 
being found at the poles of the bacterial cells. T-test analysis confirms a statistically significant 









E. coli  172 
Raw Gold count TOTAL 638 
Raw Gold count at poles of cell 184 
Raw Gold NOT at poles of the cell 454 
  Proportion of gold at the poles of the cell  28.84% 







5.2.6. Wild-type levels of TatA protein are not detectable with immunogold 
labelling  
It is unknown whether overexpression of recombinant Tat proteins alters the 
distribution or localisation of Tat machinery; therefore E. coli cells expressing wild-
type levels of TatA were immunogold-labelled to detect any difference in TatA 
localisation or distribution at the inner membrane. Results show that no gold bound 
the E. coli cells (Figure 5.2.35.) and therefore overexpression of TatA protein is the 










Figure 5.2.35. Electron micrograph of E. coli cells, overexpressing WT levels of Tat machinery, 
immunogold-labelled following primary antibody detection against TatA protein. 
E. coli cells expressing WT levels of Tat protein were immunolabelled using a primary antibody 
raised against the TatA protein. There was an abundance of gold-free cells illustrating a lack of 
antigenic sites available for anti-TatA binding. Those that had bound antibody, the gold was localised 
predominantly at the inner membrane (highlighted in yellow). Images were taken on JEOL 2010F 







5.2.7. Array tomography reveals a linear clustering of TatA protein in the inner 
membrane of E. coli.  
Having unambiguously identified TatA protein in the inner membrane of E. coli, 20 
50 nm serial sections of resin-embedded E. coli overexpressing TatABC were 
sequentially imaged in the scanning electron microscope (Figure 5.2.36). A small 
3x4 montage was imaged from each of the sections at 5000 x magnification (Figure 
5.2.36.).  Following alignment of the serial sections, the image stack was 
computationally segmented such that image stacks of individual E. coli cells were 
input into subsequent image analysis (in IMOD software (Kremer et al., 1996). This 
was achieved by manually contouring the periphery of each individual bacterium, on 
each section (Figure 5.2.37., top panel). Simultaneously, the position of any gold 
particles on the section was also marked (Figure 5.2.37., bottom panel, red circles). 
This procedure was repeated for 6 cells which were chosen at random. 
     
Having successfully contoured the E. coli cells that were visible on all of the 20 
sections (Figure 5.2.38., A), 3D reconstructions of individual bacteria were generated 
(Figure 5.2.38., B). Analysis of the positions of the gold particles (and thus TatA 
protein) unveiled a cluster of TatA in the inner membrane of each E. coli cell (Figure 
5.2.39.). Notably, 4 out of 6 of the E. coli contoured exhibited a linear cluster of 
TatA in the inner membrane; whereas with 2D TEM analysis only 4% of cells 
analysed were seen to possess such a TatA cluster. Therefore, it seems likely that this 
distribution of TatA is likely to be more common than originally anticipated from 
TEM analysis (§5.2., Figure 5.2.31). This is the first time that the localisation and 


























Figure 5.2.36. Serial sections of resin-embedded E.coli cells positioned under the electron beam 
of the scanning electron microscope.  
Serial sections of resin-embedded E. coli cells, overexpressing TatABC, were transferred onto carbon-
coated glass coverslips and placed in the imaging chamber of the SEM. Image acquisition commenced 
from the top of the ribbon (yellow dashed box) and sequentially moved downwards. A 3x4 montage 
















































Figure 5.2.37. Manual 
contouring of individual 
E. coli cells to segment 
data.  
Using IMOD software, 
individual E. coli cells 
were manually contoured 
via tracing the entire 
perimeter of the cell on 
each section (images 1-16 
below). Also, the position 
of any gold was added (red 
circles below on images 1-
16).Scale bar = 250 nm.   
    


















































Figure 5.2.38. 3D reconstruction of E. coli cells 
A) Acquisition of serial electron micrographs of E. coli cells (5000X magnification) for subsequent 
contouring (coloured ellipses). Images taken on Image taken on JEOL 7401-F. B) IMOD software 






























Figure 5.2.39. 3D visualisation of a linear distribution of the TatA protein in the inner 
membrane of E. coli.  
Upon reconstruction of individual E. coli cells, the position(s) of immunolabelled TatA protein could 
be deciphered. The above reconstructions illustrate a linear distribution of TatA protein in the inner 









5.2.8. Optimisation of immunogold labelling of TatB protein in the inner 
membrane of E. coli  
Given the novel finding of the distribution of TatA protein in the inner membrane of 
E. coli (§5.2.7., see above), it still remains unknown where the TatB or TatC proteins 
localise, relative to TatA protein. TatB is known to localise with TatC at 1:1 
stoichiometric ratio (Bolhuis et al., 2001), and serves as the substrate-binding 
complex of the Tat translocase (Cline & McCaffery, 2007; Tarry et al., 2009). It 
remains elusive whether this TatBC complex serves as a nucleation point for TatA 
polymerisation and hence TatA extending out into the inner membrane (Frobel et al., 
2012), or whether a different conformation of Tat constituents occurs. Therefore 
immunogold labelling of TatB protein was attempted to gain further insight into the 
location of this protein in the inner membrane.    
Fractionation of TatABC overexpressing cells confirmed the inner membrane 
localisation of TatB protein (Figure 5.2.41). Initial immunogold labelling of the same 
cells showed a high density of gold labelling in (+) cells (Figure 5.2.39., A (+)), 
although there was significant binding to ∆tat cells (Figure 5.2.40, B ∆tat). Despite 
efforts to increase ionic and detergent concentrations, and dilution of anti-TatB 
antibody, the anti-TatB antibody still bound non-specifically to ∆tat cells, with 
clustering of gold seen (Figure 5.2.40., B (+) and ∆tat). Therefore reliable, 
unambiguous insight into the localisation of TatB protein in the inner membrane 














































Variable           
[NaCl]  
w/v /% 
0.8 1.6 0.8 1.6 2 2.5 2 2.5 2.5 2.5 
[Tween/20] 
v/v /% 
0.1 0.1 0.5 0.5 1 1 2 2 2 2 
Dilution of 
anti-TatB 
1:20 1:20 1:20 1:20 1:20 1:20 1:20 1:20 1:40 1:80 
 A        B  
 
Figure 5.2.40. Electron micrographs of E. coli cells, overexpressing TatABC, immunogold-
labelled following primary antibody detection against TatB protein. 
E. coli cells overexpressing TatABC, were immunolabelled using a primary antibody raised against 
the TatB protein [labelled (+)].Controls: cells that had Tat machinery knocked-out [labelled (Δtat)]; 
(+) cells that had the primary antibody omitted [labelled (-1)], and (+) cells immunolabelled using a 
different secondary antibody [labelled (-2)]. The primary antibody bound non-specifically in all areas 
of E. coli (images labelled A). An increase in salt and detergent concentrations (table above) 
minimised non-specific binding, with an optimal antibody concentration of 1:40 (images labelled B). 
However, the (+) and (∆tat) samples remained indistinguishable and clustering of gold was present 
(red circle). Images were taken on JEOL 2010F TEM at 12,000X magnification. Scale bar = 200 nm.  
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Figure 5.2.41. Cytoplasmic and membrane fractions of E. coli cells (overexpressing TatABC) 
immunoblotted for the detection of TatB protein.   
E. coli cells overexpressing TatABC were fractionated into cytoplasmic and inner membrane 
fractions. The fractions were resolved by SDS PAGE and immunoblotted to detect for the presence of 
TatB protein. The control was E. coli cells that have had Tat machinery knocked-out (Δtat)). Tat anti-





































TatA plays an essential role in the Tat translocation system, and insight into the 
localisation and distribution of the TatA protein is fundamental to elucidating the 
mechanism of Tat translocation. Analysis of this membrane protein in situ to avoid 
the use of detergents remains a challenging task; previous experiments have used 
YFP-labelled TatA proteins in combination with confocal microscopy to analyse Tat 
distribution in the inner membrane (Alcock et al., 2013; Leake et al., 2008). 
However, there remains a risk that TatA-XFP fusion proteins may not be properly 
active (Ray et al., 2005). In this study we have used 2D and 3D EM approaches to 
study the location and organisation of TatA, which is native, apart from the presence 
of a C-terminal His tag which has been shown not to affect activity (Bolhuis et al., 
2001). This is thus the first study to analyse active TatA complexes and the first to 
analyse TatA organisation in 3D. Given that this translocase accomplishes the 
remarkable feat of transporting large, fully-folded proteins without jeopardising 
membrane integrity, such spatial data is important for a deeper understanding of the 
system.    
To achieve unambiguous immunolabelling of TatA protein, numerous variables were 
optimised to maximise TatA protein availability for binding at the surface of the 
section and/or minimise non-specific interactions between the negatively charged 
antibodies and gold-conjugates to the positively-charged areas of the resin. Such 
variables included: buffer pH, +/- presence of a blocking agents (BSA and normal 
sera) and fixative concentrations. Whilst these variables had only a slight impact on 
the antibody binding; it was alteration of the primary antibody that made the biggest 
difference. The anti-TatA antibody is a custom-made monoclonal antibody that 
bound maximally to TatA antigen in E. coli cells. The trialling of numerous primary 
antibodies highlighted a key requirement to the success of this technique: the use of a 
high-titre, high-affinity antibody to allow the greatest dilution thus minimising non-
specific labelling.   
The highly-specific, immunogold labelling of TatA in E. coli cells shows that this 
protein is randomly distributed in the inner membrane when overexpressed at levels 
where it cannot engage in translocation owing to a lack of TatBC complexes. There 
is no evidence of a preferential localisation of this protein elsewhere within the cell.  
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However, in cells that overexpress TatBC proteins alongside TatA there is a 
distinguishable alteration in the organisation of TatA protein. A small proportion of 
cells (4%) exhibit a linear clustering of TatA in the inner membrane. 3D array 
tomography was able to provide much more insight into the localisation of TatA 
compared to the 2D data. Array tomography data revealed that TatA forms linear 
clusters in the inner membrane of E. coli.  
This is the first demonstration for an organisation of this kind for TatA. Previous 
studies have identified higher order organisations of TatA previously, including 
(Berthelmann et al., 2008) who showed TatA to form huge tubules in the cytoplasm 
of E. coli. However, their appearance is completely different under the TEM 
compared to those in this study. Furthermore, a mutation in the TatA subunit of B. 
subtilis (TatAd) TatAdCd complex triggered the formation of long fibrils. Authors 
speculated that such fibrils could be an aberrant super-assembly of TatAd. It is 
possible that the clusters seen in this study could be related to those fibrils.  
Other studies have utilised XFP-labelled TatA to analyse its distribution in bacteria. 
The issue in these instances is the finding that TatA-XFP is inactive (Alcock et al., 
2013; Ray et al., 2005). Alcock et al. (2013) expressed a Tat-YFP fusion in the 
presence of TatA paralog, TatE. They observed a doubling of export of native Tat 
substrate, showing that TatA-YFP could somehow interact with TatE and stimulate 
its activity; however the underlying reasons for this are unclear. They also observed 
that TatA can exist in both dispersed and higher oligomer states, and that the 
distribution of TatA is controlled by other components of the Tat machinery namely 
TatBC. However, it is impossible to effectively compare the data obtained in this 
study with the EM data presented in this investigation for two reasons. Firstly, it is 
possible that Alcock et al. could have measured the assembly-disassembly of TatE 
complexes, with TatA-YFP incorporated. Secondly, it is unclear how inactive TatA-
YFP complexes could have contributed to the fluorescence signals.       
The ability to identify TatA in the inner membrane allowed investigation into 
whether the E. coli cell poles serve as a prerequisite for the localisation of this 
protein. Sequestration of Tat constituents could have important implications for the 
mechanism of Tat machinery. Protein assembly at specific sites is known for other 
proteins in E. coli, which provided fundamental insight into their activity. E.g. 
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inhibitors of the FtsZ protein (that drives cytokinesis in cell division), localise to the 
cells poles creating an inhibitor-free zone at the cell centre enabling cell division 
(Lutkenhaus, 2007).   
Rose et al., 2013, showed TatA to colocalise with TatB at the cell poles (Rose et al., 
2013). They hypothesise that this colocalisation could benefit the Tat translocase 
since the cardiolipin-rich cell poles (Huang & Ramamurthi, 2010; Renner & Weibel, 
2011) could help position and/or assemble Tat, which is consistent with data showing 
that export of Tat substrate is severely impaired in E. coli cells that have been 
depleted in cardiolipin phospholipid (Mikhaleva et al., 1999). However, the same 
results were also found of E. coli cells depleted in phosphatidylethanolamine 
(Mikhaleva et al., 1999), questioning the relevance of this data regarding the polar 
export of Tat.  
Furthermore, fluorescently-labelled proteins can localise to non-biologically relevant 
regions due to attractive interactions that arise solely as a consequence of this tagging 
(Tavare et al., 2001). The data presented in this chapter omitted the use of large-
recombinant tags and analysed the TatA protein in situ. Data shows that there is no 
preferential localisation of TatA protein at the cell poles of E. coli. Further 
immunogold labelling experiments of other Tat proteins (TatB or –C) could 
consolidate this finding. Also, it would be interesting to investigate whether this 
localisation altered upon changing levels of Tat substrate since the immunogold 
labelling experiments are a “snap-shot” of Tat localisation in the inner membrane.     
It is to be remembered that the E. coli cells used in this part of the investigation are 
overexpressing Tat proteins (namely, TatA and TatABC); hence it is important to 
consider the possibility that the clustering of TatA witnessed in the inner membrane 
could be a consequence of overexpression of Tat machinery. However Matos et al. 
showed that induction of Tat machinery from a pBAD system (as used in this 
investigation), relieved  saturation of Tat machinery; demonstrating that the Tat 
proteins expressed upon induction are capable of forming active Tat complexes that 
are able to transport substrates across the inner membrane of E. coli.        
To conclude, the data in this chapter show for the first time the localisation and 
distribution of a Tat component in 3D space, in its native cellular environment. At 
present we do not know whether the linear clustering of TatA in the inner membrane 
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is consistent with a pore-forming mechanism of Tat. More specifically, we do not 
know where the other Tat constituents are localised relative to the TatA labelled in 
this study. Co-labelling immunogold experiments could identify the localisation of 
both TatA and TatB, TatC or Tat substrate in the inner membrane, and thus aid the 
interpretation of data obtained in this chapter. Of course these experiments require a 
high-titre, high-affinity antibody against any of those additional components listed. 
The methodology used in this investigation has the potential to be applied to any 
cellular antigen – not just those of the Tat machinery. The identification of individual 
proteins can unveil novel levels of organisation and consequently test mechanistic 




























Chapter 6:  
Stable expression of a non-
cleavable Tat precursor in the 


















The ability of the Tat translocase to transport fully-folded proteins into the 
periplasmic space has captured the interest and investment of the biotechnology 
industry, since it offers potential to simplify downstream processing of 
biotherapeutic proteins (reviewed in section §1.7.2).     
 
The initial studies of (Matos et al., 2012) and (Alanen et al., 2015) tested Tat’s 
capability of transporting a heterologous protein on a large scale. Results showed 
high levels of TorA-GFP export at ~0.35 g.L
-1
 with no large-scale release of 
cytoplasmic contents, confirming this translocase’s potential as a viable method of 
producing therapeutic protein. More recent data showed Tat to successfully transport 
biopharmaceuticals including human growth hormone (hGH), interferon α2b and 
antibody fragments (Alanen et al., 2015). 
 
The cytoplasm is highly organized with proteins localising to specific regions within 
this aqueous milieu; therefore knowledge of a preferential localization or distribution 
of Tat substrate shall enable us to gain deeper insight into Tat transport and 
potentially assist in the exploitation of this protein machinery for the biotechnology 
industry.  
 
In this chapter I present the first detailed EM analysis of the export of a 
biopharmaceutical, hGH, fused to a TorA signal peptide (TorA-hGH) via Tat 
machinery. hGH is a single polypeptide chain of 191 amino acids and is one of the 
most important hormones in the human body, possessing vital roles in numerous 
biological processes including cell metabolism and proliferation (Kassem et al., 
1993). Recombinant hGH is used therapeutically to treat hGH deficiency and a range 
of genetic disorders (Sanchez-Ortiga et al., 2012; Spiliotis, 2008; Takeda et al., 
2010; Vogt & Emerick, 2015).  
 
In this study I used two constructs: TorA-hGH and a mutant non–cleavable version, 
TorA(A39L)-hGH. The latter contained an alanine  leucine substitution at the final 
residue of the signal peptide, and this is predicted to block processing by leader 
peptidase. On the basis of previous data on an authentic Tat substrate (Ren et al., 
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2013), this mutation is expected to result in the mature protein being targeted to the 
periplasm, after which the protein remains integrated into the inner membrane by 
means of the uncleaved signal peptide. I used immunogold labelling and TEM 
analysis to probe the localization and distribution of these Tat substrates in situ. 
Initially, optimisation was carried out to unambiguously identify hGH within the E. 
coli cells. These data highlight the high specificity of the anti-HGH antibody used for 
labelling.  
 
Results of immunogold labelling experiments show that the TorA-hGH Tat substrate 
exhibits a random distribution in the cytoplasm and, as has been seen with the Tat 
machinery (Alcock et al., 2013; Leake et al., 2008; Rose et al., 2013), a uniform 
distribution in the inner membrane of E. coli. Formation of cytoplasmic inclusion 
bodies was identified, which is common for the heterologous expression of hGH in 
E. coli (Fahnert et al., 2004; Goeddel et al., 1979; Ikehara et al., 1984); however 
their abundance was very low. Export assays showed that the non-cleavable TorA-
hGH precursor was stably expressed at the inner membrane offering potential for the 























6.2.1. Export of TorA-hGH precursor by Tat machinery  
 
hGH has previously been shown to be exported efficiently into the periplasm of E. 
coli by Tat machinery (Matos et al., 2012). It is synthesized as a 27 kDa precursor 
protein, and was expressed with a TorA signal peptide that contains features typical 
of a Tat signal peptide (Figure 6.2.1). These include an N-terminal domain, a 
hydrophobic core region and a polar C-terminal domain ending with an Ala-Xaa-Ala 
consensus motif (shown in blue). It is this signal peptide that targets hGH 
specifically to the Tat machinery. This protein was chosen for this study since it is a 
high-value therapeutic protein produced by the biotechnology industry for treatment 
of hGH deficiencies (and associated disorders) in adults and children (Sanchez-
Ortiga et al., 2012; Spiliotis, 2008; Takeda et al., 2010; Vogt & Emerick, 2015).   
 
Figure 6.2.2 shows a typical export assay experiment in which synthesis of non-
mutated TorA-hGH precursor was induced in wild type (WT) MC4100 E. coli cells. 
At certain time points after the induction of plasmid, cells were fractionated to 
generate cytoplasm (C), membrane (M) and periplasm (P) samples which were 
analysed by SDS-PAGE and immunoblotting. Two forms of hGH are detected by 
immunoblotting of whole cell fractions: 27 kDa precursor protein and 22 kDa mature 




















Figure 6.2.1. Structure of the TorA signal peptide and the TorA-A39L variant.  
Primary structure of the 42-residue signal peptide of E. coli TorA. The consensus motif is 
highlighted in red (twin-arginine motif underlined), and the peptidase cleavage site is 
highlighted in blue. The terminal, alanine residue at position 39 (highlighted in green), was 
substituted by leucine to generate the TorA-A39L variant.      
 
Results in Figure 6.2.2 show that when hGH is fused to a non-mutant signal peptide 
(TorA-hGH), export of the substrate occurs soon after induction- at 1 hour mature 
hGH is present in the periplasm. Most hGH detected in the cytoplasm is mature 
form. This is most likely due to proteolytic cleavage of the precursor protein in the 
cytoplasm. A minimal amount of precursor protein in this fraction has been observed 
previously (Alanen et al., 2015), where it was shown precursor TorA-hGH was 
efficiently exported by the Tat machinery. Therefore, a lack of cytoplasmic precursor 
protein in this study could be due to the quick turnover of the substrate from the 
cytoplasm to the periplasm, or due to the fact that most of it is being degraded to 
mature form. At 1hr 45, the membrane fraction contains precursor TorA-hGH, with 
mature protein detected at later time points (2hr 15 onwards). The precursor protein 
is likely Tat substrate at the inner membrane undergoing translocation. The exact 
nature of mature hGH was investigated further by visualisation under the TEM 







































Figure 6.2.2. Export assay of Tat substrate (TorA-hGH) into the periplasm of E. coli.  
Western Blot to detect the presence of hGH in E. coli. Post-induction with 1 mM IPTG 
E.coli cells overexpressing hGH fused to a TorA signal peptide (TorA-hGH) were grown at 
37
o
C for 3 hours. During this time, cells were periodically harvested, normalised for OD600 = 
10 and subsequently fractionated to periplasm (P), cytoplasm (C) and membrane (M) 
fractions. Each fraction was examined for the presence of hGH by immunoblotting with anti-
hGH antibody. Results show there is a good level of export from as early as 1 hour after 
induction, shown by the presence of mature hGH (22 kDa) in the periplasm. At each time 
point there is a lack of pre-cursor (27kDa) TorA-hGH (i.e. Tat substrate) in the cytoplasmic 
fractions, indicating the substrate is either degraded or forming inclusion bodies in the cell. 
From 1hr 45min onwards there is a consistent level of precursor TorA-hGH in the membrane 
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6.2.2. Substitution at the -1 position of the signal peptide blocks maturation of 
TorA-hGH 
To further examine the export of a Tat precursor protein, the -1 alanine residue in the 
TorA signal peptide was substituted by leucine (TorA-A39L) (Figure 6.2.1.). This 
mutated signal peptide was fused to hGH and expressed in E. coli. An identical 
mutation in the TorA signal peptide was performed by (Ren et al., 2013), who 
showed that the -1 position in the signal peptide is essential for efficient maturation 
of precursor protein. The mutation completely blocked export of a Tat precursor 
protein into the periplasmic space. To test whether the same mutation blocks 
maturation of the hGH protein (and to gain more insight into the export of 
heterologous Tat substrates), the export assay was repeated with expression of 
TorA(A39L)-hGH.  
 
Consistent with the findings of (Ren et al., 2013) the precursor protein was not 
processed to any significant degree and is found almost exclusively in the membrane 
fraction as precursor protein (Figure 6.2.3., 1hr 15 onwards). The exact nature of this 
non-cleavable mutant precursor was examined further by visualisation under the EM. 
Results are presented in section 6.2.7 of this chapter.  
As seen with the wild type precursor, mature hGH was detected in the cytoplasm 
from an early time point (1hr), which most likely represents proteolytic cleavage of 
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Figure 6.2.3. Export assay of a non-cleavable Tat substrate (TorA(A39L)-hGH) into the 
periplasm of E. coli.  
Western Blot to detect the presence of non-cleavable hGH in E. coli. Post-induction with 1 
mM IPTG E.coli cells overexpressing hGH fused to a non-cleavable TorA signal peptide 
(TorA-hGH) were grown at 37
o
C for 3 hours. During this time, cells were periodically 
harvested, normalised for OD600 = 10 and subsequently fractionated to periplasm (P), 
cytoplasm (C) and membrane (M) fractions. Each fraction was examined for the presence of 
hGH by immunoblotting with anti-hGH antibody. A lack of hGH protein in the periplasm of 
any time point confirms that the Tat substrate is non-cleavable and thus remains in the inner 
membrane fraction. hGH is degraded in the cytoplasm from as early as 1hr indicated by the 
mature sized hGH (22 kDa). This is degraded by 2hr 15mins. From 1hr 15 min onwards 
there is a consistent level of precursor TorA-hGH (27 kDa) in the membrane fraction of the 





6.2.3. Immunogold labelling of TorA-hGH in E. coli cells  
 
To investigate the localisation of the Tat precursor protein further, immunogold 
labelling and electron microscopy was used to directly visualise these proteins in 
situ. E. coli cells overexpressing TorA-hGH or TorA(A39L)-hGH were fixed, stained 
and resin-embedded for analysis under the EM. The first step was to optimise 
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Figure 6.2.4. Optimisation of immunogold labelling of TorA-hGH in E. coli  
Electron micrograph of resin-embedded, sectioned, immunogold-labelled cells. E. coli cells 
overexpressing TorA-hGH (after 3hrs of induction) were immunogold labelled using anti-
hGH antibody (C). Non-specific gold was abundant in the resin, with clustering of gold 
witnessed inside of the E. coli cells. Controls were E. coli cells that lacked heterologous 
expression of the TorA-hGH protein (A+B), and cells that expressed TorA-hGH but lack 
immunolabelling with primary antibody (D). A and B: labelling of the control cells, 
irrespective of 1:20 or 1:100 dilution, illustrated the non-specific binding of the anti-hGH 
antibody since gold was distributed all over the E. coli cells and resin. D: non-specific 
binding was attributable to solely the primary antibody given a lack of gold binding when E. 
coli cells were labelled with the secondary antibody only. Images taken on JEOL 2010F 






6.2.4. Optimisation of immunogold labelling for the unambiguous identification 
of hGH in E. coli cells  
 
hGH expressed in E. coli cells was detected using an anti-hGH antibody and 
subsequently gold-labelled using a gold-conjugated secondary antibody. Gold 
labelling was performed on resin-embedded cells as described in the Materials and 
Methods (§2.10.1.14). 
Initial immunogold labelling of E. coli cells showed a large number of gold particles 
located randomly throughout the cells and in the resin (Figure 6.2.4, C). Similarly, 
cells which lacked expression of TorA-hGH and TorA(A39L)-hGH bound gold 
heavily (Figure 6.2.4, A+B), showing high levels of non-specific antibody binding 
irrespective of primary antibody dilution. Omitting the primary antibody from the 
immunolabelling process (Figure 6.2.4., D), confirmed that the non-specific binding 
observed in other samples was due to the primary anti-hGH antibody.  
 
Increasing salt and detergent concentration in dilution/wash buffers (3X and 20X, 
respectively) and increasing dilution of primary antibody to 1:1000 gave a marked 
improvement in immunogold labelling of TorA-hGH and TorA(A39L)-hGH in E. 
coli cells (Figure 6.2.5.). At these concentrations there were minimal non-specific 
interactions between positively charged tissue components and negatively charged 
antibodies.  
 
Both TorA-hGH and TorA(A39L)-hGH were found to possess a random distribution 
in the cytoplasm (Figure 6.2.5., red circle). For the mutant precursor, maturation is 
blocked; therefore gold bound at the periphery of the cell (Figure 6.2.5, middle, 
yellow circle) is very likely to be localised at the inner membrane. For the WT 
precursor, immunoblots (Figure 6.2.2.) showed evidence of maturation of hGH 
protein and thus localisation to the periplasm. Given the close spatial proximity of 
the inner membrane and periplasmic space in the E. coli cell; gold bound at the 





Analysis of E. coli cells lacking expression of hGH protein revealed gold binding at 
the cytoplasm and membrane regions (Figure 6.2.5, right); therefore to gauge the 




















Figure 6.2.5. Unambiguous immunogold labelling of TorA-hGH in E. coli  
Electron micrographs of resin-embedded, sectioned, immunogold-labelled E. coli cells. E. coli cells overexpressing WT or mutant precursor TorA-hGH were 
immunolabelled using anti-hGH antibody (+). Controls were E. coli cells that lacked expression of TorA-hGH. After increasing salt and detergent 
concentrations in wash/dilution buffers to minimise non-specific binding, both (+) cells displayed binding uniformly in the inner membrane (yellow circles) 
and in the cytoplasm (red circle).  Some gold bound the control E. coli cells (right-handside image) indicating that non-specific binding, although significantly 
reduced, was not eradicated.     
WT precursor (+) WT cells, no hGH (-) Mutant precursor (+) 
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6.2.5. Quantitative analysis of non-specific binding of anti-hGH antibody to E. 
coli cells       
 
Raw gold counts were collected from 200 randomly sampled, anti-hGH 
immunolabelled E. coli for both TorA-hGH-overexpressing cells and WT E. coli 
cells lacking expression of the hGH protein. Gold was assigned to either cytoplasmic 
or membrane compartments and the average number of gold particles per cell was  
























Figure 6.2.6. Quantitative analysis of raw gold counts of E. coli cells immunogold labelled with primary antibody detection against TorA-hGH 
protein.  
E. coli cells overexpressing TorA-hGH were immunolabelled using a primary antibody against the hGH protein. Controls were E. coli cells that lacked 
expression of hGH protein. A: Raw gold counts were taken from 200 randomly imaged E. coli from 2 separate resin blocks. Gold was assigned to either 
‘membrane + periplasm’ (labelled membrane in B) or cytoplasm compartment. The approximate number of gold at each compartment was calculated, and 
subsequently the difference between the two cell types. B: The difference in average number of gold particles at the membrane and cytoplasm of each cell type 
is shown. Error bars: CI of 2x SE. C: Statistical analysis of raw gold counts. Values represent observed and (expected) number of 10 nm gold particles in the 




E. coli  200 200 
Raw Gold count TOTAL 1241 263 
Raw Gold count at membrane + 
periplasm 
858 91 
Approx. membrane + periplasm 
gold per cell 
4.29 0.455 
Difference in the amount of gold 
at the membrane (+ periplasm) per 
cell 
4.29 / 0.455 = 9.42X 
Subcellular 







858 (783.1) 91 (165.9) 949 7.173 33.85 
Cytoplasm 383 (457.9) 172 (97.05) 555 12.23 57.88 


























































Quantification of the gold particles shows that the average number of gold particles 
per compartment in TorA-hGH-overexpressing cells was 1.9 per cell in the 
cytoplasm and 4.29 per cell at the membrane, whereas the control, WT cells bound 
approximately 0.86 in the cytoplasm and 0.45 particles in the membrane per cell, 
respectively. The labelling of the membrane bound hGH is thus highly specific; the 
membrane and periplasm of TorA-hGH-overexpressing cells contains 9.42X more 
gold particles than the membrane and periplasm of WT cells (Figure 6.2.6., A).     
 
To confirm a statistical difference of immunogold labelling between these cells at the 
cytoplasm and inner membrane, Chi-squared analysis of the raw gold count data was 
conducted (Figure 6.2.6., C); for a total chi-squared of 111.2 and 1 degree of 
freedom, P was less than 0.005. This confirms that the gold labelling distributions 
between the two cell types are significantly different.   
 
Analysis of the distribution of gold particles in the cytoplasm shows the presence of 
1.915 and 0.86 particles in the TorA-hGH overexpressing and WT cells, respectively. 
Since the particle number in WT cells represents non-specific binding, and assuming 
that the level of non-specific binding in the 2 cell types is identical, this indicates that 
TorA-hGH overexpressing cells contain an average of 1.055 particles per cell in the 
cytoplasm, which is less than the number in the membrane (4.29). Given that the 
immunoblots (Figure 6.2.2.) showed hGH to be present in the cytoplasm, some of 
these particles can be attributed to genuine cytoplasmic hGH. Therefore, we can 
conclude that this immunolabelling approach provides highly specific detection of 
TorA-hGH in the membrane fraction, whereas labelling of the cytoplasmic TorA-
hGH is less specific.  
 
6.2.6. Direct visualisation of TorA-hGH in situ 
 
The cytoplasm of bacterial cells possesses considerable spatial organisation with 
many proteins localising to specific sites within the cell (Vendeville et al., 2011). 
Recent data using fluorescently-tagged TorA showed this substrate to localise 
uniformly throughout the inner membrane (Rose et al., 2013). However, since there 
has never been any direct, high resolution visualisation of Tat substrate in situ, it is 
unknown whether any preferential localisation exists.    
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Having successfully optimised the unambiguous identification of TorA-hGH in the 
E. coli cell to a high degree of specificity, the localisation and distribution of this 
protein was investigated.  E. coli cells were induced with IPTG to overexpress TorA-
hGH for 1hr 15, 1hr 45 and 3hrs. At the given time point the cells were harvested and 
fixed, stained and prepared for immunogold analysis under the TEM. The images 
presented are representative of independent repeats of experiments.  
 
The time points were chosen because previous export assays (Figure 6.2.2.) showed 
at 1hr 15 there are good levels of export by Tat machinery with mature hGH already 
in the periplasm. At 1hr 45 mins there is increased precursor at the inner membrane, 
and at 3 hours there would have been considerable more induction of protein.  
 
In each of the immunogold labelling results (Figure 6.2.7. A-C) TorA-hGH exhibited 
a uniform distribution around the periphery of the cell (yellow circles), and a random 
distribution through the cytoplasm (red circles). This is consistent with results 
showing that the Tat machinery is evenly distributed throughout the inner membrane 
(Alcock et al., 2013; Leake et al., 2008; Rose et al., 2013).  
 
Qualitative analysis could not discern any differences that arose as a result of 
increased induction time, nor was there any preferential localisation of substrate to 
any particular region within the cell. This can be seen clearer in Figure 6.2.8., 
containing a montage of immunogold-labelled images. Controls of the same cells 
immunolabelled without a primary anti-hGH antibody did not bind any gold (Figure 






















































Figure 6.2.7. Immunogold labelling of TorA-hGH (WT precursor) at differing time points 
Electron micrographs of resin-embedded, sectioned immunogold-labelled E. coli cells. Post-
induction with 1 mM IPTG, E. coli cells overexpressing TorA-hGH (WT precursor) were 
harvested at 1hr 15 mins, 1hr 45 min and 3hr. Following biological preservation, resin 
embedding and serial sectioning, the cells were immunogold labelled using anti-hGH antibody 
(+). At each time point, the hGH localised to both the cytoplasm (red circle) and even 
distributions at the inner membrane (yellow circle). Any differences in localisation and/or 
distribution between each of the time points could not be distinguished qualitatively. Controls 
were cells that had the primary antibody omitted from the immunolabelling procedure (-).Images 
were taken on a JEOL 2010F at 15,000X magnification. Scale bar = 200 nm.           
1 hr 15 WT (+) 1 hr 15 WT (-) 
1 hr 45 WT (+) 1 hr 45 WT (-) 

















































Figure 6.2.8. Immunogold labelling of TorA-hGH (WT precursor) at 3hrs post-
induction 
Electron micrographs of resin-embedded, sectioned immunogold-labelled E. coli cells. Post-
induction with 1 mM IPTG, E. coli cells overexpressing TorA-hGH (WT precursor) were 
harvested at 3hrs. Following biological preservation, resin embedding and serial sectioning, 
the cells were immunogold labelled using anti-hGH antibody (all images). The TorA-hGH 
protein localised uniformly throughout the cytoplasm (red circle) and did not exhibit any 
preferential localisation or distribution at the inner membrane (yellow circles). Images were 





6.2.7. Direct visualisation of TorA(A39L)-hGH in situ 
 
E. coli cells overexpressing mutant precursor TorA(A39L)-hGH were 
immunolabelled to investigate whether differences exist in this protein’s localisation 
and/or distribution compared to the WT precursor. Ren et al., (2013) provided data 
that showed an unprocessed Tat substrate (possessing identical signal peptide Ala-to-
Leu mutation at the -1 position) remains membrane-bound. Immunogold labelling 
revealed, akin to the WT precursor, TorA(A39L)-hGH protein exhibits a random 
distribution in the cytoplasm (red circles) and a uniform distribution in the inner 
membrane (yellow circles) of the E. coli cell (Figure 6.2.9. and 6.2.10) (the images 
presented are representative of independent repeats of experiments). Therefore these 
data, in combination with immunoblots of export assays, provide additional evidence 
that an unprocessed Tat precursor remains membrane-associated despite being 
unable to undergo cleavage by signal peptidases in the periplasm.         
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1 hr 15 mutant (+) 1 hr 15 mutant (-) 
1 hr 45 mutant (+) 1 hr 45 mutant (-) 
3 hr mutant (+) 3 hr mutant (-) 
Figure 6.2.9. Immunogold labelling of TorA-hGH (mutant precursor) at different time 
points 
Electron micrographs of resin-embedded, sectioned immunogold-labelled E. coli cells. Post-
induction with 1 mM IPTG, E. coli cells overexpressing TorA-hGH (mutant precursor) were 
harvested at 1hr 15 mins, 1hr 45 min and 3hr. Following biological preservation, resin 
embedding and serial sectioning, the cells were immunogold labelled using anti-hGH antibody 
(+). At each time point, the hGH localised to both the cytoplasm (red circle) and even 
distributions at the inner membrane (yellow circle). Any differences in localisation and/or 
distribution between each of the time points could not be distinguished qualitatively. Controls 
were cells that had the primary antibody omitted from the immunolabelling procedure (-).Images 





























Figure 6.2.10. Immunogold labelling of TorA-hGH (mutant precursor) at 3hrs post-
induction 
Electron micrographs of resin-embedded, sectioned immunogold-labelled E. coli cells. Post-
induction with 1 mM IPTG, E. coli cells overexpressing TorA-hGH (mutant precursor) were 
harvested at 3hrs. Following biological preservation, resin embedding and serial sectioning, 
the cells were immunogold labelled using anti-hGH antibody (all images). The TorA-hGH 
protein localised uniformly throughout the cytoplasm (red circle) and did not exhibit any 
preferential localisation or distribution at the inner membrane (yellow circles). Images were 





6.2.8. TorA-hGH and TorA(A39L) form cytoplasmic inclusion bodies  
 
Extensive analysis of E. coli cells overexpressing TorA-hGH and TorA(A39L)-hGH 
showed some cells to possess insoluble aggregates of hGH protein, termed - 
inclusion bodies (IBs). The images presented are representative of independent 
repeats of experiments.  These are electron-dense regions in the cytoplasm of the cell 
(Figure 6.2.11., blue box) and heavily labelled with the anti-hGH antibody. The IBs 
were present in all 3 time points imaged with no apparent variation in their 
abundance.   
 
This is the first time that IBs have been seen for heterologous proteins that are to be 
exported by Tat machinery. Such details could only be identified by this direct 
visualisation of E. coli cells. These bodies are found in the ‘membrane’ fraction in 
the export assays shown earlier (Figure 6.2.2. and 6.2.3.), but this more direct 
method shows that at some proportion of the protein in this fraction is in insoluble 
IBs. 
 
IBs complicate the production of therapeutic proteins since they contain inactive, 
denatured aggregated protein (Yamaguchi & Miyazaki, 2014), making purification of 
a biologically active therapeutic protein inefficient and costly. However, the cells 
imaged in this study had a very low abundance of IBs, present in only 10 of 200 cells 
sampled.  
 
It is to be remembered that visualisation of IBs is reliant on a part of the inclusion 
body being exposed when sectioned. Given that analysis under the TEM is a 2D 
projection of only 50 nm of a whole cell E. coli cell (up to 3 µm in length), a cell not 
possessing an IB via TEM analysis, does not mean it does not contain one. Therefore 
to gain a better understanding of the abundance of these inclusion bodies further 



































Figure 6.2.11. Immunogold labelling of TorA-hGH (WT and mutant precursor) at different 
time points 
Electron micrographs of resin-embedded, sectioned immunogold-labelled E. coli cells. Post-
induction with 1 mM IPTG, E. coli cells overexpressing TorA-hGH (WT and mutant precursor) 
were harvested at 1hr 15 mins, 1hr 45 min and 3hr. Following biological preservation, resin 
embedding and serial sectioning, the cells were immunogold labelled using anti-hGH antibody 
(+). At each time point, for both WT and mutant precursor, the hGH aggregated to form inclusion 
bodies (IBs) in the cytoplasm of the cells. The abundance of IBs between the two substrates and 
time points was not discernible. Images were taken on a JEOL 2010F at 15,000X magnification.  
Scale bar = 200 nm.       
 
3 hr WT hGH 3 hr mutant hGH 
 
 
1.25 hr WT hGH 
 
1.25 hr mutant hGH 
 
1.75 hr WT hGH 
 
1.75 hr mutant hGH 
195 
 
6.2.9. Increased expression of Tat machinery does not alter localisation or 
distribution of Tat substrate in E. coli  
 
Experiments in this study have used WT levels of Tat machinery and overexpressed 
substrate. No preferential localisation or distribution of Tat substrates within the 
cytoplasm or membrane could be detected. Therefore, to investigate whether 
substrate localisation and/or distribution is affected by the amount of Tat machinery 
available, export assays of E. coli cells overexpressing both TatABC machinery and 
TorA-hGH substrate were conducted.  
 
TatABC and TorA-hGH were induced simultaneously in E. coli cells that have had 
the Tat operon knocked out (i.e. ∆tat cells). At certain times after induction of 
plasmids, cells were fractionated to generate cytoplasm (C), membrane (M) and 
periplasm (P) samples which were analysed by SDS-PAGE and immunoblotting. 
 
Immunoblotting using an anti-Strep antibody confirmed expression of Tat 
machinery: from 1hr 45 onwards TatC-strep was present in the inner membrane 
(Figure 6.2.14). A second immunoblot using an anti-TatA antibody provided 
additional confirmation of Tat machinery expression. Again, from 1hr 45 onwards 
TatA was expressed in the membrane fraction (Figure 6.2.13). This protein also 
partially localised to the cytoplasm, which has been seen previously (Berthelmann et 
al., 2008).  
 
To check that the overexpressed Tat machinery was capable of translocation, the 
same fractions were immunoblotted for the presence of substrate (Figure 6.2.12). 
Precursor TorA-hGH was detected in the cytoplasm and membrane from very early 
on (1hr); however no mature hGH was detected in the periplasm until 1hr 45. The 
expression of mature hGH in the periplasm was short-lived with it being degraded by 









Figure 6.2.12. Export assay of Tat substrate (TorA-hGH) into the periplasm of E. coli 
with increased expression of Tat machinery: immunoblotting for detection of TatC 
Western Blot to detect the presence of hGH in E. coli. Post-induction with 1 mM IPTG 
E.coli cells overexpressing hGH fused to a TorA signal peptide (TorA-hGH), and TatABC 
were grown at 37
o
C for 3 hours. During this time, cells were periodically harvested, 
normalised for OD600 = 10 and subsequently fractionated to periplasm (P), cytoplasm (C) and 
membrane (M) fractions. To check for successful expression of Tat machinery, each fraction 
was examined for the presence of TatC by immunoblotting with anti-Strep antibody. Results 




























Figure 6.2.13. Export assay of Tat substrate (TorA-hGH) into the periplasm of E. coli 
with increased expression of Tat machinery: immunoblotting for detection of TatA 
Western Blot to detect the presence of hGH in E. coli. Post-induction with 1 mM IPTG 
E.coli cells overexpressing hGH fused to a TorA signal peptide (TorA-hGH), and TatABC 
were grown at 37
o
C for 3 hours. During this time, cells were periodically harvested, 
normalised for OD600 = 10 and subsequently fractionated to periplasm (P), cytoplasm (C) and 
membrane (M) fractions. Each fraction was examined for the presence of TatA by 
immunoblotting with anti-TatA antibody. TatA was present in both the cytoplasm and 
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Figure 6.2.14. Export assay of Tat substrate (TorA-hGH) into the periplasm of E. coli 
with increased expression of Tat machinery: immunoblotting for detection of hGH 
Western Blot to detect the presence of hGH in E. coli. Post-induction with 1 mM IPTG 
E.coli cells overexpressing hGH fused to a TorA signal peptide (TorA-hGH), and TatABC 
were grown at 37
o
C for 3 hours. During this time, cells were periodically harvested, 
normalised for OD600 = 10 and subsequently fractionated to periplasm (P), cytoplasm (C) and 
membrane (M) fractions. Each fraction was examined for the presence of hGH by 
immunoblotting with anti-hGH antibody. Results show that after 1 hour, precursor hGH (27 
kDa) is present in both cytoplasmic and membrane fractions. The substrate remains in the 
membrane fraction until 3hrs. At 1hr 45, the cytoplasmic substrate is degraded into its 
mature form (22 kDa), and the amount of this protein gradually decreases over the remainder 
of the experiment. Only at 1hr 45 is the mature substrate seen in the periplasmic fraction.    
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Figure 6.2.15. Export assay of TorA-hGH into the periplasm of E. coli cells lacking 
expression of Tat machinery  
Western Blot to detect the presence of hGH in E. coli. Post-induction with 1 mM IPTG 
E.coli cells overexpressing hGH fused to a TorA signal peptide (TorA-hGH) and lacking 
expression of Tat machinery i.e. ∆tat were grown at 37oC for 3 hours. During this time, cells 
were periodically harvested, normalised for OD600 = 10 and subsequently fractionated to 
periplasm (P), cytoplasm (C) and membrane (M) fractions. Each fraction was examined for 
the presence of hGH by immunoblotting with anti-hGH antibody. Results show that mature 
hGH (22 kDa) is present in the cytoplasm from very early on (1 hr). Precursor Hgh (27 kDa) 
expression increases at 1hr 30. Membranous hGH is detected at 2hr 15 onwards. As 
expected, given the lack of Tat machinery, no hGH is located in the periplasm.   
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Figure 6.2.16. Immunogold labelling of TorA-hGH and TatA with increased expression 
of Tat machinery, 1hr 45 min post-induction. 
Electron micrographs of resin-embedded, sectioned immunogold-labelled E. coli cells. Post-
induction with 1 mM IPTG, E. coli cells overexpressing TorA-hGH and TatABC were 
harvested at 1hr 45 min. Following biological preservation, resin embedding and serial 
sectioning, the cells were immunogold labelled using anti-hGH antibody (top right and 
bottom right) and anti-TatA antibody (top left). Top-right: despite increased expression of 
Tat machinery, there was no alteration in the localisation and distribution of the hGH protein 
in either the cytoplasm (red circle) or membrane (yellow circle). hGH still aggregated into 
inclusion bodies (bottom right). Top-left: the TatA protein localised to both the cytoplasm 
(red circle) and inner membrane regions (yellow circle), with no preferential distribution or 
localisation witnessed. Controls were cells that had the primary antibody omitted from the 
immunolabelling procedure (-). These cells lacked gold binding, confirming no non-specific 
binding of gold-conjugated secondary antibody. Images were taken on a JEOL 2010F at 





At 2hrs the cytoplasmic precursor TorA-hGH started to degrade. Some precursor 
remained membrane-localised throughout the duration of the export assay. Given that 
successful transport was only seen for a short period, and based on previous data IN 
this chapter, it is likely that these bands represent inclusion bodies. Since the cells are 
co-expressing two plasmids it is likely that they are being subjected to considerable 
stress. To test whether this is the case, the export assay was repeated but with only 
expression of TorA-hGH in ∆tat background. E. coli cells overexpressing TorA-hGH 
(∆tat background) were fractionated to generate cytoplasm (C), membrane (M) and 
periplasm (P) samples which were analysed by SDS-PAGE and immunoblotting with 
anti-hGH antibody. Some non-specific binding was observed.  
 
As expected, results show that there is no mature hGH in the periplasm since Tat 
machinery is not expressed. As with co-expression experiments (Figure 6.2.15.), 
precursor TorA-hGH is expressed in the cytoplasm from as early as 1 hour after 
plasmid induction and is cleaved to mature hGH from 1hr 30 onwards. However, this 
mature hGH is more stable than in the co-expression experiment (Figure 6.2.12), 
residing in the cytoplasm until 3 hours. Therefore it is sensible to infer that 
expression of a second plasmid confers stress to the cell, and the heterologous 
protein was either degraded or aggregated into inclusion bodies.  
 
Despite significant degradation of hGH upon co-expression of Tat machinery and 
substrate, export was observed, albeit briefly, at 1hr 45. Analysis of this sample by 
immunogold labelling and EM imaging revealed no difference in localisation and/or 
distribution of TatA protein (Figure 6.2.16, top-left) or hGH substrate (Figure 6.2.16, 
top right). A negative control in which primary antibody was omitted during 
immunolabelling showed that the secondary gold-conjugated antibody was not 
binding non-specifically (Figure 6.2.16, bottom left). As anticipated, inclusion bodies 










E. coli is one of the most widely-used prokaryotic organisms for the production of 
heterologous proteins for therapeutic or commercial uses; it is exploited for the 
production of over a third of currently-licensed therapeutic proteins (Walsh, 2010). 
Purification of such proteins from the periplasm offers two main advantages: firstly, 
there are fewer proteins in this cellular compartment, which simplifies downstream 
processing. Secondly, the oxidising environment facilitates disulphide bond 
formation. Heterologous proteins reach the periplasm by virtue of a signal peptide 
fused to its N-terminus. Once the protein is in the periplasm the signal peptide is 
cleaved off by specific proteases to release the mature protein into the periplasmic 
space (reviewed in: (Miot & Betton, 2004)).   
To maximise periplasmic yields it is important to identify limiting factors to the 
high-yield production of heterologous proteins. Conventionally, the protein of 
interest is fused to a Sec-signal peptide to target it to the inner membrane (Georgiou 
& Segatori, 2005; Pugsley, 1993); however a pre-requisite of translocation is that the 
protein is unfolded. The limitation here is that once the protein is in the periplasm, it 
has to refold correctly. The Tat translocase bypasses this issue by transporting fully-
folded proteins across the inner membrane into the periplasm.    
Initial studies confirmed the capability of the Tat system to transport a heterologous 
protein to a high-yield (Matos et al., 2012), and  more recent data has shown that 
substrates are not limited to GFP with Tat being able to transport human growth 
hormone (hGH), scFV and interferon α2b (Alanen et al., 2015). It is currently 
unknown whether Tat is capable of transporting these proteins on a large, industrial 
scale.   
The data presented in this chapter investigated the export of a heterologous substrate 
– hGH – fused to a TorA signal peptide (TorA-hGH). Also, a substrate with a subtle 
mutation in the signal peptide was analysed in parallel: TorA(A39L)-hGH. This 
mutation has been shown to block maturation of the precursor at the inner membrane 
(Ren et al., 2013). This is the first time that the export of a heterologous Tat substrate 
has been analysed in detail with direct, 2D visualisation of the substrate in situ.   
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Results of export assays presented in this chapter showed, for the first time, that 
precursor hGH is being degraded in the cytoplasm from as early as 1 hour after 
plasmid induction. This degradation is detrimental to the yield of hGH because the 
availability of precursor for Tat transport is significantly reduced.   
E. coli contains many cytoplasmic proteases that play vital roles in regulating protein 
levels and eliminating damaged or abnormal proteins. Heterologous proteins can be 
regarded as unwanted by the cell, and thus stress proteins are induced to rapidly 
degrade the protein (Baney & Mujacic, 2004; Goff & Goldberg, 1985).   
Whilst Tat has already been shown to export TorA-hGH (Matos et al., 2012), 
previous studies have only taken a “snap shot” of protein localisation at 3 hours post-
induction of plasmid (Alanen et al., 2015). The data presented in this chapter is the 
first time export of the TorA-hGH has been studied in detail over the course of its 
induction. Detection of this early degradation provides vital preliminary insight into 
hGH export, and this degradation is something that can be minimised prior to large-
scale trials.    
Strategies for minimising the proteolysis of heterologous recombinant proteins have 
been studied (Murby et al., 1996). A favoured approach, already adopted in this 
study, is targeting the protein to the periplasm where proteolysis is less extensive 
(Georgiou & Segatori, 2005). Alternately, alteration of host cell can be tested. For 
example, an E. coli strain that lacks expression of La protease (cytoplasmic protease 
responsible for degradation of non-native proteins) has been shown to stabilise 
recombinant proteins (Gottesman, 1990).   
Export assays of mutant precursor showed that the Ala  Leu mutation at -1 position 
of the signal peptide successfully blocked maturation of TorA-hGH. Further analysis, 
using immunogold labelling and TEM visualisation, showed that the blocked 
precursor localised to the inner membrane. Further confirmation of this localisation 
is required by repeating the export assay of mutant precursor, but in cells with the 
Tat operon knocked-out (∆tat cells). A lack of gold binding at the periphery of the 
cell would confirm that mutant precursor is stably expressed at the inner membrane 
in Tat-expressing cells.  
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From a bioprocessing perspective, the stable expression of a non-cleavable Tat 
precursor (which is exposed at the periplasmic face of the inner membrane (Karlsson 
et al., 2012; Ren et al., 2013), offers potential for the Tat system to be exploited for 
the development of cell surface display technologies.  
Bacterial cell surface display involves expressing recombinant, heterologous proteins 
on the surface of cells. It is a versatile technique that has wide applicability, 
implicated in numerous technologies such as library screening, protein engineering 
or use as whole cell biocatalysts.  
In E. coli proteins are usually displayed on the outer membrane (OM) surface- 
however: incorporation of foreign proteins in the OM can be toxic to the cell; the 
presence of lipopolysaccharides can sterically hinder interactions between expressed 
protein and binding-partner, and assembly at cellular appendages (e.g. flagella or 
pilli) can disrupt assembly of the recombinant protein (Chen & Georgiou, 2002). 
Therefore, expression on the inner membrane of spheroblasts (E. coli cells that have 
had their OM removed), has been shown to be a viable alternative: a technique 
termed ‘Anchored Periplasmic Expression’ (APEx).  
APEx involves the N- or C-terminal fusion of heterologous proteins to the plasma 
membrane of bacteria. Initially single chain fragment variables (scFVs) were 
expressed when the technique was first developed (Harvey et al., 2004), but whole 
antibodies and other proteins have since been expressed to significantly develop this 
technique for uses such as protein library screening (Lee et al., 2013). Conventional 
means of expressing proteins at the surface of spheroblasts by N- or C-terminal 
fusions often encounters the uncertainty as to which side of the cytoplasmic 
membrane the recombinant protein is expressed i.e. the cytoplasmic side where the 
protein is rendered inaccessible or the periplasmic side where it is available for 
binding. The same could be argued for proteins expressed by the Tat machinery; 
however recent protease accessibility experiments confirmed that heterologous 
proteins (that have mutated signal peptides), are expressed solely on the periplasmic 
side of the cytoplasmic membrane (Ren et al,. 2013).     
scFV has recently been shown to be exported by Tat machinery (Karlsson et al., 
2012), simplifying the APEx technique by bypassing requirement of an N- or C-
terminal fusion and instead using an endogenous inner membrane protein complex: 
205 
 
Tat. The data presented in this chapter present preliminary evidence that this is now 
possible with another heterologous protein exported by the Tat machinery: hGH.    
Prokaryotic production of recombinant hGH has its drawbacks: recombinant, 
overexpressed hGH aggregates to form inclusion bodies which require expensive 
denaturation and refolding steps to recover a biologically-active hormone. Also, 
Gram-negative bacteria possess an outer membrane bilayer which contains LPS. 
These are immunogenic and have to be removed prior to administering to humans or 
animals (Demain & Vaishnav, 2009). APEx expression of hGH in E. coli 
spheroblasts would avoid these issues and offers the possibility for Tat-expressed 
hGH to be implicated in cell surface display technology such as affinity maturation 
of hGH (Levin & Weiss, 2006).   
Visualisation of hGH-overexpressing cells showed the formation of inclusion bodies 
that contained insoluble, aggregated hGH. These bodies limit the recoverable yield of 
active hGH and protein recovery from them is costly. However- IBs were not 
abundant in the sample, present in only 5% of cells visualised (10 out of 200 cells 
imaged); therefore there is a need to gain further insight into their prevalence.  
Identifying IBs relies on exposing a portion of the IB during sectioning. Therefore 
more cells need to be analysed, or whole cell reconstructions of numerous E. coli 
obtained to gauge a better idea of the abundance of these IB. Also, these cells were 
only induced for 3 hours – in the biotechnology industry the cells undergo batch 
fermentation with expression lasting in excess of 10 hours. It would be interesting to 
see whether the prevalence of IBs increased significantly with increased induction of 
TorA-hGH and how it compared to conventional cytoplasmic expression systems of 
hGH. If there is indeed a low abundance of IBs when TorA-hGH is secreted into the 
periplasm this would give a strong advantage to using Tat machinery for the 
production of recombinant hGH, since downstream processing would be much more 
time- and cost-efficient.  
Finally- visualisation of the TorA-hGH precursor revealed a random distribution in 
the cytoplasm and a uniform distribution in the inner membrane. These data mirror 
previous results of substrate localisation studies which used fluorescently tagged 
TorA (Rose et al., 2013). TorA-mCherry exhibited a uniform staining throughout the 
inner membrane of E. coli suggesting the lack of a preferential localisation of this 
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substrate within the cell. A similar distribution was also seen in the cytosol. To 
increase the resolution obtained from the data presented in this chapter, which is only 
a 2D projection of cells, a 3D reconstruction of whole E. coli cells has the potential 
to provide deeper insight into the organisation of substrate in the cytoplasm and at 
the inner membrane.  
To conclude, the data presented in this chapter have provided further insight into 
export of heterologous substrates via tat machinery. The identification of early 
precursor degradation and formation of inclusion bodies in the cytoplasm has 
highlighted specific activities that require further investigation and/or optimisation 
prior to large-scale expression of recombinant hGH. The stable expression of a non-
cleavable Tat precursor highlights potential for Tat machinery to be exploited for 

















































7.0 Final Discussion 
A considerable proportion of our knowledge regarding the Tat translocase has 
originated from studies on the Tat system of E. coli. This translocase is highly 
conserved amongst Gram-negative bacteria (Oates et al., 2003), and is comprised of 
3 essential proteins: TatA, TatB and TatC (Bogsch et al., 1998; Sargent et al., 1998; 
Sargent et al., 1999). The organisation of this translocase in the inner membrane and 
its structure has been the focus of many studies over the past years (reviewed in 
chapter 1). In a steady-state situation, when there is no substrate to be transported, 
this translocase consists of a substrate-binding 370 kDa Tat(A)BC complex, and a 
separate heterogeneous TatA complex that ranges in size from 100 kDa to over 500 
kDa (Oates et al., 2005).  
Low resolution structures of the TatA complex generated from EM analysis showed 
that these complexes have ring-shaped structures of variable diameter (9 – 13 nm), 
with an internal channel large enough to accommodate even the largest Tat substrate, 
TorA (90 kDa) (Gohlke et al., 2005). It was the identification of an internal channel 
that has underpinned the currently most accepted mechanism of Tat translocation: the 
pore-forming mechanism. This mechanism predicts that substrate binding to the 
Tat(A)BC complex (Alami et al., 2003; Alami et al., 2002; Cline & Mori, 2001; 
McDevitt et al., 2006) triggers the recruitment of TatA proteins (Mori & Cline, 
2002) to form the active size-fitting translocase, TatABC, through which the 
substrate can traverse the inner membrane, and gain entry to the periplasmic space 
(Gohlke et al., 2005; Oates et al., 2005). However in light of more recent evidence 
from biochemical and structural studies, which indicate that such variation in TatA 
size and structure (Baglieri et al., 2012; Barnett et al., 2008; Beck et al., 2013; van 
der Ploeg et al., 2011) is not common to all Tat complexes, the validity of the pore-
forming model is uncertain. Therefore, the mechanism of Tat translocation is still 
very much unresolved. Further insight into the structure and localisation of Tat 
complexes from both Gram-positive and Gram–negative bacteria will undoubtedly 
play key roles in elucidating more information on how this remarkable protein 
machinery operates.   
In this investigation, electron microscopy has been used to gain novel insight into the 
structure, localisation and distribution of Tat complexes from both Gram-negative 
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and Gram–positive bacteria. Preliminary structural characterisation of TatAyCy 
complex from B. subtilis was conducted alongside further investigation into the 
localisation and distribution of TatABC and its substrates in the inner membrane. 
The work presented in this thesis largely supports previous biochemical and 
microscopy-based observations on these Tat complexes from both Gram-positive and 
Gram–negative bacteria.   
In the first chapter presented in this thesis, the TatAyCy complex from B. subtilis 
was isolated and purified for direct visualisation under the TEM. Despite being 
smaller than its Gram-negative counterpart, this complex’s arrangement in the inner 
membrane is parallel to that of TatABC in E. coli, whereby a substrate-binding 
complex TatAyCy (200 kDa) is expressed alongside a separate pool of TatAy (200 
kDa) (Barnett et al., 2009).          
Preliminary 2D structural characterisation of detergent-solubilised TatAyCy 
complexes revealed circular particles, ranging from 12 - 14 nm in diameter. It 
remains uncertain whether this observed heterogeneity under the electron microscope 
is inherent and important for Tat translocase function or is an artefact of sample 
preparation. However, in light of this data showing that a Tat complex from a Gram-
positive bacterium is able to functionally complement the Gram-negative system of 
E. coli, it highlights that there are no system-specific factors in the Gram-positive B. 
subtilis which contribute to the operation of Tat machinery. Therefore, it is sensible 
to assume that these Tat machineries operate by the same mechanism and the 
heterogeneity observed between the two  is an artefact if their isolation (i.e. detergent 
extraction) and is therefore not likely to be necessary for function. For example, there 
could be differing lipid retention during the purification of Gram-positive versus 
Gram-negative Tat complexes. This variation could affect stability of the protein-
detergent complexes and thus induce heterogeneity in the detergent-solubilised Tat 
complexes. Alternatively, the heterogeneity of Tat complexes could be a 
consequence of the protein’s sensitivity to proteolysis, whereby the Tat 
proteins/complexes would be cleaved into by-products of varying sizes. 
3D EM structures of TatAd showed this protein complex lacks a pore large enough 
to support translocation on its own (Beck et al., 2013). Together, this and the 
aforementioned findings question the biological significance of the large 
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heterogeneity seen for E. coli TatA, and are instead in favour of an alternative model 
of Tat that is flexible enough to transport a wide range of substrates. For example- 
the coalescence of numerous relatively homogeneous TatA/TatAy/TatAd and 
TatBC/TatAyCy/TatAdCd complexes to form Tat translocases of differing sizes. The 
inherent heterogeneity of TatAyCy revealed in this study is likely to be an 
identification of the flexibility of this complex, and could explain why this complex 
is capable of transporting substrates other than its endogenous YwbN (45 kDa) 
(Barnett et al., 2009).  
A control of serially diluted TatAyCy complexes was necessary to gauge the true 
population of TatAyCy complexes under the TEM. Results showed that as the 
dilution of the TatAyCy protein increased, the average diameter of the particles also 
increased. This detergent-induced variation in complex appearance (i.e. size) under 
the EM is supported by evidence showing that detergent-solubilised TatA forms 
complexes even when expressed in the absence of TatBC components (Porcelli et al., 
2002). Furthermore, detergent-only samples were found to contain particles, albeit in 
lower abundance than TatAyCy complexes, which were of the same diameter to the 
TatAyCy PDCs. Together these results demonstrate the implications that detergent-
solubilisation has on the structural analysis of membrane proteins, and reiterates the 
need to circumvent the use of detergents in this field of research. Therefore the 
remainder of findings presented in this thesis endeavoured to analyse the Tat 
machinery and/or its substrates avoiding the analysis of detergent-solubilised 
complexes.   
The next avenue of research involved the reconstitution of TatAyCy into liposomes 
for topography analysis via AFM. Liposomes are synthetic membrane mimetics; 
therefore reconstitution of an integral membrane protein into these vesicles provides 
a lipid bilayer for the protein- an environment more natural than detergent-
solubilised complexes. Reconstitution of TatAyCy into liposomes proved difficult. I 
identified numerous parameters that are important for reconstitution of Tat 
complexes into liposomes. From the data presented in this chapter, it seems that 
lower L:P ratios, liposomes consisting of single lipid type (i.e. DOPC) and use of 




Analysis of the Tat proteoliposomes under the AFM tip was ambiguous, with very 
few protein-like features detected. The lack of such features is owed to the difficulty 
in reconstituting a high density of Tat proteins into liposomes. Protein reconstitution 
involves a complex interplay between the aforementioned parameters, and successful 
reconstitution of Tat protein would require significant further empirical optimisation. 
Therefore, an alternative means for directly visualising Tat in the inner membrane, 
circumventing the use of detergent, was desired. To achieve this, I developed the 
novel combinatorial approach of array tomography with immunogold labelling to 
unambiguously identify TatA in the inner membrane of E. coli.   
TatA plays an essential role in the translocation system, and any hypothesis 
regarding Tat’s mechanism of translocation makes predictions about the localisation 
and distribution of TatA in the inner membrane. Therefore, insight into the 
arrangement of this protein is fundamental to elucidating the mechanism of Tat 
translocation.  
Direct visualisation of the TatA protein in its native cellular environment, in 3D 
space, revealed TatA to cluster along the inner membrane in a TatBC-dependent 
manner. This is the first time that the localisation and distribution of a Tat component 
has been visualised in 3D space, in situ. 
Previous efforts to gain this level of insight have utilised TatA-XFP fusion proteins. 
Data derived from these studies are complicated by the fact that fluorescently-tagged 
TatA proteins are inactive and can aggregate at the membrane (Alcock et al., 2013; 
Ray et al., 2005). Therefore, we are unable to compare data from such studies to 
those obtained in this study.     
The higher resolution of labelling in this study in combination with the 3D 
appreciation of the localisation of TatA provided further insight into the Tat 
translocase. Remembering that we are labelling specifically for TatA, current models 
of the mechanism of Tat protein transport make specific predictions about the 
oligomeric state of TatA and whether or how this changes during the transport cycle. 
For example, the pore-forming model of Tat translocation predicts that there is a 
‘pool’ of TatA protein positioned in the membrane “waiting” for a substrate to 
binding the Tat(A)BC complex (Gohlke et al., 2005; Sargent et al., 2001) (Figure 
7.1, top panel). The identification of individual TatA proteins in a linear cluster in the 
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inner membrane in this study could be consistent with the pore-forming model of 
Tat, whereby a ‘pool’ of TatA protein is required for complex assembly (Gohlke et 
al., 2005; Sargent et al., 2001).  
However, since I have only labelled for a single protein and sectioned the E. coli at 
50 nm intervals (hence each protein in the TatA cluster is 50 nm apart from the next 
TatA protein), one of two situations could be represented with this clustering of 
TatA. Either: a single TatBC serves as a nucleation site with a row of TatA along the 
inner membrane (Figure 7.1., middle panel); or there are separate Tat complexes 
awaiting substrate binding (Figure 7.1., bottom panel). Given that the higher order 
oligomer formation of the TatA complex is absolutely dependent on the presence of 
TatBC (Mori and Cline., 2002), and that I only see this clustering of TatA along the 
inner membrane when TatBC are co-expressed with TatA (not TatA alone), this 
localisation of TatA could be a higher order oligomeric structure of TatA. 
Furthermore, TatBC exists in a 1:1 ratio with TatA being expressed at an ~20-fold 
excess (Bolhius et al., 2001; Sargent et al., 2001), it is possible that there could be a 
single TatBC complex serving as a single nucleation site for subsequent binding of 
multiple TatA  protomers upon substrate binding. The observed heterogeneity in the 
number of TatA proteins in each cluster could reflect the dynamic polymerisation of 























Figure 7.1. Arrangement of TatA in the inner membrane of E. coli  
According to the pore-forming model of Tat translocation, a pool of heterogeneous 
TatA proteins are located in close proximity to the Tat(A)BC substrate-binding 
complex. Upon substrate binding, it is predicted that TatA proteins are recruited to 
the Tat(A)BC complex to form the active translocase through which the substrate is 
transported (top panel). The arrangement of Tat constituents in the inner membrane 
is ambiguous. It is unknown whether the TatA proteins are located adjacent to each 
other with TatBC forming a nucleation point (middle panel), or multiple Tat 
complexes are located adjacent to each other (bottom panel).        
 
The relative location of other Tat proteins remains unknown. Such information 
would add further detail to the distribution of TatA observed in this investigation; 
and therefore remains an important avenue for future work. Previous array 
tomography studies have only ever utilised fluorescently-conjugated proteins to 
quantitatively determine the protein composition of synaptic vesicles (Collman et al., 
2015; Horstmann et al., 2012; Kay et al., 2013; Reichelt et al., 2012). However, the 
resolution of labelling in these experiments it not as high as what has been achieved 
in this study; and the use of immunogold avoids the requirement of fluorescently 
conjugated tags onto the protein of interest.  
Until now, the technique of array tomography has been used almost exclusively in 
the field of neuroscience; however our novel development of array tomography, in 
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combination with the high-resolution immunogold labelling of proteins, has the 
potential to be applied to any cellular antigen- not just those of Tat machinery or of 
E. coli.  
The identification of individual proteins can unveil novel levels of organisation and 
consequently test mechanistic hypotheses. For example, Besson et al. (2015) 
identified an alteration in localisation of the PAR protein complex: the polarisation 
of this complex in mother cells is an essential process for cell division and thus 
development of fly notum in Drosophila (Besson et al., 2015). Alternatively, 
alterations in subcellular protein distributions patterns was ascertained to specific 
adhesive and mechanical properties of human fibroblast cells, and consequently able 
to identify metastasizing tumour cells (Rönnlund et al., 2013).  
The high-resolution of labelling afforded by the combinatorial technique used in this 
study, in combination with the efficiency of image acquisition and lack of 
requirement for fluorescently-conjugated proteins (such as those used in the 
aforementioned studies (Besson et al., 2015; Rönnlund et al., 2013)), has the 
potential to reveal novel insight into specific proteins. Additionally, the immunogold 
labelling of serially sectioned samples overcomes the difficulties of protein labelling 
in electron tomography. For example, a sufficient density of gold particles is required 
on the section surface to allow accurate reconstruction of a 3D volume.         
In a continued effort to gain further insight into the Tat translocase in the inner 
membrane, the technique of immunogold labelling was further utilised to analyse Tat 
substrates, in situ, directly under the EM. In the final chapter of this thesis, the export 
of a heterologous Tat substrate was analysed. A TorA signal peptide was fused to the 
hGH protein to form a 26 kDa precursor. Given the potential application of the Tat 
system to the biotech industry (Alanen et al., 2015; Matos et al., 2012) the export of 
this biotechnologically-relevant precursor protein was investigated. This was the first 
time that the export of a heterologous Tat substrate has been analysed in detail with 
direct, 2D visualisation of the substrate, in situ.    
Results of export assays revealed that the precursor protein was degraded from an 
early time point. This novel insight implicates the exploitation of the Tat translocase 
for export of biotherapeutic proteins: degradation of the heterologous precursor 
reduces the amount of protein available for export and hence decreases the final yield 
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of hGH. Additionally, inclusion bodies (IBs) containing aggregates of hGH protein 
were visualised under the TEM. Similarly, this affects the biotechnological 
application of Tat machinery since IBs of hGH are likely to contain aggregated, 
denatured hGH and thus limit the yield of recoverable hGH (Yamaguchi & 
Miyazaki, 2014). Strategies to minimise precursor degradation and to further 
investigate the true abundance of the IBs remains important future work.   
A mutant precursor protein with a subtle mutation in the signal peptide was analysed 
in parallel to the wild-type. In support of previous biochemical data (Ren et al., 
2013), this mutation blocked maturation of the precursor protein and was 
consequently expressed at the inner membrane for the duration of the expression 
period. The stable expression of a non-cleavable precursor at periplasmic face of the 
inner membrane (Karlsson et al., 2012; Ren et al., 2013) offers potential for the Tat 
system to be exploited for the development of bacterial cell surface display 
technologies. The ability to express hGH on the periplasmic face of the inner 
membrane offers the possibility that Tat-exported hGH can be utilised in affinity 
maturation experiments. Future work remains to see the possible yield of Tat-
exported hGH on a large scale.  
Additionally, it remains to be seen whether Tat is capable of stably expressing other 
signal peptide mutants on the periplasmic face of the inner membrane. scFV has 
already been identified as a substrate capable of Tat export  (Alanen et al., 2015). 
Stable expression of this protein, via the APEx technology, has already been 
employed in library screening studies (Jung et al., 2007; Qiu et al., 2010); Tat offers 
potential as a system capable of overexpressing large, heterologous protein at the 
inner membrane without becoming saturated (Ren et al., 2013). This would facilitate 
and accelerate the potential of APEx technology for high-throughput screening of 
protein libraries to identify novel antibodies against disease cell surface antigens.  
Direct visualisation of hGH permitted novel insight into the localisation and 
distribution of a Tat substrate in an E. coli cell. Immunogold labelling revealed 
TorA-hGH to exhibit a random distribution in the cytoplasm and a uniform 
distribution in the inner membrane, which mirrors results of previous substrate 
localisation experiments (Rose et al., 2013). Deeper insight into the organisation of 
the Tat substrate in the cytoplasm and inner membrane would be provided through 
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3D reconstruction(s) of whole E. coli cells, and thus remains as future work; whilst 
Tat would be too small to see as a complex, the immunogold labelling could reveal 
any larger structures/arrangements that it forms inside the cell.       
To conclude, the initial part of this investigation illustrated how detergent 
solubilisation of an integral membrane protein implicates structural analysis, and the 
structural information gained must be treated with caution. Therefore, I successfully 
circumvented the use of detergent to analyse the Tat machinery in its native cellular 
environment. The novel development of array tomography in combination with 
immunogold labelling enabled the direct, unambiguous visualisation of TatA in the 
inner membrane of E. coli. The 3D visualisation of this protein unveiled, for the first 
time, that the TatA protein forms a linear cluster in the inner membrane, in a TatBC-
dependent manner. Capitalising on the ability of the immunogold labelling to 
identify any cellular antigen, the stable expression of a non-cleavable Tat precursor 
substrate demonstrated the potential for this translocase to be exploited for cell-
surface display technologies. The visualisation of other Tat proteins, its substrates or 
possible neighbouring constituents remains important future work and will enable 
higher levels of understanding regarding the arrangement, and thus activity, of this 
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Secretory pathwayThe twin-arginine translocation (Tat) system accomplishes the remarkable feat of translocating large – even
dimeric – proteins across tightly sealed energy-transducing membranes. All of the available evidence indicates
that it is unique in terms of both structure and mechanism; however its very nature has hindered efforts to
probe the core translocation events. At the heart of the problem is the fact that two large sub-complexes are
believed to coalesce to form the active translocon, and ‘capturing’ this translocation event has been too difﬁcult.
Nevertheless, studies on the individual components have come a longway in recent years, and structural studies
have reached the point where educated guesses can be made concerning the most interesting aspects of Tat. In
this article we review these studies and the emerging ideas in this ﬁeld. This article is part of a Special Issue
entitled: Protein trafﬁcking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey.
© 2014 Published by Elsevier B.V.1. Introduction
The twin arginine translocase (Tat) is a protein transport pathway
that exists in Archaea, bacteria and plant chloroplasts. In bacteria, it
exports proteins across the plasma membrane and is important for
many processes including energy metabolism, formation of the cell
envelope, bioﬁlm formation, heavy metal resistance, nitrogen-ﬁxing
symbiosis, bacterial pathogenesis and others [1,2]. What makes this
protein transport system unusual compared to other transport systems
(such as the general secretory, or Sec pathway) is its ability to transport
fully folded proteins across membranes. This remarkable feat has no
requirement for ATP as an energy source, and relies solely on the proton
motive force (PMF) [3–5].
The mechanism of translocation remains poorly understood, in part
due to a lack of high resolution structural information on this complex
and its individual components. That said, a number of recent biophysical
and structural studies have provided a more detailed picture of the
action and composition of this translocase, particularly with respect to
the early events prior to the actual translocation event. This review
discusses the key information from each of these studies. Much of this
article will focus on the Escherichia coli (E. coli) Tat system, but relevant
data on the Gram-positive homologs from Bacillus subtilis (B. subtilis)
and the chloroplast Tat system are also mentioned. A more detailed
analysis of Gram-positive Tat systems is given elsewhere in this volume
by Goosens et al. [6].in trafﬁcking and secretion in
albey.
on).2. The Tat system's substrates
The extent to which different organisms utilise the Tat pathway
varies signiﬁcantly. Gram-positive bacteria such as Staphylococcus
aureus or B. subtilis have fewpredicted substrates [7–9], whereas enteric
bacteria typically possess around 20–30 substrates [10]. Whilst the
rationale for using this translocase remains unclear for some Tat
substrates, three key underlying factors have been identiﬁed. The ﬁrst
is a requirement for the enzymatic insertion of complex cofactors in
the cytoplasm prior to transport, thereby bypassing the requirement
for extra mechanisms to ﬁrstly, separately export the cofactor and
then subsequently catalyse its insertion in the periplasm [1]. The second
motive is avoidance of metal ions that compete for insertion into the
active site, and lastly, the transport of hetero-oligomeric complexes
that optimally assemble in the cytoplasm [11,12]. The latter is achieved
through proteins forming complexes with other proteins that possess
an N-terminal Tat signal peptide [13].
Navigation to the Tat translocase is dictated by the presence of an N-
terminal signal peptide that possesses an overall tripartite architecture
of: a polar amino terminal (N) domain, hydrophobic core (H) region
and a polar carboxyl (C) domain (Fig. 1). Despite the Sec- and Tat-
type signal peptides having the same basic structure and a similar
terminal Ala-X-Ala motif, studies on Tat signals revealed a highly
conserved SRRxFLK motif [14,15] located at the junction of the N- and
H-domains. The twin-arginine motif gives this translocase its name.
Both arginines are critical in chloroplast Tat signals [16], but less so in
bacteria, where mutation of a single arginine in bacteria only affects
the rate of translocation, whereas mutation of both completely
abolishes transport [17–19]. Within the SRRxFLK motif, three determi-
nants are important: the twin-arginine pair, the hydrophilic−1 residue
Fig. 1. The Tat signal peptide. A polar amino domain (N-region), hydrophobic core (H-region), and polar carboxyl domain (C-region) comprise the tripartite structure of a Tat signal
peptide, which is located at the N-terminus of the substrate protein. On average they are less hydrophobic than Sec-speciﬁc signals, as well as being longer (on average 38 to 24 amino
acids, respectively). Tat signal peptides are distinguished by their conserved twin-argininemotif in theN-region. The C-terminal region houses an A-x-Amotif, which is a consensus cleav-
age site for removal of the signal peptide by signal peptidase.
1621R. Patel et al. / Biochimica et Biophysica Acta 1843 (2014) 1620–1628and the hydrophobic +2 residue (+/− relative to the twin-arginine
pair). However, while Tat and Sec signal peptides share a similar overall
architecture, it is not the twin arginine pair alone that prevents
mistargeting to the Sec pathway. Tat signal peptides are less hydropho-
bic than those used in Sec-targeting [20], and the C-region of certain Tat
signal peptides houses basic residues, which are seldom found in the
same region of Sec signal peptides. The latter is believed to hinder
engagement with Sec machinery [21–23].
3. Tat Translocase components and complexes
3.1. The Tat subunits
Three integral membrane proteins form the minimal set of compo-
nents for the assembly of the Tat translocase in E. coli: TatA, TatB and
TatC. These proteins are expressed from the tatABC operon and reside
in the cytoplasmic membrane arranged as a Tat(A)BC substrate binding
complex and a separate TatA complex (Fig. 2). TatA is an 89 amino acid
protein (9.6 kDa) that consists of a short periplasmic N-terminal region,
a transmembrane helix that is linked via a hinge region to a cytosolically
exposed amphipathic helix (APH), and a highly unstructured,
cytoplasmically-exposed C-terminal region [24–26]. This arrangement
is supported by spectroscopy studies, which indicate that the APH lies
along the surface of the membrane [27,28]. Additionally, solid-state
NMR has shown the TMH to cross the cytoplasmic membrane at a 17°
tilt [29]. An N-out topology is the favoured orientation of TatA in the
cytoplasmic membrane and is supported by recent NMR data of the
TatA component of a Gram-positive homolog, TatAd [30,31]. Some
studies have predicted that TatA may also have a dual topology, on theFig. 2. Component organisation of the E. coli Tat system. In Gram-negative bacteria the Tat
translocase system is usually made up of three integral membrane proteins, encoded by
the tatABC operon. Both TatA and TatB are single-span transmembrane proteins that pos-
sess: a short periplasmic N-terminal region; single-span transmembrane helix; hinge re-
gion; amphipathic helix lying along the cytoplasm-membrane interface and a highly
charged, unstructured C-terminus. In contrast, TatC is a polytopic protein that is predicted
to contain 6 transmembrane spans, with both the N- and C- termini in the cytoplasm. In
E. coli a TatA paralog exists, TatE, which is encoded elsewhere in the genome.basis of data that suggest the N-terminal region of TatA can also be
accessed from the cytoplasm [32]. Moreover, there is evidence of
soluble TatA in bacteria and chloroplasts [33–39]; however the
functional relevance of this soluble TatA pool remains controversial.
TatB consists of 171 amino acids with a molecular mass of 18.5 kDa.
Despite sharing a 20% sequence similarity with TatA [40] and a very
similar predicted secondary structure (Fig. 2), TatB and TatA carry out
functionally distinct roles within the Tat translocase [41].
TatC consists of 258 amino acids with a molecular mass of 28.9 kDa.
As predicted by its secondary structure, this protein traverses the
membrane 6 times, possessing an N-in C-in topology [42]. The tatABC
gene products form two distinct membrane complexes at steady state:
a TatBC-containing substrate binding complex and a separate TatA
complex. It is in this former 370 kDa Tat(A)BC complex where most of
TatB and -C are found at a 1:1 stoichiometric ratio [43]. TatA (found at
~ 25 and 50 fold higher concentrations than TatB and TatC, respectively
[44]), is present as highly heterogeneous complexes ranging from
100–500 kDa [43,45,46] and is not required for TatBC complex assembly
[47].
The composition of the Tat system differs signiﬁcantly in most
Gram-positive bacteria; all except Streptomycetes contain only tatAC
genes [48,49]. In those examples studied to date, the TatA protein is
bifunctional [50]. The best characterised Tat system in this type of
bacteria is found in B. subtilis — a non-pathogenic soil bacterium,
which contains two discrete Tat systems that operate in parallel, yet
possess different substrate speciﬁcities [48]. The ﬁrst of the two is
TatAdCd, whose only substrate identiﬁed at present is the phosphodies-
terase, PhoD [49]. The second translocase is TatAyCy, which exports
YwbN, an iron-dependent DyP-peroxidase [49]. There is a third tatA
gene encoding the TatAc protein, which like TatAd, was recently
shown to form small homogeneous complexes and restore export of
TorA in a ΔAEmutant [51].
Reminiscent of the situation in E. coli, the TatAyCy system is com-
posed of two types of membrane protein complexes: TatAyCy and
TatAy that have been reported to form ~200 kDa complexes (as judged
by gel ﬁltration chromatography) [37,52]. Likewise, TatAdCd exists as a
~230 kDa complex, alongside a separate and discrete TatAd complex of
~160 kDa[50,53]. The TatAd and TatAy proteins are bifunctional fulﬁll-
ing the role of the TatB protein that would otherwise be present in
Gram-negative bacteria [50,54].
In addition to these bacterial TatAC-containing complexes being
smaller than their E. coli counterparts (TatABC is ~370 kDa on BN gels
[43,45,55]), the lack of a tatB gene and TatA heterogeneity appear to
be conserved features of Gram-positive bacteria. This is an important
point because the remarkable heterogeneity of E. coli TatA complexes
has been considered to be a key element of current translocationmodels
(see below)[53].
Finally, E. coli also possesses a TatA paralogue, TatE. This 67 amino
acid protein possesses 57% sequence identity to TatA [25] and is thought
to have arisen from a gene duplication of tatA [56]. Whilst it can fulﬁl
TatA activity if overexpressed [41], there is no evidence for a speciﬁc
role for this protein, and indeed many Gram-negative bacteria lack a
tatE gene [46,57].
Fig. 3. The topology of TatC within the cytoplasmic membrane +/− the presence of TatB
and precursor protein. A. Shows the N-in C-in arrangement of the multi-spanning TatC
proteinwithin the cytoplasmicmembrane. B. Shows how the TatBC complexmay arrange
itselfwithin the cytoplasmicmembraneupon precursor binding. Critical interactions iden-
tiﬁed from cross linking studies are starred. TatBmakes three vital contacts to TatC. Name-
ly: to TMH 5 of TatC (blue) and its second periplasmic loop (green/yellow). TatB (pink)
could be accommodated within the groove of TatC which was shown to exist from recent
crystallisation data (§3.2.1). The ﬁrst periplasmic loop (red/orange) fails to make contact
with TatB, yet is in close proximity to a neighbouring TatC; lending to the idea that this
loop is implicated in self-assembly andmaintaining the stability of the TatBC complex. Re-
cent data allude to a hairpin-like insertion of the precursor signal peptide (shown in
black). The signal peptide makes vital contacts to the extreme N-terminus of TatC and
its ﬁrst cytoplasmic loop (orange/yellow).
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3.2.1. Structural characterisation of the TatBC complex
Early cross-linking studies conducted in chloroplasts demonstrated
that a Tat-dependent substrate could be cross-linked to the Hcf106-
cpTatC complex (equivalent to TatBC in bacteria) [58], demonstrating
that this is the initial receptor for the Tat pathway. Similar binding
characteristics were observed for the TatBC complex of E. coli [59]. In
both instances full translocation was prevented by the absence of a
PMF, and these studies represent good evidence that the TatBC complex
does indeed carryout the binding of a substrate [58]. These complexes
were initially shown to be large (370–500 kDa), multi-subunit entities
using Blue Native Polyacrylamide Gel Electrophoresis [43,46,60].
Electron microscopy characterisation of the TatBC complex present-
ed a hemispherical complex ranging from 11–17 nm in diameter [60]. It
was inferred by Tarry et al. that the size of the complex is large enough
to accommodate 7 copies of TatB and TatC in equimolar ratio [43,60].
The central cavity within the hemisphere was not large enough to
accommodate the substrate; although it was shown to expand upon
substrate binding [60]. The functional role of this cavity is not clearly
understood, however it is predicted to be implicated in signal peptide
insertion once the precursor protein has been recognised by Tat
[61,62]. The substrate itself is shown to bind to the periphery of the
TatBC complex with a maximum of two substrates bound per complex,
which possibly indicates a negatively cooperative binding event. In this
review we have presented a feasible assembly for the TatBC complex,
using the structure of TatC recently resolved by Ramasamy et al. [63].
In this hypothetical assembly, the substrate binding would have a
knock on effect on the adjacent TatC monomers by “closing off” binding
sites to neighbouring TatC proteins. The second substrate bindingwould
therefore be most favourable on the opposite side of the complex, sim-
ilar to that observed by Tarry et al. [60].
Recent structural characterisation of the individual TatC components
has hugely contributed to the understanding of its functional role. TatC
is the largest and most conserved component of the Tat machinery in
both bacteria and chloroplasts [54]. It plays a central role in the translo-
cation event, ranging from substrate recognition and binding, to the re-
cruitment of other Tat components [36]. The predicted topology
of TatC shows the protein to form 6 transmembrane helices with the
N- and C-termini residing in the cytoplasm (Fig. 3) [64]. Recent 3D
crystallisation studies on TatC from Aquifex aeolicus present a “glove-
like structure” [63,65], where TatC appeared to assemble into a concave
structure as a result of transmembrane helix (TMH) TMH5 and TMH6
being shorter in length relative to the remaining helices (Fig. 3)[65].
Data showing that TMH5 could interact with the TMH of TatB suggests
that a functional role for the “groove” of TatC is possible: it could accom-
modate a single TatB protein- or at least in part (Fig. 3B). Additionally,
the interaction of TatC's periplasmic loops with TMHs of neighbouring
TatC proteins, suggests they most likely possess a role of maintaining
the stability of the complex (Fig. 3)[65].
The residues that line the groove of this glove-like structure are pre-
dominantly aromaticwith the potential to bind the lysine on the amphi-
pathic helix of the signal peptide [63]. This characteristic shape and
residue environment may imply a possible site for signal peptide inser-
tion into the bilayer [61]. In compliment, mutation within the N termi-
nus of TMH1 and the ﬁrst cytoplasmic loop are involved in substrate
binding. Compilation of these studies and recent studies suggest the
substrate is bound inside the TatC protein with the linker region
forming a hairpin around TMH4 of TatC. The possible association of
the TatBC unit with the substrate bound is shown in Fig. 4.
3.2.2. Recent mechanistic studies on the TatBC complex
It has been well documented that the Tat substrate-binding site in
E. coli consists of a hetero-oligomeric complex of TatB and TatC
(Hcf106 and cpTatC in the thylakoid Tat system). Whilst it is known
that the Tat-dependent precursor binds to this complex for subsequenttranslocation into the periplasm/thylakoid lumen, the precise details of
this interaction have only started coming to light in recent years. This
information is vital for elucidating the most ambiguous topic of this
translocase — its mechanism of translocation.
TatC is known to be the primary site of interaction between a Tat RR-
precursor protein and the substrate-binding complex [59,60,62,66–71].
Site speciﬁc cross-linking has elucidated that RR-precursors make con-
tact to the cytosolically exposed extreme N-terminus and ﬁrst cytosolic
loop of TatC (Fig. 3B) [72]. This data is in agreementwith results demon-
strating that the signal sequences of membrane-bound Tat substrates
are still accessible to proteases and can be detached by disrupting elec-
trostatic interactions [73,74].
To gain further insight into this interaction between TatC and RR-
precursor proteins, a random mutagenesis study was performed with
the aim of identifying regions within TatC that are essential for protein
transport [75]. Mirroring the results mentioned previously, conserved
residues of TatC that are essential for its activity were identiﬁed in its
Fig. 4. Cytoplasmic-view of a Tat RR-precursor protein binding to the TatBC substrate-
binding complex. This schematic amalgamates available structural and cross-linking
data on the TatBC complex to hypothesise how TatB and TatC could arrange themselves
in the cytoplasmic membrane upon precursor binding. We hypothesise that for Tat pre-
cursors to bind an individual binding site, whilst the complex still accommodates 7 copies
of TatBC in equimolar ratio, the TatBC complex could arrange itself as shown. Not only
would this satisfy the aforementioned cross-linking data, an arrangement such as this
would be in agreement with EM data of SufI-bound TatBC; in that the Tat precursor
would bind to the periphery of the TatBC complex. It is plausible that precursor binding
to the shown position could alter the accessibility of neighbouring binding sites and there-
fore result in the Tat translocase exhibiting negative cooperativity.
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inactivating mutations localised in the ﬁrst two periplasmic loops of
TatC (P1 and P2). Whilst additional insertion and deletion analysis sup-
ported the idea that these regions are essential for transport, it remains
unclear as towhat roles theymay fulﬁl. Inactivatingmutations in P1 and
P2 did not affect insertion of TatC into the membrane or make it unsta-
ble, nor did they inhibit the formation of TatBC substrate-binding com-
plexes. More speciﬁcally, the P1 loop fails tomake contactwith TatB, yet
is in close proximity to a neighbouring TatC (Fig. 3B) [75]. The P2 loop
makes contact with neighbouring TatC [42], TatB and TatA [72]. Zoufaly
et al. [72] inferred that the P2 loop of TatCmay be involved inmaintain-
ing the stability and functional interaction between TatB and TatC, since
a P142S substitution mutation in this region suppressed the defective
transport of a mutant KK-precursor protein [76]. Mutational studies
on the TatC protein in chloroplasts revealed the functional signiﬁcance
of the stromal loops, where the 1st and 2nd loops are involved in self-
assembly as well as interaction with other Tat components [77].
Despite it being well documented that TatB and TatC form a stable,
substrate-binding complex, there is a deﬁciency of molecular details
on speciﬁc sites of contact between the two proteins and the precursor
protein. In the aforementioned study [75], in addition to the N-terminal
region of TatC making contact with the RR-signal peptide, cross-linking
analysis also revealed that this region comes into close contact with
TatB; reinforcing the molecular neighbourhood of these two proteins
[75]. In light of the data showing that TatB possesses the capability to di-
rectly interact with RR signal peptides [59,68,70,71,78], including resi-
dues ﬂanking the RR-pair [59,68], it is suggested that TatB functionally
cooperates with TatC by forming part of the signal binding pocket [72].Lausberg et al. found evidence for a tight cooperation of TatB and
TatC during recognition of Tat signal peptides. To analyse which regions
are involved in the substrate binding event, this study searched for sup-
pressor TatB or TatC mutants that successfully supressed the transloca-
tion defect of mutant precursor TorA(D2+)-MalE [79]. Three mutations
were found (TatC K18E, TatB L9P and TatB L9Q) which each displayed
clear synergies with a L9F mutation of TatC i.e. restored export of
TorA(D2+)-MalE; adding strong genetic evidence for a tight coopera-
tion of TatB and TatC during signal peptide recognition, and for the par-
ticipation of both components in the formation of a speciﬁc signal
peptide binding site [79].
According to the topology model of TatB, position 9 is located at the
periplasmic-oriented end of the TatB TMH. Such a location reﬂects one
of two situations. Either the effects of these mutations are long-range
conformational ones in that they are transmitted via the TMH of TatB
to a binding pocket located on the cytoplasmic face of the TatBC recep-
tor complex. Or, they could affect precursor binding at a stage when the
signal peptide and the early mature part of the precursor had been
transferred to an advanced-stage binding site that would reach out as
far as the periplasmic end of the TMH of TatB.
Beyond recognition of the RR-precursor, it has remained question-
able as to which component of the TatBC substrate-binding complex
mediates the transmembrane insertion of the RR-signal peptide; com-
mencing translocation of the protein. Frobel et al. showed that despite
a lack of TatB, the signal sequence of translocation-incompetent sub-
strates was removed, in addition to the premature cleavage of the signal
sequence from a substrate capable of translocation [80]. This lends itself
to the idea thatwhen a precursor protein interactswith TatB, it prevents
the premature cleavage of the signal peptide; revealing a potential
insertase activity of TatC in addition to further evidence for the concert-
ed activity of TatB and TatC in recognising Tat substrates.
Although it is well established that TatB is part of the substrate bind-
ing site, its precise function in the substrate-binding process has
remained elusive. Maurer et al. demonstrated that upon precursors
being targeted to the cytoplasmicmembrane via their RR-motif they be-
come surrounded by TatB and make contact to its TMH and APH [62].
This interaction is then lost upon translocation, lending itself to the
idea that the close vicinity of TatB and precursor is an intermediate
binding step that occurs prior to translocation [62]. This same study
found homooligomeric complexes of TatB, containing potentially 2 or
3 TatB monomers, bound to a single precursor molecule. Dimerisation
of TatB has previously been demonstrated [81], and this suggests that
TatB may assemble into an oligomeric binding site that is capable of
transiently accommodating large parts of the folded precursor protein
[62]. A model of TatB-precursor protein interaction is speculated in
Maurer et al., which is in line with a hairpin-like insertion of Tat signal
peptides [62].
In recent years there has been frequentmention of a hairpin-like in-
sertion of Tat-dependent signal sequences into the cytoplasmic and thy-
lakoid membrane (Fig. 3B). It is proposed that once the RR-signal
sequence is recognised by the TatBC substrate-binding complex, it is
threaded deep into the receptor complex reaching out as far as the peri-
plasmic end of the TatB TMH; resulting in the formation of a hairpin
loop topology of the signal peptide and early mature region of the pre-
cursor protein. This hypothesis is experimentally supported by numer-
ous studies. In E. coli, the N-terminus of TatB was found to cross-link to
precursors TorA and SufI prior to translocation completion [62]. For the
same region of TatB, suppressor mutations were found to compensate
the translocation defect of mutant TorA precursors [70,79]. Finally,
translocation can progress to completion despite the N-terminus of an
RR signal peptide being covalently bound to TatC in thylakoids [68].
Until recently there had been a lack of information regarding the
precise logistics of substrate binding. A recent study by Ma and Cline
gained insight into the topology of bound precursors [82]. They found
that Cys residues inserted into the signal peptide failed to produce di-
mers, proposing that each signal peptide is bound to an individual
1624 R. Patel et al. / Biochimica et Biophysica Acta 1843 (2014) 1620–1628binding site (Fig. 4). It was also identiﬁed that the Tat substrate binding
complex has the capability of bindingmore than one precursor protein.
More interestingly, they identiﬁed that cross-linked dimer and tetramer
were readily transported into the lumen without breaking the linkage,
concluding that multiple occupied receptor units operate coordinately
to transport the oligomer [82].
A later study conducted by Celedon and Cline performed binding
analyses on both intact membranes and puriﬁed thylakoid Tat com-
plexes in an attempt to further elucidate the stoichiometry of binding
to this complex [83]. Their results verymuchmirrored that of the afore-
mentioned study in that they found the Tat complex bound multiple
precursor proteins [82]. More speciﬁcally, each Tat substrate-binding
complex had the capability of binding 8 precursor proteins that were
each independently functional for transport. With sufﬁcient Tha4, all
sites were active for simultaneous transport [83]. Despite evidence for
simultaneous transport of Tat substrates occurring [82], it is not certain
whether this occurs for all Tat substrates; perhaps each site has the
same probability of undertaking translocation [83].
On a different note, it still remains to be determined whether this
protein transport system displays any form of cooperativity during sub-
strate binding i.e. does Tat's afﬁnity for its RR-precursor proteins alter
upon a substrate already having bound the translocase? In agreement
with Cline et al., Celedon and Cline found no evidence of cooperativity
when examining the binding step [83,84]. However, Tarry et al. inferred
that Tat displayed a negative cooperativity for the E. coli Tat system in
light of evidence that TatBC complexes possessed only one or two
bound precursors [60]. Again in contrast, Alder and Theg described a
positive cooperativity for the translocation of a Tat precursor. This
study kinetically characterised cpTat-mediated protein translocation,
where the protein transport displayed a sigmoidal rate-substrate rela-
tionship; indicating allosteric proteins. The measured Hill coefﬁcient
of 1.8 was postulated to result from 2 binding sites per translocation
with strong cooperativity. However, it could not be determined wheth-
er such characteristics were exhibited at the binding or translocation
step [85]. Clearlymore research needs to be employed in this area to ab-
solutely identify which form of cooperativity is displayed during
substrate-binding to the Tat translocase.
Once the precursor protein has been recognised by and subsequently
bound to TatBC, it is still unclear as to how the Tat-dependent substrate
traverses the membrane. A real-time FRET experiment analysed the ki-
netics of precursor interactions with the Tat translocase [86]. Results
showed that once the membrane becomes energised there is a delay in
cargo migration away from the binding site; suggesting that the Δ is
not directly responsible for promoting migration of the Tat precursor
across the membrane [86]. Moreover, it was found that TatA increases
the afﬁnity of the TatBC receptor complex for the precursor in the pres-
ence of amembrane potential [86]. These data are in agreementwith the
hypothesis that TatBC andTatA oligomerisation occurs in thepresence of
a Δ with or without the cargo. It is plausible that this oligomerisation
process is responsible for the lag phase observed. The subsequent loss
of FRET signal after such phase is rapid, signifying that migration of the
mature domain from TatABC is fairly quick post-oligomerisation [86].
Despite this, it still remains unclear whether the mature domain of the
Tat-dependent protein proceeds directly across the membrane after
oligomerisation of TatABC orwhether there is an additional kinetic inter-
mediate e.g. the protein residing within a pore [86].
Whilst a wealth of information regarding substrate binding focuses
on the TatBC complex, there is evidence for the involvement of TatA
during the early stages of translocation. Since E. coli TatBC complexes
contain TatA when puriﬁed [46,87], it is unsurprising that Frobel et al.
reported TatA to be an early interacting partner of the TatBC receptor
complex [88]. The ﬁnding that cross-links between TatA and Tat-
dependent precursors were not obtained in the absence of TatBC, not
only highlights the intramembrane proximity of TatBC and TatA, but
also strongly suggests that a functional hierarchy exists between Tat
precursors and Tat subunits i.e. the interaction with TatA requires thatthe precursor has already been recognised by the TatBC substrate bind-
ing complex [88]. Moreover, the precursor contacts to TatA were sensi-
tive to the dissipation of the PMF. Hence, this interactionwith TatA does
not directly correspond with the precursor binding to the TatBC but in-
stead represents a subsequent targeting event that is dependent on the
presence of a PMF [88].
More speciﬁcally, the RR-precursorsmade contact to theN-proximal
region of the TMH of TatA. Considering data that showed the precursor
protein to make contact with the N-terminal region of TatB [62], a pos-
sible explanation for this interaction would be the deep insertion of a
Tat signal sequence prior to translocation. Furthermore, once a TatA
monomer is recruited to the TatBC receptor, it is possible it could
serve as a ‘nucleation point’ for the subsequent recruitment of addition-
al TatA to form the active translocase [88]. This is supported by the ﬁnd-
ing that oligomerisation of Tha4 (the thylakoid TatA homolog) occurred
upon binding of a Tat signal peptide [89].
3.3. The TatA complex
Vital to elucidating the mechanism of the twin arginine translocase
is gaining structural insight into the individual Tat components. TatA
is one such component, which through oligomerisation with other
TatA protomers has been predicted to form the ‘pore’ of this translocase
in the cytoplasmic membrane, permitting the passage of fully-folded
proteins into the periplasm.
Whilst electron microscopy structures of TatA showed ring-like
complexes, there is a lack of detail on the arrangement of TatA oligo-
mers within this ring. Nor is there any information on how TatA facili-
tates the transport of fully-folded proteins with such an arrangement
[90]. Through the use of solution NMR, Rodriguez at al. generated a
model for the TatA oligomer, which was subsequently utilised to pro-
pose a structure of the oligomeric complex [91]. Combination of these
structures with molecular dynamic simulations permitted predictions
as to how TatA might mediate the translocation of Tat-dependent pre-
cursors across the membrane.
The precise oligomeric state of TatA varies in cell membranes and
detergent micelles [60,90,92,93]. The interfacial contacts obtained be-
tween TatA TMHs and dodecylphosphocholine (DPC) micelles in
Rodriguez et al. are consistent with previous EPR studies of TatA in
C12E9 [27]. For the 9-mer repeat of a TatA oligomer, the crossing angle
of each subunit's TMH is 4.2°, meaning there is a narrow contact surface
whereby large increase in subunit numbers results in small changes in
intersubunit contacts. However, the APH extend out from the pore
axis meaning that the varying subunit number in this instance would
avoid APHs making contact. These components of TatA may provide
an upper limit to oligomer size in light of the fact that inter-APH dis-
tances decrease upon the addition of subunits.
On a different note, TatA proteins possess a conserved polar residue
at the N-terminal end of the TMH [40]. Through molecular dynamics
conducted in this study it is postulated that when TatA oligomerises,
this residue resides in the centre of a TatA pore and is water accessible
[94]. The position of this residue results in a pore that is only hydropho-
bic for 3 turns of the TMH; approximately half that of a typical mem-
brane bilayer [94]. Further simulations indicated that this pore can
house lipids, but they are distorted relative to those in the surrounding
membrane. It is predicted that these lipids could provide an energetic
barrier to the loss of protons during transport [94]. This thinned and
distorted membrane within the pore of a TatA oligomer would provide
a clear pathway for the translocation of the substrate protein, giving a
reasonable explanation for how substrates traverse the cytoplasmic
membrane through the pore of TatA.
Additionally, when TatA oligomerises during translocation, it must
reorient in the cytoplasmic membrane to generate the 4.2° shallow
crossing angles for TMH packing. Such movement would result in the
entire APH of TatA lying along the surface of the membrane, which is
in agreement with data that found changes in accessibility of Tha4
Fig. 5.Mechanism of Tat translocation. A substrate bearing a twin-arginine signal peptide
is recognised by the TatBC complex in a resting membrane. The ﬁgure shows two pro-
posed models for the subsequent translocation event involving the TatA complex. A.
Trap-door model: the amphipathic helix (APH) of the TatA protein has dual topology. In
a resting membrane the APH lies along the cytoplasmic face, to form a one-sided lid com-
plex. Upon substrate recognition the APH ﬂips into the bilayer, providing a tightly regulat-
ed pore for the translocation of the substrate in the presence of a membrane potential. B.
Membrane-weakening model: The APH of TatA in the resting state aligns parallel to the
cytoplasmic membrane. The recognition of a substrate induces a topological change in
the APH so that it partially perturbs the lipid bilayer, leading to the de-stabilisation of
the lipid bilayer. Subsequently, this permits the translocation of the substrate in a less reg-
ulated manner.
1625R. Patel et al. / Biochimica et Biophysica Acta 1843 (2014) 1620–1628APH upon substrate binding [95]. This relocalisation would pull the
TMH of TatA into the cytoplasmic leaﬂet of the membrane, reducing
the length of the TMH. Further shortening occurs due to the presence
of a conserved polar residue at position 8 in the N-terminal region of
the TMH.As a consequence, a hydrophobicmismatch is generatedwith-
in the membrane bilayer resulting in its thinning and lipid disordering
within the pore of TatA. Therefore, to add to the model of translocation
for Tat, this study suggests that a bound substrate is located over a
thinned and disordered patch of membrane that is susceptible to rup-
ture [94].
To continue the theme of subunit organisation of TatA within the
lipid bilayer, a site-directed spin labelling study shed light on how the
TMHs of TatA are arranged in the membrane [27]. As already men-
tioned, single-molecule electron microscopy of detergent-solubilised
TatA has shown TatA to exist as ring-shaped structures with variable di-
ameters [90]. The largest of these complexes contained cavities that
could accommodate large, folded Tat substrates, leading to models
that proposed TatA complexes to provide the translocation pore in the
assembling translocase. With the assumption that the TatA ring has a
transmembrane orientation, it is likely that the TMH of TatA forms part
of the ring wall. However, the extent to which the APH and C-terminal
tail of TatA contribute to this wall structure as opposed to the cap
is unclear. It also remains unknown as to how the TMH of this Tat
component may pack together to form rings of variable diameter, nor
do we know which residues within the TMH lie at the inter-helical
binding surfaces [27].
White et al. hypothesise that the TMH of TatA are positioned side-
by-side during pore formation. Their EPR study detected interactions
between Ile112 on one side of each TMH and Val14 on the other, sug-
gesting a Ille112-Val14 arrangement of helices for TatA during pore for-
mation [27]. Of course, other regions of TatA could be positioned within
the ring or on either side of the wall of TMHs.
However, the exact nature and functionality of TatA-type complexes
was made more confusing by recent structural studies that showed the
TatE component of E. coli, which can functionally substitute for TatA, to
form complexes that are much smaller and more homogeneous than
TatA complexes [93]. More speciﬁcally, the solubilised TatE forms
ring-shaped complexes of 6–8 nm in diameter that are much too
small to accommodate the larger Tat substrates like TorA that is 90
kDa. The small size of TatE complexes would appear to preclude this
protein from possessing a pore-forming role, suggesting another mech-
anism of Tat translocation whereby TatABC contributes the bulk of the
translocation channel and TatA/E activates it [93]. This is supported by
data illustrating that the thylakoidal TatC is actively involved in the
translocation event as opposed to solely being the primary binding
site for the substrate protein [68].
Another possibility is that multiple TatA or TatE complexes bind to
the TatABC complex once the substrate has bound, with ﬂexibility in
pore size arising from different number of TatA/E protomers [93]. This
model is supported by the identiﬁcation of multi-ringed structures of
TatE i.e. modular interaction of smaller rings to produce a larger
super-structure [93]. In agreement with the inferences from TatE elec-
tron microscopy data, ultrastructural characterisation of TatAd com-
plexes from B. subtilis suggests that these too are smaller and more
homogeneous than E. coli TatA complexes, with no indication of a pore
that would be large enough to translocate large fully-folded Tat sub-
strates. In this study, it was shown that TatAd, which can also substitute
for TatA, forms a ring-shaped structure of ~7.5–9 nm in diameter,
possessing a potential cavity or pore of 2.5–3 nm that is occluded at
one end by a lid-like structure [51]. The authors speculate that this lid
structure is comprised of the APH and C-terminal tails of TatAd since
these are the most ﬂexible regions of the protein. It is predicted that
this lid serves to seal the translocation channel, maintaining the integri-
ty of the membrane.
As for TatE, the small size of the pore has major implications on the
mechanism of translocation and supports the above model of thecoalescence of relatively homogeneous Tat(A)BC and multiple TatA or
TatE complexes. It also questions the functional relevance of TatA het-
erogeneity in E. coli. Simply put, additional functional studies are re-
quired to understand the nature and role of TatA-type complexes with
respect to the overall Tat mechanism.4. Mechanism of translocation — summary and emerging ideas
There appears to be a general agreement that the substrate binds ini-
tially to TatBC (Hcf106-cpTatC in thylakoids), and this binding is inde-
pendent of other Tat components [58]. Once the precursor is bound to
the substrate-binding TatBC complex, the TatA complex associates
with the TatBC complex in the presence of a ΔpH [66]. It is likely that
the initial binding of the substrate requires only TatB and TatC, while
the TatA is recruited once substrate binding has occurred. It is at this
point that uncertainty starts in earnest: the active translocon has
never been ‘captured’ in any sense apart from cross-linking studies
and our understanding of the core translocation event is accordingly
vague, but the recent structural data have led to plausible models for
the mechanism of translocation (Fig. 5): the translocation pore model
and the membrane destabilisation model [96].
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The “trapdoor mechanism” is based on the hypothesis that the to-
pology of TatA has the ability of to ﬂip its amphipathic helix (APH) do-
main into the membrane from its resting position along the
cytoplasmic face of the membrane [97]. In E. coli, TatA is a highly abun-
dant protein relative to TatB and TatC and its ability to form complexes
of variable size suggested a possible role as translocation pore [46,98].
The idea of a “Trap door” gained prominencewith the ﬁrst 3Dmodel
of the TatA complex constructed by single particle electron microscopy.
This study showed twomain points: the presence of a cupped pore-like
structure was generated and the presence of a range of complex sizes
[46,90,99].
In a more recent study, Walther et al. explored the concept of a
“Charge Zipper mechanism”, portraying a simulated model where
the C-terminus region of TatA permits a hairpin fold between the
C-terminus and APH using complementary charge interactions [100].
This theoretical work is more inclined to the pore-forming model
where the APH C-terminus hairpin ﬂips into the membrane, to provide
an internal hydrophilic coating of the pore.
In addition, the substrate itself has been shown to carry a motif
which is capable of interacting with TatA [62]. This study suggests the
binding conformation between the substrate and TatA iswhat is expect-
ed if TatA was to surround the substrate as if it were a pore. This sug-
gests that TatA may be interacting with the substrate which then
leads to a seeding of monomeric TatA to form a pore. In a recent review
this substrate interaction and seeding process of TatA is interpreted as
mode of pore formation using the PMF [61].
4.2. Membrane weakening model
The concept of membrane weakening was ﬁrst presented by Bruser
and Sanders, who hypothesised that TatA's role is not to form a pore but
instead aggregate in an unordered manner, which would result in the
formation of Tat complexes large enough to destabilise the membrane
[101]. One reason for proposing an alternative mechanism is due to
the relatively low abundance of Tha4 (TatA ortholog) found in the
membrane of chloroplast, as opposed to the excessive level detected
in E. coli. As a result, making it more difﬁcult for Tha4 to bind to sub-
strate and rapidly form a membrane-inserting structure round it.
As structural data on the Tat components has mounted over the re-
cent years, this mode of transport is now considered more feasible.
Walther et al. resolved the structure of TatAd usingNMR,where the am-
phipathic helix was shown to partially incorporate into the membrane
bilayer during a conformational change [31]. In contrast to the other-
wise predicted ﬂip topology in the pore model, these NMR studies sug-
gest that the topology of TatA may not be as ﬂexible during the
conformation change as initially anticipated [31,97,102]. The swing of
the APH from the cytoplasmic face into the bilayer would imply a
‘lipid disrupting property’ [31].
Another structural characterisation of the TatAd complex performed
3D reconstruction using single particle electron microscopy. Mirroring
the results of Gohlke et al., this study also identiﬁed the one-sided lid
structure in TatA [90]. However, the structural characterisation of this
TatAd pore, suggests it may not be able to accommodate substrate
[103]. This implies that the pore-like structure assembled from TatA
may not actually function as a pore and instead function in membrane
destabilisation or active translocon stabilisation after it has been recruit-
ed to the substrate-bound complex [104].
Whenmembrane destabilisation is considered as a possible mode of
mechanism it must be emphasised that the speciﬁcity of substrate
transport is also compromised. Therefore for this mechanism to func-
tion correctly there must be a maintenance system in place to counter-
act the destabilisation and prevent leakage of ions. It was proposed that
this ismediated by a phage shock protein PspA in E. coli and its homolog
VIPPI in chloroplasts [105,106]. From the evidence of phylogeneticconservation and ability of TatA to interact with PspA, this method of
membrane stabilisation during export could conceivably be a core ele-
ment of this proposed membrane weakening model [107].
In summary, we are still a long way from understanding Tat. Struc-
tural advances have helped a great deal, but the transient nature of the
elusive ‘super-complex’ has presented a huge barrier to more rapid
progress. Studies on other protein translocases were revolutionised by
experimental tricks to trap substrates within the translocation channel.
Unfortunately, the Tat system has resolutely refused to play this game
and substrates are either rapidly translocated or completely rejected.
Nevertheless, real advances have been made in the last few years and
some of the most essential pieces of the jigsaw are coming into place.
Further efforts in this direction may enable us to catch this remarkable
system in ﬂagrante and understand its unique mechanism.
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